UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

Form 10-Q
(Mark one)
þ
QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the Quarterly Period Ended September 30, 2017
or
o
Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
For the Transition Period from                      to                      .
Commission File Number 1-15202

W. R. BERKLEY CORPORATION
(Exact name of registrant as specified in its charter)
Delaware
 
22-1867895
(State or other jurisdiction of
 
(I.R.S. Employer
incorporation or organization)
 
Identification No.)
 
 
 
475 Steamboat Road, Greenwich, Connecticut
 
06830
(Address of principal executive offices)
 
(Zip Code)
 
(203) 629-3000
 
 
(Registrant’s telephone number, including area code)
 
 
 
 
 
None
 
Former name, former address and former fiscal year, if changed since last report .
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes þ      No o
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes þ      No o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer þ
Accelerated filer o
Non-accelerated filer o
Smaller reporting company o
 
 
(Do not check if a smaller reporting company)
Emerging growth company o
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o      No þ
Number of shares of common stock, $.20 par value, outstanding as of November 6, 2017 : 121,794,758
 




TABLE OF CONTENTS
 
 
 
 
 
 
 
 
EX-10.1
EX-31.1
EX-31.2
EX-32.1
EX-101 INSTANCE DOCUMENT
EX-101 SCHEMA DOCUMENT
EX-101 CALCULATION LINKBASE DOCUMENT
EX-101 LABELS LINKBASE DOCUMENT
EX-101 PRESENTATION LINKBASE DOCUMENT
EX-101 DEFINITION LINKBASE DOCUMENT




Part I — FINANCIAL INFORMATION
Item 1.
Financial Statements
W. R. BERKLEY CORPORATION AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
(In thousands, except share data)
 
September 30,
2017
 
December 31,
2016
 
(Unaudited)
 
(Audited)
Assets
 
 
 
Investments:
 
 
 
Fixed maturity securities
$
13,873,690

 
$
13,190,668

Investment funds
1,119,907

 
1,198,146

Real estate
1,391,274

 
1,184,981

Arbitrage trading account
488,238

 
299,999

Equity securities available for sale

614,025

 
669,200

Loans receivable
74,229

 
106,798

Total investments
17,561,363

 
16,649,792

Cash and cash equivalents
773,997

 
795,285

Premiums and fees receivable
1,818,836

 
1,701,854

Due from reinsurers
1,739,835

 
1,743,980

Deferred policy acquisition costs
534,091

 
537,890

Prepaid reinsurance premiums
473,766

 
413,140

Trading account receivables from brokers and clearing organizations
297,208

 
484,593

Property, furniture and equipment
399,924

 
349,432

Goodwill
173,422

 
144,513

Accrued investment income
139,864

 
127,047

Other assets
423,770

 
402,550

Total assets
$
24,336,076

 
$
23,350,076

 
 
 
 
Liabilities and Equity
 
 
 
Liabilities:
 
 
 
Reserves for losses and loss expenses
$
11,654,346

 
$
11,197,195

Unearned premiums
3,409,628

 
3,283,300

Due to reinsurers
228,539

 
213,128

Trading account securities sold but not yet purchased
44,937

 
51,179

Federal and foreign income taxes
116,608

 
119,597

Other liabilities
923,369

 
916,318

Senior notes and other debt
1,759,929

 
1,760,595

Subordinated debentures
728,071

 
727,630

Total liabilities
18,865,427

 
18,268,942

Equity:
 
 
 
Preferred stock, par value $.10 per share:
 
 
 
Authorized 5,000,000 shares; issued and outstanding - none

 

Common stock, par value $.20 per share:
 
 
 
Authorized 500,000,000 shares, issued and outstanding, net of treasury shares, 121,769,109 and 121,193,599 shares, respectively
47,024

 
47,024

Additional paid-in capital
1,040,575

 
1,037,446

Retained earnings
6,880,062

 
6,595,987

Accumulated other comprehensive income
153,759

 
55,568

Treasury stock, at cost, 113,348,809 and 113,924,319 shares, respectively
(2,690,884
)
 
(2,688,817
)
Total stockholders’ equity
5,430,536

 
5,047,208

Noncontrolling interests
40,113

 
33,926

Total equity
5,470,649

 
5,081,134

Total liabilities and equity
$
24,336,076

 
$
23,350,076


See accompanying notes to interim consolidated financial statements.

1




W. R. BERKLEY CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED)
(In thousands, except per share data)

 
For the Three Months
 
For the Nine Months
 
Ended September 30,
 
Ended September 30,
 
2017
 
2016
 
2017
 
2016
REVENUES:
 
 
 
 
 
 
 
Net premiums written
$
1,571,183

 
$
1,607,365

 
$
4,782,272

 
$
4,913,656

Change in net unearned premiums
10,317

 
(21,421
)
 
(62,028
)
 
(240,584
)
Net premiums earned
1,581,500

 
1,585,944

 
4,720,244

 
4,673,072

Net investment income
142,479

 
145,668

 
426,601

 
404,850

Net realized investment gains
183,959

 
175,738

 
276,760

 
207,508

Other-than-temporary impairments

 

 

 
(18,114
)
Revenues from non-insurance businesses
89,786

 
80,242

 
225,033

 
305,787

Insurance service fees
33,612

 
32,135

 
100,475

 
109,437

Other income
6

 

 
695

 

Total revenues
2,031,342

 
2,019,727

 
5,749,808

 
5,682,540

OPERATING COSTS AND EXPENSES:
 
 
 
 
 
 
 
Losses and loss expenses
1,081,174

 
965,856

 
3,025,475

 
2,852,339

Other operating costs and expenses
600,822

 
606,348

 
1,821,155

 
1,770,450

Expenses from non-insurance businesses
86,412

 
78,865

 
221,389

 
291,127

Interest expense
36,821

 
37,043

 
110,419

 
104,019

Total operating costs and expenses
1,805,229

 
1,688,112

 
5,178,438

 
5,017,935

Income before income taxes
226,113

 
331,615

 
571,370

 
664,605

Income tax expense
(63,295
)
 
(110,952
)
 
(174,305
)
 
(214,789
)
Net income before noncontrolling interests
162,818

 
220,663

 
397,065

 
449,816

Noncontrolling interests
(764
)
 
(13
)
 
(2,560
)
 
(689
)
Net income to common stockholders
$
162,054

 
$
220,650

 
$
394,505

 
$
449,127

 
 
 
 
 
 
 
 
NET INCOME PER SHARE:
 
 
 
 
 
 
 
Basic
$
1.29

 
$
1.80

 
$
3.17

 
$
3.66

Diluted
$
1.26

 
$
1.72

 
$
3.05

 
$
3.50


See accompanying notes to interim consolidated financial statements.





2



W. R. BERKLEY CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED)
(In thousands)
 
For the Three Months
 
For the Nine Months
 
Ended September 30,
 
Ended September 30,
 
2017
 
2016
 
2017
 
2016
Net income before noncontrolling interests
$
162,818

 
$
220,663

 
$
397,065

 
$
449,816

Other comprehensive income (loss):
 
 
 
 
 
 
 
Change in unrealized currency translation adjustments
28,592

 
(19,470
)
 
71,574

 
(77,389
)
Change in unrealized investment gains (losses), net of taxes
(8,168
)
 
(47,676
)
 
26,598

 
134,213

Other comprehensive income (loss):
20,424

 
(67,146
)
 
98,172

 
56,824

Comprehensive income
183,242

 
153,517

 
495,237

 
506,640

Noncontrolling interests
(731
)
 
44

 
(2,541
)
 
(623
)
Comprehensive income to common stockholders
$
182,511

 
$
153,561

 
$
492,696

 
$
506,017


See accompanying notes to interim consolidated financial statements.

3



W. R. BERKLEY CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (UNAUDITED)
(In thousands)
 
For the Nine Months
 
Ended September 30,
 
2017

2016
COMMON STOCK:
 
 
 
Beginning and end of period
$
47,024

 
$
47,024

ADDITIONAL PAID-IN CAPITAL:
 
 
 
Beginning of period
$
1,037,446

 
$
1,005,455

Restricted stock units issued
(27,047
)
 
(3,421
)
Restricted stock units expensed
30,176

 
25,431

End of period
$
1,040,575

 
$
1,027,465

RETAINED EARNINGS:
 
 
 
Beginning of period
$
6,595,987

 
$
6,178,070

Net income to common stockholders
394,505

 
449,127

Dividends
(110,430
)
 
(107,661
)
End of period
$
6,880,062

 
$
6,519,536

ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)
 
 
 
Unrealized investment gains:
 
 
 
Beginning of period
$
427,154

 
$
180,695

Unrealized gains on securities not other-than-temporarily impaired
25,712

 
133,866

Unrealized gains on other-than-temporarily impaired securities
905

 
413

End of period
453,771

 
314,974

Currency translation adjustments:
 
 
 
Beginning of period
(371,586
)
 
(247,393
)
Net change in period
71,574

 
(77,389
)
End of period
(300,012
)
 
(324,782
)
Total accumulated other comprehensive income (loss)
$
153,759

 
$
(9,808
)
TREASURY STOCK:
 
 
 
Beginning of period
$
(2,688,817
)
 
$
(2,563,605
)
Stock exercised/vested
25,584

 
5,023

Stock repurchased
(28,378
)
 
(99,870
)
Stock incentive plans expensed
727

 

End of period
$
(2,690,884
)
 
$
(2,658,452
)
NONCONTROLLING INTERESTS:
 
 
 
Beginning of period
$
33,926

 
$
32,962

Contributions
3,646

 
2,474

Net income
2,560

 
689

Other comprehensive loss, net of tax
(19
)
 
(66
)
End of period
$
40,113

 
$
36,059

See accompanying notes to interim consolidated financial statements.

4



W. R. BERKLEY CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)
(In thousands)
 
For the Nine Months
 
Ended September 30,
 
2017
 
2016
CASH FROM OPERATING ACTIVITIES:
 
 
 
Net income to common stockholders
$
394,505

 
$
449,127

Adjustments to reconcile net income to net cash from operating activities:
 
 
 
Net investment gains
(276,760
)
 
(189,394
)
Depreciation and amortization
78,137

 
69,153

Noncontrolling interests
2,560

 
689

Investment funds
(51,907
)
 
(60,387
)
Stock incentive plans
31,883

 
27,033

Change in:
 
 
 
Arbitrage trading account
(2,835
)
 
(4,777
)
Premiums and fees receivable
(112,420
)
 
(92,372
)
Reinsurance accounts
(42,319
)
 
(154,939
)
Deferred policy acquisition costs
4,483

 
(51,795
)
Income taxes
(15,451
)
 
89,007

Reserves for losses and loss expenses
422,657

 
440,486

Unearned premiums
121,583

 
269,287

Other
(32,258
)
 
(64,608
)
Net cash from operating activities
521,858

 
726,510

CASH USED IN INVESTING ACTIVITIES:
 
 
 
Proceeds from sale of fixed maturity securities
3,081,619

 
1,074,630

Proceeds from sale of equity securities
137,062

 
123,187

Distributions from investment funds
265,371

 
5,630

Proceeds from maturities and prepayments of fixed maturity securities
2,860,678

 
2,189,365

Purchase of fixed maturity securities
(6,530,466
)
 
(4,280,457
)
Purchase of equity securities
(17,049
)
 
(127,303
)
Real estate purchased
(159,006
)
 
(207,829
)
Change in loans receivable
32,574

 
159,128

Net additions to property, furniture and equipment
(74,268
)
 
(37,895
)
Change in balances due to security brokers
39,978

 
102,981

Cash received in connection with business disposition

 
250,216

Payment for business purchased net of cash aquired
(70,570
)
 
(53,524
)
Net cash used in investing activities
(434,077
)
 
(801,871
)
CASH (USED IN) FROM FINANCING ACTIVITIES:
 
 
 
Repayment of senior notes and other debt
(1,788
)
 
(70,567
)
Net proceeds from issuance of debt

 
386,848

Cash dividends to common stockholders
(93,371
)
 
(30,654
)
Purchase of common treasury shares
(28,378
)
 
(99,870
)
Other, net
(3,835
)
 
(1,376
)
Net cash (used in) from financing activities
(127,372
)
 
184,381

Net impact on cash due to change in foreign exchange rates
18,303

 
413

Net change in cash and cash equivalents
(21,288
)
 
109,433

Cash and cash equivalents at beginning of year
795,285

 
763,631

Cash and cash equivalents at end of period
$
773,997

 
$
873,064

See accompanying notes to interim consolidated financial statements.

5



W. R. Berkley Corporation and Subsidiaries
NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED )

(1) General
The unaudited consolidated financial statements, which include the accounts of W. R. Berkley Corporation and its subsidiaries (the “Company”) have been prepared on the basis of U.S. generally accepted accounting principles (“GAAP”) for interim financial information. Accordingly, they do not include all the information and notes required by GAAP for annual financial statements. The unaudited consolidated financial statements reflect all adjustments, consisting only of normal recurring items, which are necessary to present fairly the Company’s financial position and results of operations on a basis consistent with the prior audited consolidated financial statements. Operating results for interim periods are not necessarily indicative of the results that may be expected for the year. All significant intercompany accounts and transactions have been eliminated. The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the revenues and expenses reflected during the reporting period. For further information related to a description of areas of judgment and estimates and other information necessary to understand the Company’s financial position and results of operations, refer to the audited consolidated financial statements and notes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2016 . Reclassifications have been made in the 2016 financial statements as originally reported to conform to the presentation of the 2017 financial statements.
The income tax provision has been computed based on the Company’s estimated annual effective tax rate. The effective tax rate for the quarter differs from the federal income tax rate of 35% principally because of tax-exempt investment income, as well as the new requirement in 2017 to recognize tax benefits for stock compensation in income tax expense.

(2) Per Share Data
The Company presents both basic and diluted net income per share (“EPS”) amounts. Basic EPS is calculated by dividing net income by the weighted average number of common shares outstanding during the period (including 4,087,731 common shares held in a grantor trust established in March 2017). The common shares held in the grantor trust are for delivery upon settlement of vested but mandatorily deferred restricted stock units ("RSUs"). Shares held by the grantor trust do not affect diluted shares outstanding since the shares deliverable under vested RSUs were already included in diluted shares outstanding. Diluted EPS is based upon the weighted average number of basic and common equivalent shares outstanding during the period and is calculated using the treasury stock method for stock incentive plans. Common equivalent shares are excluded from the computation in periods in which they have an anti-dilutive effect.
The weighted average number of common shares used in the computation of basic and diluted earnings per share was as follows:
 
For the Three Months
 
For the Nine Months
 
Ended September 30,
 
Ended September 30,
(In thousands)
2017
 
2016
 
2017
 
2016
Basic
125,818

 
122,562

 
124,363

 
122,652

Diluted
128,944

 
128,556

 
129,289

 
128,501


(3) Recent Accounting Pronouncements

Recently adopted accounting pronouncements:

In May 2015, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2015-09, Disclosures about Short-Duration Contracts. ASU 2015-09 requires companies that issue short duration insurance contracts to disclose additional information, including: (i) incurred and paid claims development tables; (ii) frequency and severity of claims; and (iii) information about material changes in judgments made in calculating the liability for unpaid claim adjustment expenses, including reasons for the change and the effects on the financial statements. The Company adopted this updated guidance on January 1, 2016 with regard to the annual requirements and on January 1, 2017 with regard to the interim requirements. The amendments in ASU 2015-09 are applied retrospectively by providing comparative disclosures for each period presented, except for those requirements that apply only to the current period. As the requirements are disclosure only, the adoption of this guidance did not impact our financial condition or results of operations, but did result in additional disclosures.


6



In March 2016, the FASB issued ASU 2016-09, Improvements to Employee Share-Based Payment Accounting. ASU 2016-09 includes provisions intended to simplify various previous provisions related to how share-based payments are accounted for and presented in the financial statements. Under the new guidance, excess tax benefits (deductions for share based payment awards for tax purposes that exceed the compensation cost recognized for financial reporting purposes) are reported within the income tax expense financial statement line item. Previously, excess tax benefits were reported within additional paid in capital. The Company adopted this updated guidance on January 1, 2017 prospectively. The adoption of this guidance did not have a material impact on the Company's financial condition or results of operations.

All other accounting and reporting standards that became effective in 2017 were either not applicable to the Company or their adoption did not have a material impact on the Company. 

Accounting and reporting standards that are not yet effective:

In May 2014, the FASB issued ASU 2014-09, Revenue from Customers. ASU 2014-09 clarifies the principles for recognizing revenue. While insurance contracts are not within the scope of this updated guidance, the Company’s insurance service fee revenue and non-insurance business revenue will be subject to this updated guidance. The updated guidance requires an entity to recognize revenue as performance obligations are met, in order to reflect the transfer of promised goods or services to customers in an amount that reflects the consideration the entity is entitled to receive for those goods or services. The updated guidance, as amended by ASU 2015-14, is effective for public business entities for annual and interim reporting periods beginning after December 15, 2017. The adoption of this guidance is not expected to have a material effect on the Company’s financial condition or results of operations.
    
In January 2016, the FASB issued ASU 2016-01, Financial Instruments.  ASU 2016-01 amends the accounting guidance for financial instruments to require all equity investments to be measured at fair value with changes in the fair value recognized through net income (other than those accounted for under equity method of accounting or those that result in consolidation of the investee).  The updated guidance is effective for public business entities for annual reporting periods beginning after December 15, 2017 and interim periods within those years.  The adoption of this guidance is not expected to have a material effect on the Company’s financial condition upon adoption, but will impact results of operations after adoption of this guidance as unrealized gains and losses on equity securities will no longer be reported directly in accumulated other comprehensive income (AOCI), but will instead be reported in net income.

In February 2016, the FASB issued ASU 2016-02, Leases, which amends the accounting and disclosure guidance for leases.  This guidance retains the two classifications of a lease, as either an operating or finance lease, both of which will require lessees to recognize a right-of-use asset and a lease liability for leases with terms of more than 12 months. The right-of-use asset and the lease liability will be determined based upon the present value of cash flows. Finance leases will reflect the financial arrangement by recognizing interest expense on the lease liability separately from the amortization expense of the right-of-use asset. Operating leases will recognize lease expense (with no separate recognition of interest expense) on a straight-line basis over the term of the lease. The accounting by lessors is not significantly changed by the updated guidance.  The updated guidance is effective for reporting periods beginning after December 15, 2018, and will require that the earliest comparative period presented include the measurement and recognition of existing leases with an adjustment to equity as if the updated guidance had always been applied. The Company is currently evaluating the impact that the adoption of this guidance will have on its results of operations, financial position and liquidity.

     In June 2016, the FASB issued ASU 2016-13, Financial Instruments - Credit Losses, which amends the accounting guidance for credit losses on financial instruments. The updated guidance amends the current other-than-temporary impairment model for available-for-sale debt securities by requiring the recognition of impairments relating to credit losses through an allowance account and limits the amount of credit loss to the difference between a security’s amortized cost basis and its fair value. This guidance also applies a new current expected credit loss model for determining credit-related impairments for financial instruments measured at amortized cost.  The updated guidance is effective for reporting periods beginning after December 15, 2019. The Company will not be able to determine the impact the adoption of this guidance will have on its results of operations, financial position or liquidity until the year the guidance becomes effective.

All other recently issued but not yet effective accounting and reporting standards are either not applicable to the Company or are not expected to have a material impact on the Company.




7



(4) Acquisitions/Disposition

In March 2017, the Company acquired an 89.5% ownership interest for $73.3 million in a company engaged in providing textile solutions world-wide. The fair value of the assets acquired and liabilities assumed have been estimated based on a third party valuation.

The following table summarizes the estimated fair value of net assets acquired and liabilities assumed for the business combination completed in 2017:
(In thousands)
2017
 
 
Cash and cash equivalents
$
2,721

Real estate, furniture and equipment
7,042

Goodwill
28,522

Intangible assets
32,395

Other assets
9,862

Total assets acquired
80,542

 
 
Other liabilities assumed
(2,251
)
Noncontrolling interest
(5,000
)
  Net assets acquired
$
73,291


In February 2016, the Company acquired an 85% ownership interest for $42.3 million in a company engaged in the distribution of promotional merchandise.

8



(5) Consolidated Statement of Comprehensive Income

The following table presents the components of the changes in accumulated other comprehensive income ("AOCI"):
(In thousands)
Unrealized Investment Gains (Losses)
 
                             Currency Translation Adjustments
 
Accumulated Other Comprehensive Income
As of and for the nine months ended September 30, 2017:
 
 
 
 
Changes in AOCI
 
 
 
 
Beginning of period
$
427,154

 
$
(371,586
)
 
$
55,568

Other comprehensive income before reclassifications
109,277

 
71,574

 
180,851

Amounts reclassified from AOCI
(82,679
)
 

 
(82,679
)
Other comprehensive income
26,598

 
71,574

 
98,172

Unrealized investment loss related to non-controlling interest
19

 

 
19

End of period
$
453,771

 
$
(300,012
)
 
$
153,759

Amounts reclassified from AOCI
 
 
 
 
 
Pre-tax
$
(127,198
)
(1)
$

 
$
(127,198
)
Tax effect
44,519

(2)

 
44,519

After-tax amounts reclassified
$
(82,679
)
 
$

 
$
(82,679
)
Other comprehensive income
 
 
 
 
 
Pre-tax
$
50,148

 
$
71,574

 
$
121,722

Tax effect
(23,550
)
 

 
(23,550
)
Other comprehensive income
$
26,598

 
$
71,574

 
$
98,172

 
 
 
 
 
 
As of and for the three months ended September 30, 2017:
 
 
 
 
Changes in AOCI
 
 
 
 
Beginning of period
$
461,906

 
$
(328,604
)
 
$
133,302

Other comprehensive income before reclassifications
19,968

 
28,592

 
48,560

Amounts reclassified from AOCI
(28,136
)
 

 
(28,136
)
Other comprehensive (loss) income
(8,168
)
 
28,592

 
20,424

Unrealized investment loss related to non-controlling interest
33

 

 
33

End of period
$
453,771

 
$
(300,012
)
 
$
153,759

Amounts reclassified from AOCI
 
 
 
 
 
Pre-tax
$
(43,286
)
(1)
$

 
$
(43,286
)
Tax effect
15,150

(2)

 
15,150

After-tax amounts reclassified
$
(28,136
)
 
$

 
$
(28,136
)
Other comprehensive (loss) income
 
 
 
 
 
Pre-tax
$
(8,563
)
 
$
28,592

 
$
20,029

Tax effect
395

 

 
395

Other comprehensive (loss) income
$
(8,168
)
 
$
28,592

 
$
20,424

 
 
 
 
 
 
_________________________
(1) Net investment gains in the consolidated statements of income.
(2) Income tax expense in the consolidated statements of income.


9



(In thousands)
Unrealized Investment Gains (Losses)
 
           Currency Translation Adjustments
 
Accumulated Other Comprehensive Income (Loss)
As of and for the nine months ended September 30, 2016:
 
 
 
 
Changes in AOCI
 
 
 
 
Beginning of period
$
180,695

 
$
(247,393
)
 
$
(66,698
)
Other comprehensive income (loss) before reclassifications
170,824

 
(77,389
)
 
93,435

Amounts reclassified from AOCI
(36,611
)
 

 
(36,611
)
Other comprehensive income (loss)
134,213

 
(77,389
)
 
56,824

Unrealized investment loss related to non-controlling interest
66

 

 
66

End of period
$
314,974

 
$
(324,782
)
 
$
(9,808
)
Amounts reclassified from AOCI
 
 
 
 
 
Pre-tax
$
(56,325
)
(1)
$

 
$
(56,325
)
Tax effect
19,714

(2)

 
19,714

After-tax amounts reclassified
$
(36,611
)
 
$

 
$
(36,611
)
Other comprehensive income (loss)
 
 
 
 
 
Pre-tax
$
198,808

 
$
(77,389
)
 
$
121,419

Tax effect
(64,595
)
 

 
(64,595
)
Other comprehensive income (loss)
$
134,213

 
$
(77,389
)
 
$
56,824

 
 
 
 
 
 
As of and for the three months ended September 30, 2016:
 
 
 
 
Changes in AOCI
 
 
 
 
Beginning of period
$
362,593

 
$
(305,312
)
 
$
57,281

Other comprehensive loss before reclassifications
(20,968
)
 
(19,470
)
 
(40,438
)
Amounts reclassified from AOCI
(26,708
)
 

 
(26,708
)
Other comprehensive loss
(47,676
)
 
(19,470
)
 
(67,146
)
Unrealized investment loss related to non-controlling interest
57

 

 
57

End of period
$
314,974

 
$
(324,782
)
 
$
(9,808
)
Amounts reclassified from AOCI
 
 
 
 
 
Pre-tax
$
(41,090
)
(1)
$

 
$
(41,090
)
Tax effect
14,382

(2)

 
14,382

After-tax amounts reclassified
$
(26,708
)
 
$

 
$
(26,708
)
Other comprehensive loss
 
 
 
 
 
Pre-tax
$
(72,188
)
 
$
(19,470
)
 
$
(91,658
)
Tax effect
24,512

 

 
24,512

Other comprehensive loss
$
(47,676
)
 
$
(19,470
)
 
$
(67,146
)
 
 
 
 
 
 
_______________
(1) Net investment gains in the consolidated statements of income.
(2) Income tax expense in the consolidated statements of income.




10



(6) Statements of Cash Flow
Interest payments were $134,291,000 and $124,791,000 and income taxes paid were $182,487,000 and $99,161,000 in the nine months ended September 30, 2017 and 2016 , respectively.

(7) Investments in Fixed Maturity Securities
At September 30, 2017 and December 31, 2016 , investments in fixed maturity securities were as follows:
 
(In thousands)
Amortized
Cost
 
Gross Unrealized
 
Fair
Value
 
Carrying
Value
Gains
 
Losses
 
September 30, 2017
 
 
 
 
 
 
 
 
 
Held to maturity:
 
 
 
 
 
 
 
 
 
State and municipal
$
65,372

 
$
15,212

 
$

 
$
80,584

 
$
65,372

Residential mortgage-backed
14,024

 
1,452

 

 
15,476

 
14,024

Total held to maturity
79,396

 
16,664

 

 
96,060

 
79,396

Available for sale:
 
 
 
 
 
 
 
 
 
U.S. government and government agency
402,901

 
10,828

 
(2,124
)
 
411,605

 
411,605

State and municipal:
 
 
 
 
 
 
 
 
 
Special revenue
2,730,653

 
80,144

 
(5,469
)
 
2,805,328

 
2,805,328

State general obligation
481,070

 
21,377

 
(565
)
 
501,882

 
501,882

Pre-refunded
282,488

 
21,052

 
(173
)
 
303,367

 
303,367

Corporate backed
380,351

 
11,775

 
(499
)
 
391,627

 
391,627

Local general obligation
384,930

 
26,566

 
(531
)
 
410,965

 
410,965

Total state and municipal
4,259,492

 
160,914

 
(7,237
)
 
4,413,169

 
4,413,169

Mortgage-backed securities:
 
 
 
 
 
 
 
 
 
Residential (1)
1,064,705

 
12,696

 
(8,860
)
 
1,068,541

 
1,068,541

Commercial
251,387

 
1,641

 
(1,450
)
 
251,578

 
251,578

Total mortgage-backed securities
1,316,092

 
14,337

 
(10,310
)
 
1,320,119

 
1,320,119

Asset-backed
2,389,187

 
9,836

 
(10,405
)
 
2,388,618

 
2,388,618

Corporate:
 
 
 
 
 
 
 
 
 
Industrial
2,569,673

 
70,054

 
(2,842
)
 
2,636,885

 
2,636,885

Financial
1,335,101

 
43,636

 
(4,716
)
 
1,374,021

 
1,374,021

Utilities
255,478

 
12,760

 
(907
)
 
267,331

 
267,331

Other
42,183

 
2

 
(48
)
 
42,137

 
42,137

Total corporate
4,202,435

 
126,452

 
(8,513
)
 
4,320,374

 
4,320,374

Foreign
909,608

 
32,889

 
(2,088
)
 
940,409

 
940,409

Total available for sale
13,479,715

 
355,256

 
(40,677
)
 
13,794,294

 
13,794,294

Total investments in fixed maturity securities
$
13,559,111

 
$
371,920

 
$
(40,677
)
 
$
13,890,354

 
$
13,873,690


11



(In thousands)
Amortized
Cost
 
Gross Unrealized
 
Fair
Value
 
Carrying
Value
Gains
 
Losses
December 31, 2016
 
 
 
 
 
 
 
 
 
Held to maturity:
 
 
 
 
 
 
 
 
 
State and municipal
$
72,582

 
$
12,453

 
$

 
$
85,035

 
$
72,582

Residential mortgage-backed
15,944

 
1,693

 

 
17,637

 
15,944

Total held to maturity
88,526

 
14,146

 

 
102,672

 
88,526

Available for sale:
 
 
 
 
 
 
 
 
 
U.S. government and government agency
496,187

 
20,208

 
(2,593
)
 
513,802

 
513,802

State and municipal:
 
 
 
 
 
 
 
 
 
Special revenue
2,791,211

 
58,559

 
(26,315
)
 
2,823,455

 
2,823,455

State general obligation
524,682

 
16,964

 
(5,139
)
 
536,507

 
536,507

Pre-refunded
356,535

 
19,181

 
(165
)
 
375,551

 
375,551

Corporate backed
410,933

 
6,172

 
(6,452
)
 
410,653

 
410,653

Local general obligation
360,022

 
15,682

 
(2,367
)
 
373,337

 
373,337

Total state and municipal
4,443,383

 
116,558

 
(40,438
)
 
4,519,503

 
4,519,503

Mortgage-backed securities:
 
 
 
 
 
 
 
 
 
Residential (1)
1,034,301

 
15,431

 
(12,950
)
 
1,036,782

 
1,036,782

Commercial
155,540

 
304

 
(2,981
)
 
152,863

 
152,863

Total mortgage-backed securities
1,189,841

 
15,735

 
(15,931
)
 
1,189,645

 
1,189,645

Asset-backed
1,913,830

 
5,971

 
(11,941
)
 
1,907,860

 
1,907,860

Corporate:
 
 
 
 
 
 
 
 
 
Industrial
2,315,567

 
71,007

 
(7,174
)
 
2,379,400

 
2,379,400

Financial
1,369,001

 
39,543

 
(11,270
)
 
1,397,274

 
1,397,274

Utilities
229,154

 
10,801

 
(2,411
)
 
237,544

 
237,544

Other
54,073

 
299

 
(63
)
 
54,309

 
54,309

Total corporate
3,967,795

 
121,650

 
(20,918
)
 
4,068,527

 
4,068,527

Foreign
858,773

 
46,794

 
(2,762
)
 
902,805

 
902,805

Total available for sale
12,869,809

 
326,916

 
(94,583
)
 
13,102,142

 
13,102,142

Total investments in fixed maturity securities
$
12,958,335


$
341,062

 
$
(94,583
)
 
$
13,204,814

 
$
13,190,668

____________
(1)
Gross unrealized gains and (losses) for residential mortgage-backed securities include $85,907 and $(818,691) as of September 30, 2017 and December 31, 2016 , respectively, related to securities with the non-credit portion of other-than-temporary impairments (“OTTI”) recognized in accumulated other comprehensive income.

The amortized cost and fair value of fixed maturity securities at September 30, 2017 , by contractual maturity, are shown below. Actual maturities may differ from contractual maturities because certain issuers may have the right to call or prepay obligations.
 
(In thousands)
Amortized
Cost
 
Fair Value
Due in one year or less
$
745,010

 
$
750,479

Due after one year through five years
5,089,768

 
5,210,268

Due after five years through ten years
3,248,254

 
3,396,461

Due after ten years
3,145,963

 
3,197,551

Mortgage-backed securities
1,330,116

 
1,335,595

Total
$
13,559,111

 
$
13,890,354

At September 30, 2017 and December 31, 2016, there were no investments that exceeded 10% of common stockholders' equity, other than investments in United States government and government agency securities.



12



(8) Investments in Equity Securities Available for Sale
At September 30, 2017 and December 31, 2016 , investments in equity securities were as follows:
 
(In thousands)
Cost
 
Gross Unrealized
 
Fair
Value
 
Carrying
Value
Gains
 
Losses
 
September 30, 2017
 
 
 
 
 
 
 
 
 
Common stocks
$
83,709

 
$
339,297

 
$
(3,486
)
 
$
419,520

 
$
419,520

Preferred stocks
125,076

 
71,147

 
(1,718
)
 
194,505

 
194,505

Total
$
208,785

 
$
410,444

 
$
(5,204
)
 
$
614,025

 
$
614,025

December 31, 2016
 
 
 
 
 
 
 
 
 
Common stocks
$
94,998

 
$
351,906

 
$
(1,046
)
 
$
445,858

 
$
445,858

Preferred stocks
125,589

 
101,392

 
(3,639
)
 
223,342

 
223,342

Total
$
220,587

 
$
453,298

 
$
(4,685
)
 
$
669,200

 
$
669,200



(9) Arbitrage Trading Account
At September 30, 2017 and December 31, 2016 , the fair and carrying values of the arbitrage trading account were $488 million and $300 million , respectively. The primary focus of the trading account is merger arbitrage. Merger arbitrage is the business of investing in the securities of publicly held companies which are the targets in announced tender offers and mergers. Arbitrage investing differs from other types of investing in its focus on transactions and events believed likely to bring about a change in value over a relatively short time period (usually four months or less).
The Company uses put options, call options and swap contracts in order to mitigate the impact of potential changes in market conditions on the merger arbitrage trading account. These options and contracts are reported at fair value. As of September 30, 2017 , the fair value of long option contracts outstanding was $1 million (notional amount of $33 million ) and the fair value of short option contracts outstanding was $1 million (notional amount of $54 million ). Other than with respect to the use of these trading account securities, the Company does not make use of derivatives.


(10) Net Investment Income
Net investment income consists of the following:  
 
For the Three Months
 
For the Nine Months
 
Ended September 30,
 
Ended September 30,
(In thousands)
2017
 
2016
 
2017
 
2016
Investment income earned on:
 
 
 
 
 
 
 
Fixed maturity securities, including cash and cash equivalents and loans receivable
$
118,834

 
$
114,271

 
$
347,976

 
$
331,448

Investment funds
15,200

 
25,293

 
50,744

 
60,385

Arbitrage trading account
4,418

 
6,441

 
16,235

 
12,883

Real estate
5,042

 
585

 
14,894

 
4,552

Equity securities available for sale
604

 
1,069

 
1,845

 
3,217

Gross investment income
144,098

 
147,659

 
431,694

 
412,485

Investment expense
(1,619
)
 
(1,991
)
 
(5,093
)
 
(7,635
)
Net investment income
$
142,479

 
$
145,668

 
$
426,601

 
$
404,850



(11) Investment Funds
The Company evaluates whether it is an investor in a variable interest entity (VIE). Such entities do not have sufficient equity at risk to finance their activities without additional subordinated financial support, or the equity investors, as a group, do not have the characteristics of a controlling financial interest (primary beneficiary).  The Company determines whether it is the

13



primary beneficiary of an entity subject to consolidation based on a qualitative assessment of the VIE's capital structure, contractual terms, nature of the VIE's operations and purpose, and the Company's relative exposure to the related risks of the VIE on the date it becomes initially involved in the VIE and on an ongoing basis. The Company is not the primary beneficiary in any of its investment funds, and accordingly, carries its interests in investment funds under the equity method of accounting.
    
The Company’s maximum exposure to loss with respect to these investments is limited to the carrying amount reported on the Company’s consolidated balance sheet and its unfunded commitments which were $442 million as of September 30, 2017.
Investment funds consisted of the following:
 
Carrying Value as of
 
Income (Loss) from Investment Funds
 
September 30,
 
December 31,
 
For the Nine Months Ended September 30,
(In thousands)
2017
 
2016
 
2017
 
2016
Real estate
$
614,508

 
$
641,783

 
$
30,661

 
$
33,028

Energy
85,817

 
91,448

 
(12,763
)
 
7,174

Hedge equity

 
73,913

 
(1,164
)
 
791

Other funds
419,582

 
391,002

 
34,010

 
19,392

Total
$
1,119,907

 
$
1,198,146

 
$
50,744


$
60,385


The Company's share of the earnings or losses of investment funds is generally reported on a one-quarter lag in order to facilitate the timely completion of the Company's consolidated financial statements.

(12) Real Estate

Investment in real estate represents directly owned property held for investment, as follows:    
 
Carrying Value
 
September 30,
 
December 31,
(In thousands)
2017
 
2016
Properties in operation
$
451,669

 
$
457,237

Properties under development
939,605

 
727,744

Total
$
1,391,274

 
$
1,184,981


In 2017, properties in operation included a long-term ground lease in Washington, D.C., a hotel in Memphis, Tennessee, an office complex in New York City and office buildings in West Palm Beach and Palm Beach, Florida. Properties in operation are net of accumulated depreciation and amortization of $20,378,000 and $14,996,000 as of September 30, 2017 and December 31, 2016, respectively. Related depreciation expense was $5,382,000 and $4,117,000 for the nine months ended September 30, 2017 and 2016, respectively. Future minimum rental income expected on operating leases relating to properties in operation is $4,966,133 in 2017, $28,251,980 in 2018, $30,174,146 in 2019, $29,415,103 in 2020, $30,054,813 in 2021, $29,966,679 in 2022 and $467,192,215 thereafter.

Properties under development include an office building in London and a mixed-use project in Washington, D.C.


14



(13) Loans Receivable
Loans receivable are as follows:
(In thousands)
September 30, 2017
 
December 31, 2016
Amortized cost (net of valuation allowance):
 
 
 
  Real estate loans
$
59,487

 
$
92,415

  Commercial loans
14,742

 
14,383

  Total
$
74,229

 
$
106,798

 
 
 
 
Fair value:
 
 
 
  Real estate loans
$
60,372

 
$
92,415

  Commercial loans
16,243

 
15,884

  Total
$
76,615

 
$
108,299

 
 
 
 
Valuation allowance:
 
 
 
  Specific
$
1,200

 
$
1,200

  General
2,183

 
2,197

  Total
$
3,383

 
$
3,397

 
 
 
 
 
For the Three Months Ended September 30,
 
 
2017
 
2016
  Increase in valuation allowance
$

 
$
467

 
 
 
 
 
For the Nine Months Ended September 30,
 
 
2017
 
2016
(Decrease) increase in valuation allowance
$
(14
)
 
$
1,128

Loans receivable in non-accrual status were $4.5 million and $5.4 million as of September 30, 2017 and December 31, 2016, respectively.
The Company monitors the performance of its loans receivable and assesses the ability of the borrower to pay principal and interest based upon loan structure, underlying property values, cash flow and related financial and operating performance of the property and market conditions. Loans receivable with a potential for default are further assessed using discounted cash flow analysis and comparable cost and sales methodologies, if appropriate.
The real estate loans are secured by commercial real estate primarily located in New York. These loans generally earn interest at floating LIBOR-based interest rates and have maturities (inclusive of extension options) through August 2025. The commercial loans are with small business owners who have secured the related financing with the assets of the business. Commercial loans primarily earn interest on a fixed basis and have varying maturities generally not exceeding 10 years.
In evaluating the real estate loans, the Company considers their credit quality indicators, including loan to value ratios, which compare the outstanding loan amount to the estimated value of the property, the borrower’s financial condition and performance with respect to loan terms, the position in the capital structure, the overall leverage in the capital structure and other market conditions. Based on these considerations, none of the real estate loans were considered to be impaired at September 30, 2017, and accordingly, the Company determined that a specific valuation allowance was not required.


15



(14) Realized and Unrealized Investment Gains (Losses)

  Realized and unrealized investment gains (losses) are as follows:
 
For the Three Months Ended September 30,
 
For the Nine Months Ended September 30,
(In thousands)
2017
 
2016
 
2017
 
2016
Realized investment gains (losses):
 
 
 
 
 

 
 

Fixed maturity securities:
 
 
 
 
 

 
 

Gains
$
8,763

 
$
33,798

 
$
21,795

 
$
66,972

Losses
(197
)
 
(1,150
)
 
(4,162
)
 
(5,570
)
Equity securities available for sale
34,720

 
8,441

 
109,566

 
13,037

Investment funds (1)
124,228

 
(3,788
)
 
125,383

 
(9,041
)
Real estate
1,956

 
687

 
4,892

 
5,247

Other (2)
 
14,489

 
137,750

 
19,286

 
136,863

Net realized gains on investments sales
183,959

 
175,738

 
276,760

 
207,508

Other-than-temporary impairments (3)

 

 

 
(18,114
)
   Net investment gains
183,959

 
175,738

 
276,760

 
189,394

Income tax expense
(64,386
)
 
(61,508
)
 
(96,866
)
 
(66,288
)
    After-tax net realized investment gains
$
119,573

 
$
114,230

 
$
179,894

 
$
123,106

Change in unrealized investment gains of available for sale securities:
 
 
 
 
 

 
 

Fixed maturity securities
$
(10,627
)
 
$
(45,388
)
 
$
84,214

 
$
169,933

Previously impaired fixed maturity securities
61

 
(1,406
)
 
905

 
413

Equity securities available for sale
(2,126
)
 
(28,517
)
 
(44,812
)
 
12,433

Investment funds
4,129

 
3,143

 
9,841

 
16,028

Total change in unrealized investment gains
(8,563
)
 
(72,168
)
 
50,148

 
198,807

Income tax benefit (expense)
423

 
24,493

 
(23,550
)
 
(64,594
)
Noncontrolling interests
5

 
57

 
19

 
66

After-tax change in unrealized investment gains of available for sale securities
$
(8,135
)
 
$
(47,618
)
 
$
26,617

 
$
134,279

______________________
(1) Investment funds includes a gain of $124.3 million from the sale of an investment in an office building located in Washington, D.C. for the three and nine months ended September 30, 2017.

(2) Other includes a gain of $134.9 million from the sale of Aero Precision Industries and certain related aviation services business for the three and nine months ended September 30, 2016.

(3) There were no other than temporary impairments (OTTI) for the three and nine months ended September 30, 2017, or for the three months ended September 30, 2016. OTTI for the nine months ended September 30, 2016 of $18.1 million were related to common stock.

           


 




16



(15) Securities in an Unrealized Loss Position
The following tables summarize all securities in an unrealized loss position at September 30, 2017 and December 31, 2016 by the length of time those securities have been continuously in an unrealized loss position:  
   
Less Than 12 Months
 
12 Months or Greater
 
Total
(In thousands)
Fair Value
 
Gross
Unrealized
Losses
 
Fair Value
 
Gross
Unrealized
Losses
 
Fair Value
 
Gross
Unrealized
Losses
September 30, 2017
 
 
 
 
 
 
 
 
 
 
 
U.S. government and government agency
$
118,066

 
$
1,048

 
$
48,880

 
$
1,076

 
$
166,946

 
$
2,124

State and municipal
650,353

 
5,797

 
119,087

 
1,440

 
769,440

 
7,237

Mortgage-backed securities
527,034

 
5,000

 
221,923

 
5,310

 
748,957

 
10,310

Asset-backed securities
1,116,878

 
8,033

 
130,734

 
2,372

 
1,247,612

 
10,405

Corporate
651,373

 
5,395

 
57,557

 
3,118

 
708,930

 
8,513

Foreign government
220,860

 
2,072

 
1,599

 
16

 
222,459

 
2,088

Fixed maturity securities
3,284,564

 
27,345

 
579,780

 
13,332

 
3,864,344

 
40,677

Common stocks
4,678

 
3,095

 
9,387

 
391

 
14,065

 
3,486

Preferred stocks

 

 
23,957

 
1,718

 
23,957

 
1,718

Equity securities available for sale
4,678

 
3,095

 
33,344

 
2,109

 
38,022

 
5,204

Total
$
3,289,242

 
$
30,440

 
$
613,124

 
$
15,441

 
$
3,902,366

 
$
45,881

 
 
 
 
 
 
 
 
 
 
 
 
December 31, 2016
 
 
 
 
 
 
 
 
 
 
 
U.S. government and government agency
$
112,709

 
$
1,252

 
$
35,450

 
$
1,341

 
$
148,159

 
$
2,593

State and municipal
1,562,614

 
35,553

 
133,034

 
4,885

 
1,695,648

 
40,438

Mortgage-backed securities
625,903

 
11,103

 
109,066

 
4,828

 
734,969

 
15,931

Asset-backed securities
1,010,836

 
5,340

 
201,693

 
6,601

 
1,212,529

 
11,941

Corporate
1,035,245

 
13,448

 
65,147

 
7,470

 
1,100,392

 
20,918

Foreign government
213,246

 
1,985

 
24,820

 
777

 
238,066

 
2,762

Fixed maturity securities
4,560,553

 
68,681

 
569,210

 
25,902

 
5,129,763

 
94,583

Common stocks
336

 
22

 
8,755

 
1,024

 
9,091

 
1,046

Preferred stocks

 

 
22,034

 
3,639

 
22,034

 
3,639

Equity securities available for sale
336

 
22

 
30,789

 
4,663

 
31,125

 
4,685

Total
$
4,560,889

 
$
68,703

 
$
599,999

 
$
30,565

 
$
5,160,888

 
$
99,268


Fixed Maturity Securities – A summary of the Company’s non-investment grade fixed maturity securities that were in an unrealized loss position at September 30, 2017 is presented in the table below:  
($ in thousands)
Number of
Securities
 
Aggregate
Fair Value
 
Gross Unrealized
Loss
Foreign government
9

 
$
55,292

 
$
462

Mortgage-backed securities
6

 
5,975

 
150

Corporate
3

 
2,852

 
211

Asset-backed securities
3

 
1,331

 
115

Total
21

 
$
65,450

 
$
938






17



For OTTI of fixed maturity securities that management does not intend to sell or, to be required to sell, the portion of the decline in value that is considered to be due to credit factors is recognized in earnings, and the portion of the decline in value that is considered to be due to non-credit factors is recognized in other comprehensive income.
 
The Company has evaluated its fixed maturity securities in an unrealized loss position and believes the unrealized losses are due primarily to temporary market and sector-related factors rather than to issuer-specific factors. None of these securities are delinquent or in default under financial covenants. Based on its assessment of these issuers, the Company expects them to continue to meet their contractual payment obligations as they become due and does not consider any of these securities to be OTTI.
Preferred Stocks – At September 30, 2017 , there was one preferred stock in an unrealized loss position, with a fair value of $24.0 million and a gross unrealized loss of $1.7 million . Based upon management’s view of the underlying value of the security, the Company does not consider the equity security to be OTTI. For the nine months ended September 30, 2017 and 2016, there was no OTTI for preferred stocks.
Common Stocks – At September 30, 2017 , there were three common stocks in an unrealized loss position, with an aggregate fair value of $14.1 million and a gross unrealized loss of $3.5 million . Based upon management's view of the underlying value of these securities, the Company does not consider these equity securities to be OTTI. There was no OTTI of common stocks for the nine months ended September 30, 2017. For the nine months ended September 30, 2016, OTTI for common stocks was $ 18.1 million .

(16) Fair Value Measurements

The Company’s fixed maturity and equity securities classified as available for sale and its trading account securities are carried at fair value. Fair value is defined as “the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.” The Company utilizes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three broad levels, as follows:
Level 1 - Quoted prices (unadjusted) in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date.  
Level 2 - Quoted prices for similar assets or valuations based on inputs that are observable.
Level 3 - Estimates of fair value based on internal pricing methodologies using unobservable inputs. Unobservable inputs are only used to measure fair value to the extent that observable inputs are not available.
Substantially, all of the Company’s fixed maturity securities were priced by independent pricing services. The prices provided by the independent pricing services are estimated based on observable market data in active markets utilizing pricing models and processes, which may include benchmark yields, reported trades, broker/dealer quotes, issuer spreads, two-sided markets, benchmark securities, bids, offers, sector groupings, matrix pricing and reference data. The pricing services may prioritize inputs differently on any given day for any security based on market conditions, and not all inputs are available for each security evaluation on any given day. The pricing services used by the Company have indicated that they will only produce an estimate of fair value if objectively verifiable information is available. The determination of whether markets are active or inactive is based upon the volume and level of activity for a particular asset class. The Company reviews the prices provided by pricing services for reasonableness and periodically performs independent price tests of a sample of securities to ensure proper valuation.
If prices from independent pricing services are not available for fixed maturity securities, the Company estimates the fair value. For Level 2 securities, the Company utilizes pricing models and processes which may include benchmark yields, sector groupings, matrix pricing, reported trades, broker/dealer quotes, issuer spreads, two-sided markets, bids, offers and reference data. Where broker quotes are used, the Company generally requests two or more quotes and sets a price within the range of quotes received based on its assessment of the credibility of the quote and its own evaluation of the security. The Company generally does not adjust quotes received from brokers. For securities traded only in private negotiations, the Company determines fair value based primarily on the cost of such securities, which is adjusted to reflect prices of recent placements of securities of the same issuer, financial projections, credit quality and business developments of the issuer and other relevant information.
For Level 3 securities, the Company generally uses a discounted cash flow model to estimate the fair value of fixed maturity securities. The cash flow models are based upon assumptions as to prevailing credit spreads, interest rate and interest rate volatility, time to maturity and subordination levels. Projected cash flows are discounted at rates that are adjusted to reflect illiquidity, where appropriate.


18



The following tables present the assets and liabilities measured at fair value on a recurring basis as of September 30, 2017 and December 31, 2016 by level:
(In thousands)
Total
 
Level 1
 
Level 2
 
Level 3
September 30, 2017
 
 
 
 
 
 
 
Assets:
 
 
 
 
 
 
 
Fixed maturity securities available for sale:
 
 
 
 
 
 
 
U.S. government and government agency
$
411,605

 
$

 
$
411,605

 
$

State and municipal
4,413,169

 

 
4,413,169

 

Mortgage-backed securities
1,320,119

 

 
1,320,119

 

Asset-backed securities
2,388,618

 

 
2,388,444

 
174

Corporate
4,320,374

 

 
4,320,374

 

Foreign government
940,409

 

 
940,409

 

Total fixed maturity securities available for sale
13,794,294

 

 
13,794,120

 
174

Equity securities available for sale:
 
 
 
 
 
 
 
Common stocks
419,520

 
410,133

 

 
9,387

Preferred stocks
194,505

 

 
190,649

 
3,856

Total equity securities available for sale
614,025

 
410,133

 
190,649

 
13,243

Arbitrage trading account
488,238

 
275,818

 
212,420

 

Total
$
14,896,557

 
$
685,951

 
$
14,197,189

 
$
13,417

Liabilities:
 
 
 
 
 
 
 
Trading account securities sold but not yet purchased
$
44,937

 
$
44,851

 
$
86

 
$

 
 
 
 
 
 
 
 
December 31, 2016
 
 
 
 
 
 
 
Assets:
 
 
 
 
 
 
 
Fixed maturity securities available for sale:
 
 
 
 
 
 
 
U.S. government and government agency
$
513,802

 
$

 
$
513,802

 
$

State and municipal
4,519,503

 

 
4,519,503

 

Mortgage-backed securities
1,189,645

 

 
1,189,645

 

Asset-backed securities
1,907,860

 

 
1,907,677

 
183

Corporate
4,068,527

 

 
4,068,527

 

Foreign government
902,805

 

 
902,805

 

Total fixed maturity securities available for sale
13,102,142

 

 
13,101,959

 
183

Equity securities available for sale:
 
 
 
 
 
 
 
Common stocks
445,858

 
429,647

 
7,457

 
8,754

Preferred stocks
223,342

 

 
219,680

 
3,662

Total equity securities available for sale
669,200

 
429,647

 
227,137

 
12,416

Arbitrage trading account
299,999

 
224,623

 
75,376

 

Total
$
14,071,341

 
$
654,270

 
$
13,404,472

 
$
12,599

Liabilities:
 
 
 
 
 
 
 
Trading account securities sold but not yet purchased
$
51,179

 
$
51,089

 
$
90

 
$

There were no significant transfers between Levels 1 and 2 during the nine months ended September 30, 2017 or during the year ended December 31, 2016 .




19



The following tables summarize changes in Level 3 assets and liabilities for the nine months ended September 30, 2017 and for the year ended December 31, 2016 :
 
  
Gains (Losses) Included in:
(In thousands)
Beginning
Balance
 
Earnings (Losses)
 
Other
Comprehensive
Income (Loss)
 
Impairments
 
Purchases
 
(Sales)
 
Paydowns / Maturities
 
Transfers
 
Ending
Balance
In / (Out)
Nine months ended September 30, 2017:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fixed maturities securities available for sale:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Asset-backed securities
$
183

 
$
2

 
$
32

 
$

 
$

 
$
(43
)
 
$

 
$

 
$
174

Corporate

 

 

 

 

 

 

 

 

Total
183

 
2

 
32

 

 

 
(43
)
 

 

 
174

Equity securities available for sale:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Common stocks
8,754

 

 
633

 

 

 

 

 

 
9,387

Preferred stocks
3,662

 
19

 

 

 
175

 

 

 

 
3,856

Total
12,416

 
19

 
633

 

 
175

 

 

 

 
13,243

Arbitrage trading account

 
8

 

 

 

 
(8
)
 

 

 

Total
$
12,599

 
$
29

 
$
665

 
$

 
$
175

 
$
(51
)
 
$

 
$

 
$
13,417

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Year ended December 31, 2016:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fixed maturities securities available for sale:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Asset-backed securities
$
199

 
$
3

 
$
16

 
$

 
$

 
$

 
$
(35
)
 
$

 
$
183

Corporate
154

 
177

 

 

 

 
(331
)
 

 

 

Total
353

 
180

 
16

 

 

 
(331
)
 
(35
)
 

 
183

Equity securities available for sale:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Common stocks
7,829

 

 
160

 

 
765

 

 

 

 
8,754

Preferred stocks
3,624

 
38

 

 

 

 

 

 

 
3,662

Total
11,453

 
38

 
160

 

 
765

 

 

 

 
12,416

Arbitrage trading account
176

 
(176
)
 

 

 

 

 

 

 

Total
$
11,982

 
$
42

 
$
176

 
$

 
$
765

 
$
(331
)
 
$
(35
)
 
$

 
$
12,599

During the nine months ended September 30, 2017 and for the year ended December 31, 2016, there were no t ransfers out of Level 3.





20



(17) Reserves for Loss and Loss Expenses

The Company's reserves for losses and loss expenses are comprised of case reserves and incurred but not reported liabilities (IBNR). When a claim is reported, a case reserve is established for the estimated ultimate payment based upon known information about the claim. As more information about the claim becomes available over time, case reserves are adjusted up or down as appropriate. Reserves are also established on an aggregate basis to provide for IBNR liabilities and expected loss reserve development on reported claims.

Loss reserves included in the Company’s financial statements represent management’s best estimates based upon an actuarially derived point estimate and other considerations. The Company uses a variety of actuarial techniques and methods to derive an actuarial point estimate for each operating unit. These methods include paid loss development, incurred loss development, paid and incurred Bornhuetter-Ferguson methods and frequency and severity methods. In circumstances where one actuarial method is considered more credible than the others, that method is used to set the point estimate. The actuarial point estimate may also be based on a judgmental weighting of estimates produced from each of the methods considered. Industry loss experience is used to supplement the Company’s own data in selecting “tail factors” in areas where the Company’s own data is limited. The actuarial data is analyzed by line of business, coverage and accident or policy year, as appropriate, for each operating unit.

The establishment of the actuarially derived loss reserve point estimate also includes consideration of qualitative factors that may affect the ultimate losses. These qualitative considerations include, among others, the impact of re-underwriting initiatives, changes in the mix of business, changes in distribution sources and changes in policy terms and conditions.

The key assumptions used to arrive at the best estimate of loss reserves are the expected loss ratios, rate of loss cost inflation, and reported and paid loss emergence patterns. Expected loss ratios represent management’s expectation of losses at the time the business is priced and written, before any actual claims experience has emerged. This expectation is a significant determinant of the estimate of loss reserves for recently written business where there is little paid or incurred loss data to consider. Expected loss ratios are generally derived from historical loss ratios adjusted for the impact of rate changes, loss cost trends and known changes in the type of risks underwritten. Expected loss ratios are estimated for each key line of business within each operating unit. Expected loss cost inflation is particularly important for the long-tail lines, such as excess casualty, and claims with a high medical component, such as workers’ compensation. Reported and paid loss emergence patterns are used to project current reported or paid loss amounts to their ultimate settlement value. Loss development factors are based on the historical emergence patterns of paid and incurred losses, and are derived from the Company’s own experience and industry data. The paid loss emergence pattern is also significant to excess and assumed workers’ compensation reserves because those reserves are discounted to their estimated present value based upon such estimated payout patterns.

Loss frequency and severity are measures of loss activity that are considered in determining the key assumptions described in our discussion of loss and loss expense reserves, including expected loss ratios, rate of loss cost inflation and reported and paid loss emergence patterns. Loss frequency is a measure of the number of claims per unit of insured exposure, and loss severity is a measure of the average size of claims. Factors affecting loss frequency include the effectiveness of loss controls and safety programs and changes in economic activity or weather patterns. Factors affecting loss severity include changes in policy limits, retentions, rate of inflation and judicial interpretations.

Another factor affecting estimates of loss frequency and severity is the loss reporting lag, which is the period of time between the occurrence of a loss and the date the loss is reported to the Company. The length of the loss reporting lag affects our ability to accurately predict loss frequency (loss frequencies are more predictable for lines with short reporting lags) as well as the amount of reserves needed for incurred but not reported losses (less IBNR is required for lines with short reporting lags). As a result, loss reserves for lines with short reporting lags are likely to have less variation from initial loss estimates. For lines with short reporting lags, which include commercial automobile, primary workers’ compensation, other liability (claims-made) and property business, the key assumption is the loss emergence pattern used to project ultimate loss estimates from known losses paid or reported to date. For lines of business with long reporting lags, which include other liability (occurrence), products liability, excess workers’ compensation and liability reinsurance, the key assumption is the expected loss ratio since there is often little paid or incurred loss data to consider. Historically, the Company has experienced less variation from its initial loss estimates for lines of businesses with short reporting lags than for lines of business with long reporting lags.

The key assumptions used in calculating the most recent estimate of the loss reserves are reviewed each quarter and adjusted, to the extent necessary, to reflect the latest reported loss data, current trends and other factors observed.

        


21









The table below provides a reconciliation of the beginning and ending reserve balances:
 
September 30,
(In thousands)
2017
 
2016
Net reserves at beginning of year
$
9,590,265

 
$
9,244,872

Net provision for losses and loss expenses:
 
 
 
Claims occurring during the current year (1)
2,998,687

 
2,838,777

Decrease in estimates for claims occurring in prior years (2) (3)
(7,648
)
 
(23,518
)
Loss reserve discount accretion
34,436

 
37,080

Total
3,025,475

 
2,852,339

Net payments for claims:
 

 
 

Current year
628,078

 
612,615

Prior year
1,996,977

 
1,931,454

Total
2,625,055

 
2,544,069

Foreign currency translation
57,789

 
(6,266
)
Net reserves at end of period
10,048,474

 
9,546,876

Ceded reserve at end of period
1,605,872

 
1,550,954

Gross reserves at end of period
$
11,654,346

 
$
11,097,830

_______________________________________
(1)
Claims occurring during the current year are net of loss reserve discounts of $ 16,787,000 and $ 12,085,000 for the nine months ended September 30, 2017 and 2016, respectively.
(2)
The decrease in estimates for claims occurring in prior years is net of loss reserve discount. On an undiscounted basis, the estimates for claims occurring in prior years decreased by $ 30,609,000 and $ 45,813,000 for the nine months ended September 30, 2017 and 2016, respectively.
(3)
For certain retrospectively rated insurance policies and reinsurance agreements, reserve development is offset by additional or return premiums. Favorable development, net of additional and return premiums, was $31 million and $42 million for the nine months ended September 30, 2017 and 2016, respectively.

In 2017, favorable prior year development (net of additional and return premiums) of $31 million included $62 million of favorable development for the Insurance segment, partially offset by $31 million of adverse development for the Reinsurance segment. The favorable development for the Insurance segment was primarily attributable to workers' compensation business (including excess workers' compensation). The favorable workers' compensation development was spread across many accident years, including prior to 2008, but was most significant in accident years 2014 and 2015. The favorable workers' compensation development reflects a continuation of the benign loss cost trends experienced during 2016, particularly the favorable claim frequency trends (i.e., number of reported claims per unit of exposure). The adverse development for the Reinsurance segment was due to reserve strengthening associated with claims impacted by the change in the Ogden discount rate in the U.K., as well as adverse development in the U.S. facultative casualty excess of loss business. The Ogden rate is the discount rate used to calculate lump-sum bodily injury payouts in the U.K., and was reduced by the U.K. Ministry of Justice from +2.5% to -0.75%; the adverse development mostly related to U.K. motor bodily injury claims which we reinsured on an excess of loss basis in accident years 2012 through 2016. The adverse development on U.S. facultative casualty business related to construction-related risks in accident years 2008 and prior.

In 2016, favorable prior year development (net of additional and return premiums) of $ 42 million included $ 38 million for the Insurance segment and $ 4 million for the Reinsurance segment. The favorable development for the Insurance segment was primarily attributable to workers' compensation business, partially offset by adverse development for commercial auto liability and medical and other professional liability. The favorable development for workers' compensation stems from accident years 2003 through 2015, but is concentrated in accident years 2014 and 2015; it reflects claims frequency trends (i.e., number of reported claims per unit of exposure) that continue to be better than we expected. The unfavorable development for commercial auto liability was driven by higher large loss activity than expected in accident years 2014 and 2015, and the

22



unfavorable development for medical professional liability was primarily in accident years prior to 2013 and stemmed from a class of medical professional liability business that we discontinued writing in 2013.

(18) Fair Value of Financial Instruments
The following table presents the carrying amounts and estimated fair values of the Company’s financial instruments:
   
September 30, 2017
 
December 31, 2016
(In thousands)
Carrying Value
 
Fair Value
 
Carrying Value
 
Fair Value
Assets:
 
 
 
 
 
 
 
Fixed maturity securities
$
13,873,690

 
$
13,890,354

 
$
13,190,668

 
$
13,204,814

Equity securities available for sale
614,025

 
614,025

 
669,200

 
669,200

Arbitrage trading account
488,238

 
488,238

 
299,999

 
299,999

Loans receivable
74,229

 
76,615

 
106,798

 
108,299

Cash and cash equivalents
773,997

 
773,997

 
795,285

 
795,285

Trading account receivables from brokers and clearing organizations
297,208

 
297,208

 
484,593

 
484,593

Liabilities:
 
 
 
 
 
 
 
Due to broker
58,973

 
58,973

 
19,416

 
19,416

Trading account securities sold but not yet purchased
44,937

 
44,937

 
51,179

 
51,179

Subordinated debentures
728,071

 
728,291

 
727,630

 
687,504

Senior notes and other debt
1,759,929

 
1,946,700

 
1,760,595

 
1,914,727

The estimated fair values of the Company’s fixed maturity securities, equity securities available for sale and arbitrage trading account securities are based on various valuation techniques that rely on fair value measurements as described in Note 16 above. The fair value of loans receivable are estimated by using current institutional purchaser yield requirements for loans with similar credit characteristics, which is considered a Level 2 input. The fair value of the senior notes and other debt and the subordinated debentures is based on spreads for similar securities, which is considered a Level 2 input.

(19) Reinsurance

The following is a summary of reinsurance financial information:
   
For the Three Months
 
For the Nine Months
 
Ended September 30,
 
Ended September 30,
(In thousands)
2017
 
2016
 
2017
 
2016
Written premiums:
 
 
 
 
 
 
 
Direct
$
1,679,389

 
$
1,643,870

 
$
5,127,465

 
$
5,061,646

Assumed
194,769

 
224,979

 
570,052

 
702,265

Ceded
(302,975
)
 
(261,484
)
 
(915,245
)
 
(850,255
)
Total net premiums written
$
1,571,183

 
$
1,607,365

 
$
4,782,272

 
$
4,913,656

 
 
 
 
 
 
 
 
Earned premiums:
 
 
 
 
 
 
 
Direct
$
1,692,453

 
$
1,647,033

 
$
4,972,755

 
$
4,824,768

Assumed
202,972

 
216,758

 
605,281

 
635,443

Ceded
(313,925
)
 
(277,847
)
 
(857,792
)
 
(787,139
)
Total net premiums earned
$
1,581,500

 
$
1,585,944

 
$
4,720,244

 
$
4,673,072

 
 
 
 
 
 
 
 
Ceded losses and loss expenses incurred
$
247,104

 
$
213,065

 
$
424,905

 
$
507,258

Ceded commissions earned
$
63,222

 
$
47,315

 
$
177,524

 
$
143,809

The Company reinsures a portion of its insurance exposures in order to reduce its net liability on individual risks and catastrophe losses. The Company also cedes premiums to state assigned risk plans and captive insurance companies. Estimated

23



amounts due from reinsurers are reported net of reserves for uncollectible reinsurance of $1 million as of September 30, 2017 and December 31, 2016 .

(20) Restricted Stock Units
Pursuant to its stock incentive plan, the Company may issue restricted stock units (RSUs) to employees of the Company and its subsidiaries. The RSUs generally vest three to five years from the award date and are subject to other vesting and forfeiture provisions contained in the award agreement. RSUs are expensed pro-ratably over the vesting period. RSU expenses were $30 million and $25 million for the nine months ended September 30, 2017 and 2016 , respectively. A summary of RSUs issued in the nine months ended September 30, 2017 and 2016 follows:
 
($ in thousands)
Units
 
Fair Value
2017
855,051

 
$
58,712

2016
990,487

 
$
57,959


(21) Litigation and Contingent Liabilities
In the ordinary course of business, the Company is subject to disputes, litigation and arbitration arising from its insurance and reinsurance businesses. These matters are generally related to insurance and reinsurance claims and are considered in the establishment of loss and loss expense reserves. In addition, the Company may also become involved in legal actions which seek extra-contractual damages, punitive damages or penalties, including claims alleging bad faith in handling of insurance claims. The Company expects its ultimate liability with respect to such matters will not be material to its financial condition. However, adverse outcomes on such matters are possible, from time to time, and could be material to the Company’s results of operations in any particular financial reporting period.

(22) Business Segments
The Company’s reportable segments include the following two business segments, plus a corporate segment:
Insurance - primarily commercial insurance business, including excess and surplus lines and admitted lines in the United States, United Kingdom, Continental Europe, South America, Canada, Mexico, Scandinavia, Asia and Australia; and
Reinsurance - reinsurance business on a facultative and treaty basis, primarily in the United States, United Kingdom, Continental Europe, Australia, the Asia-Pacific Region and South Africa.
Commencing with the first quarter of 2017, the Company reclassified two businesses from the Insurance Segment to the Reinsurance segment. Reclassifications have been made to the Company's 2016 financial information to conform with this presentation.
The accounting policies of the segments are the same as those described in the summary of significant accounting policies. Income tax expense and benefits are calculated based upon the Company's overall effective tax rate.

24



Summary financial information about the Company's reporting segments is presented in the following tables. Income (loss) before income taxes by segment includes allocated investment income. Identifiable assets by segment are those assets used in or allocated to the operation of each segment.
   
Revenues
 
 
 
 
(In thousands)
Earned
Premiums
 
Investment
Income 
 
Other
 
Total (1)
 
Pre-Tax
Income
(Loss)
 
Net Income
(Loss) to Common Stockholders
Three months ended September 30, 2017
 
 
 
 
 
 
 
 
 
 
Insurance
$
1,433,729

 
$
105,924

 
$

 
$
1,539,653

 
$
171,478

 
$
123,240

Reinsurance
147,771

 
21,528

 

 
169,299

 
(57,643
)
 
(35,074
)
Corporate, other and eliminations (2)

 
15,027

 
123,404

 
138,431

 
(71,681
)
 
(45,685
)
Net investment gains

 

 
183,959

 
183,959

 
183,959

 
119,573

  Total
$
1,581,500

 
$
142,479

 
$
307,363

 
$
2,031,342

 
$
226,113

 
$
162,054

Three months ended September 30, 2016
 
 
 
 
 
 
 
 
 
 
Insurance
$
1,423,635

 
$
111,300

 
$

 
$
1,534,935

 
$
210,498

 
$
140,730

Reinsurance
162,309

 
27,567

 

 
189,876

 
27,321

 
18,725

Corporate, other and eliminations (2)

 
6,801

 
112,377

 
119,178

 
(81,942
)
 
(53,035
)
Net investment gains

 

 
175,738

 
175,738

 
175,738

 
114,230

  Total
$
1,585,944

 
$
145,668

 
$
288,115

 
$
2,019,727

 
$
331,615

 
$
220,650

Nine months ended September 30, 2017:
 
 
 
 
 
 
 
 
 
 
Insurance
$
4,262,485

 
320,552

 
$

 
$
4,583,037

 
$
557,605

 
$
381,736

Reinsurance
457,759

 
67,798

 

 
525,557

 
(38,279
)
 
(20,801
)
Corporate, other and eliminations (2)

 
38,251

 
326,203

 
364,454

 
(224,716
)
 
(146,324
)
Net investment gains

 

 
276,760

 
276,760

 
276,760

 
179,894

  Total
$
4,720,244

 
$
426,601

 
$
602,963

 
$
5,749,808

 
$
571,370

 
$
394,505

Nine months ended September 30, 2016:
 
 
 
 
 
 
 
 
 
 
Insurance
$
4,180,985

 
$
304,904

 
$

 
$
4,485,889

 
$
586,651

 
$
394,746

Reinsurance
492,087

 
77,119

 

 
569,206

 
79,215

 
54,885

Corporate, other and eliminations (2)

 
22,827

 
415,224

 
438,051

 
(190,655
)
 
(123,610
)
Net investment gains

 

 
189,394

 
189,394

 
189,394

 
123,106

  Total
$
4,673,072

 
$
404,850

 
$
604,618

 
$
5,682,540

 
$
664,605

 
$
449,127

_________________
(1) Revenues for Insurance from foreign countries for the three months ended September 30, 2017 and 2016 were $166 million and $187 million , respectively, and for the nine months ended September 30, 2017 and 2016 were $513 million and $546 million , respectively. Revenues for Reinsurance from foreign countries for the three months ended September 30, 2017 and 2016 were $49 million and $48 million , respectively, and for the nine months ended September 30, 2017 and 2016 were $150 million and $153 million , respectively.
(2) Corporate, other and eliminations represent corporate revenues and expenses that are not allocated to business segments.
Identifiable Assets
(In thousands)
September 30, 2017
 
December 31, 2016
Insurance
$
19,136,776

 
$
19,137,758

Reinsurance
3,243,610

 
2,524,338

Corporate, other and eliminations
1,955,690

 
1,687,980

  Consolidated
$
24,336,076

 
$
23,350,076


25




Net premiums earned by major line of business are as follows:
 
For the Three Months
 
For the Nine Months
 
Ended September 30,
 
Ended September 30,
(In thousands)
2017
 
2016
 
2017
 
2016
  Insurance:
 
 
 
 
 
 
 
Other liability
$
466,616

 
$
455,841

 
$
1,378,505

 
$
1,302,841

Workers’ compensation
378,529

 
354,185

 
1,106,616

 
1,042,503

Short-tail lines (1)
287,860

 
312,865

 
887,791

 
962,435

Commercial automobile
163,277

 
164,540

 
482,929

 
481,249

Professional liability
137,447

 
136,204

 
406,644

 
391,957

Total Insurance
1,433,729

 
1,423,635

 
4,262,485

 
4,180,985

 
 
 
 
 
 
 
 
  Reinsurance:
 
 
 
 
 
 
 
Casualty
94,478

 
97,153

 
282,430

 
301,571

Property
53,293

 
65,156

 
175,329

 
190,516

Total Reinsurance
147,771

 
162,309

 
457,759

 
492,087

 
 
 
 
 
 
 
 
Total
$
1,581,500

 
$
1,585,944

 
$
4,720,244

 
$
4,673,072

______________
(1) Short-tail lines include commercial multi-peril (non-liability), inland marine, accident and health, fidelity and surety, boiler and machinery and other lines.




26



SAFE HARBOR STATEMENT
    
This is a “Safe Harbor” Statement under the Private Securities Litigation Reform Act of 1995. Any forward-looking statements contained herein, including statements related to our outlook for the industry and for our performance for the year 2017 and beyond, are based upon the Company’s historical performance and on current plans, estimates and expectations. The inclusion of this forward-looking information should not be regarded as a representation by us or any other person that the future plans, estimates or expectations contemplated by us will be achieved. They are subject to various risks and uncertainties, including but not limited to: the cyclical nature of the property casualty industry; the impact of significant competition, including new alternative entrants to the industry; the long-tail and potentially volatile nature of the insurance and reinsurance business; product demand and pricing; claims development and the process of estimating reserves; investment risks, including those of our portfolio of fixed maturity securities and investments in equity securities, including investments in financial institutions, municipal bonds, mortgage-backed securities, loans receivable, investment funds, including real estate, merger arbitrage, energy related and private equity investments; the effects of emerging claim and coverage issues; the uncertain nature of damage theories and loss amounts; natural and man-made catastrophic losses, including as a result of terrorist activities; general economic and market activities, including inflation, interest rates, and volatility in the credit and capital markets; the impact of the conditions in the financial markets and the global economy, and the potential effect of legislative, regulatory, accounting or other initiatives taken in response, on our results and financial condition; foreign currency and political risks (including those associated with the United Kingdom's expected withdrawal from the European Union, or "Brexit") relating to our international operations; our ability to attract and retain key personnel and qualified employees; continued availability of capital and financing; the success of our new ventures or acquisitions and the availability of other opportunities; the availability of reinsurance; our retention under the Terrorism Risk Insurance Program Reauthorization Act of 2015; the ability of our reinsurers to pay reinsurance recoverables owed to us; other legislative and regulatory developments, including those related to business practices in the insurance industry; credit risk related to our policyholders, independent agents and brokers; changes in the ratings assigned to us or our insurance company subsidiaries by rating agencies; the availability of dividends from our insurance company subsidiaries; potential difficulties with technology and/or data security; the effectiveness of our controls to ensure compliance with guidelines, policies and legal and regulatory standards; and other risks detailed from time to time in the Company’s filings with the Securities and Exchange Commission. These risks and uncertainties could cause our actual results for the year 2017 and beyond to differ materially from those expressed in any forward-looking statement we make. Any projections of growth in our revenues would not necessarily result in commensurate levels of earnings. Our future financial performance is dependent upon factors discussed in our Annual Report on Form 10-K, elsewhere in this Form 10-Q and our other SEC filings. Forward-looking statements speak only as of the date on which they are made. Except to the extent required by applicable laws, the Company does not undertake any obligation to update or revise any forward-looking statement, whether as a result of new information, future developments or otherwise.

27



Item 2.
Management’s Discussion and Analysis of Financial Condition and Results of Operations

Overview
W. R. Berkley Corporation is an insurance holding company that is among the largest commercial lines writers in the United States and operates in two business segments: Insurance and Reinsurance. Our decentralized structure provides us with the flexibility to respond quickly and efficiently to local or specific market conditions and to pursue specialty business niches. It also allows us to be closer to our customers in order to better understand their individual needs and risk characteristics. While providing our business units with certain operating autonomy, our structure allows us to capitalize on the benefits of economies of scale through centralized capital, investment, reinsurance, enterprise risk management, and actuarial, financial and corporate legal staff support. The Company’s primary sources of revenues and earnings are its insurance operations and its investments.
An important part of our strategy is to form new operating units to capitalize on various business opportunities. Over the years, the Company has formed numerous operating units that are focused on important parts of the economy in the U.S., including healthcare, cyber security, energy and agriculture, and on growing international markets, including the Asia-Pacific region, South America and Mexico.
The profitability of the Company’s insurance business is affected primarily by the adequacy of premium rates. The ultimate adequacy of premium rates is not known with certainty at the time an insurance policy is issued because premiums are determined before claims are reported. The ultimate adequacy of premium rates is affected mainly by the severity and frequency of claims, which are influenced by many factors, including natural and other disasters, regulatory measures and court decisions that define and change the extent of coverage and the effects of economic inflation on the amount of compensation for injuries or losses. General insurance prices are also influenced by available insurance capacity, i.e., the level of statutory capital and surplus employed in the industry, and the industry’s willingness to deploy that capital.
The Company’s profitability is also affected by its investment income and investment gains. The Company’s invested assets are invested principally in fixed maturity securities. The return on fixed maturity securities is affected primarily by general interest rates, as well as the credit quality and duration of the securities. Returns available on fixed maturity investments are at historically low levels.
The Company invests in equity securities, merger arbitrage securities, investment funds (including energy related funds), private equity, loans and real estate related assets. The Company's investments in investment funds and its other alternative investments have experienced, and the Company expects to continue to experience, greater fluctuations in investment income.
During the third quarter of 2017, catastrophe losses were $119 million, including $107 million related to Hurricanes Harvey, Irma, and Maria and two earthquakes in Mexico.
Commencing with the first quarter of 2017, the Company reclassified two businesses from the Insurance segment to the Reinsurance segment. Reclassifications have been made to the Company's 2016 financial information to conform with this presentation.
Critical Accounting Estimates
The following presents a discussion of accounting policies and estimates relating to reserves for losses and loss expenses, assumed premiums and other-than-temporary impairments of investments. Management believes these policies and estimates are the most critical to its operations and require the most difficult, subjective and complex judgments.
Reserves for Losses and Loss Expenses . To recognize liabilities for unpaid losses, either known or unknown, insurers establish reserves, which is a balance sheet account representing estimates of future amounts needed to pay claims and related expenses with respect to insured events which have occurred. Estimates and assumptions relating to reserves for losses and loss expenses are based on complex and subjective judgments, often including the interplay of specific uncertainties with related accounting and actuarial measurements. Such estimates are also susceptible to change as significant periods of time may elapse between the occurrence of an insured loss, the report of the loss to the insurer, the ultimate determination of the cost of the loss and the insurer’s payment of that loss.
In general, when a claim is reported, claims personnel establish a “case reserve” for the estimated amount of the ultimate payment based upon known information about the claim at that time. The estimate represents an informed judgment based on general reserving practices and reflects the experience and knowledge of the claims personnel regarding the nature and value of the specific type of claim. Reserves are also established on an aggregate basis to provide for losses incurred but not reported (“IBNR”) to the insurer, potential inadequacy of case reserves and the estimated expenses of settling claims, including legal and other fees and general expenses of administrating the claims adjustment process. Reserves are established based upon the then current legal interpretation of coverage provided.

28



In examining reserve adequacy, several factors are considered in estimating the ultimate economic value of losses. These factors include, among other things, historical data, legal developments, changes in social attitudes and economic conditions, including the effects of inflation. The actuarial process relies on the basic assumption that past experience, adjusted judgmentally for the effects of current developments and anticipated trends, is an appropriate basis for predicting future outcomes. Reserve amounts are based on management’s informed estimates and judgments using currently available data. As additional experience and other data become available and are reviewed, these estimates and judgments may be revised. This may result in reserve increases or decreases that would be reflected in our results in periods in which such estimates and assumptions are changed.
Reserves do not represent an exact calculation of liability. Rather, reserves represent an estimate of what management expects the ultimate settlement and claim administration will cost. While the methods for establishing reserves are well tested over time, some of the major assumptions about anticipated loss emergence patterns are subject to uncertainty. These estimates, which generally involve actuarial projections, are based on management’s assessment of facts and circumstances then known, as well as estimates of trends in claims severity and frequency, judicial theories of liability and other factors, including the actions of third parties which are beyond the Company’s control. These variables are affected by external and internal events, such as inflation and economic volatility, judicial and litigation trends, reinsurance coverage, legislative changes and claim handling and reserving practices, which make it more difficult to accurately predict claim costs. The inherent uncertainties of estimating reserves are greater for certain types of liabilities where long periods of time elapse before a definitive determination of liability is made. Because setting reserves is inherently uncertain, the Company cannot provide assurance that its current reserves will prove adequate in light of subsequent events.
Loss reserves included in the Company’s financial statements represent management’s best estimates based upon an actuarially derived point estimate and other considerations. The Company uses a variety of actuarial techniques and methods to derive an actuarial point estimate for each operating unit. These methods include paid loss development, incurred loss development, paid and incurred Bornhuetter-Ferguson methods and frequency and severity methods. In circumstances where one actuarial method is considered more credible than the others, that method is used to set the point estimate. For example, the paid loss and incurred loss development methods rely on historical paid and incurred loss data. For new lines of business, where there is insufficient history of paid and incurred claims data, or in circumstances where there have been significant changes in claim practices, the paid and incurred loss development methods would be less credible than other actuarial methods. The actuarial point estimate may also be based on a judgmental weighting of estimates produced from each of the methods considered. Industry loss experience is used to supplement the Company’s own data in selecting “tail factors” and in areas where the Company’s own data is limited. The actuarial data is analyzed by line of business, coverage and accident or policy year, as appropriate, for each operating unit.
The establishment of the actuarially derived loss reserve point estimate also includes consideration of qualitative factors that may affect the ultimate losses. These qualitative considerations include, among others, the impact of re-underwriting initiatives, changes in the mix of business, changes in distribution sources and changes in policy terms and conditions. Examples of changes in terms and conditions that can have a significant impact on reserve levels are the use of aggregate policy limits, the expansion of coverage exclusions, whether or not defense costs are within policy limits, and changes in deductibles and attachment points.
The key assumptions used to arrive at the best estimate of loss reserves are the expected loss ratios, rate of loss cost inflation, and reported and paid loss emergence patterns. Expected loss ratios represent management’s expectation of losses at the time the business is written, before any actual claims experience has emerged. This expectation is a significant determinant of the estimate of loss reserves for recently written business where there is little paid or incurred loss data to consider. Expected loss ratios are generally derived from historical loss ratios adjusted for the impact of rate changes, loss cost trends and known changes in the type of risks underwritten. Expected loss ratios are estimated for each key line of business within each operating unit. Expected loss cost inflation is particularly important for the long-tail lines, such as excess casualty, and claims with a high medical component, such as workers’ compensation. Reported and paid loss emergence patterns are used to project current reported or paid loss amounts to their ultimate settlement value. Loss development factors are based on the historical emergence patterns of paid and incurred losses, and are derived from the Company’s own experience and industry data. The paid loss emergence pattern is also significant to excess and assumed workers’ compensation reserves because those reserves are discounted to their estimated present value based upon such estimated payout patterns. Management believes the estimates and assumptions it makes in the reserving process provide the best estimate of the ultimate cost of settling claims and related expenses with respect to insured events which have occurred; however, different assumptions and variables could lead to significantly different reserve estimates.
Loss frequency and severity are measures of loss activity that are considered in determining the key assumptions described in our discussion of loss and loss expense reserves, including expected loss ratios, rate of loss cost inflation and reported and paid loss emergence patterns. Loss frequency is a measure of the number of claims per unit of insured exposure, and loss severity is a measure of the average size of claims. Factors affecting loss frequency include the effectiveness of loss

29



controls and safety programs and changes in economic activity or weather patterns. Factors affecting loss severity include changes in policy limits, retentions, rate of inflation and judicial interpretations.
Another factor affecting estimates of loss frequency and severity is the loss reporting lag, which is the period of time between the occurrence of a loss and the date the loss is reported to the Company. The length of the loss reporting lag affects our ability to accurately predict loss frequency (loss frequencies are more predictable for lines with short reporting lags) as well as the amount of reserves needed for incurred but not reported losses (less IBNR is required for lines with short reporting lags). As a result, loss reserves for lines with short reporting lags are likely to have less variation from initial loss estimates. For lines with short reporting lags, which include commercial automobile, primary workers’ compensation, other liability (claims-made) and property business, the key assumption is the loss emergence pattern used to project ultimate loss estimates from known losses paid or reported to date. For lines of business with long reporting lags, which include other liability (occurrence), products liability, excess workers’ compensation and liability reinsurance, the key assumption is the expected loss ratio since there is often little paid or incurred loss data to consider. Historically, the Company has experienced less variation from its initial loss estimates for lines of businesses with short reporting lags than for lines of business with long reporting lags.
The key assumptions used in calculating the most recent estimate of the loss reserves are reviewed each quarter and adjusted, to the extent necessary, to reflect the latest reported loss data, current trends and other factors observed. If the actual level of loss frequency and severity are higher or lower than expected, the ultimate losses will be different than management’s estimate. The following table reflects the impact of changes (which could be favorable or unfavorable) in frequency and severity, relative to our assumptions, on our loss estimate for claims occurring in 2016:
(In thousands)
Frequency (+/-)
Severity (+/-)
1%
 
5%
 
10%
1%
$
76,915

 
$
231,511

 
$
424,755

5%
231,511

 
392,229

 
593,126

10%
424,755

 
593,126

 
803,590

Our net reserves for losses and loss expenses of approximately $10.0 billion as of September 30, 2017 relate to multiple accident years. Therefore, the impact of changes in frequency or severity for more than one accident year could be higher or lower than the amounts reflected above. The impact of such changes would likely be manifested gradually over the course of many years, as the magnitude of the changes became evident.
Approximately $1.8 billion, or 17%, of the Company’s net loss reserves as of September 30, 2017 relate to the Reinsurance segment. There is a higher degree of uncertainty and greater variability regarding estimates of assumed loss reserves because those estimates are based, in part, upon information received from ceding companies. If information received from ceding companies is not timely or correct, the Company’s estimate of ultimate losses may not be accurate. Furthermore, due to delayed reporting of claim information by ceding companies, the claim settlement tail for assumed reinsurance is extended. Management considers the impact of delayed reporting in its selection of assumed loss development factors.
Information received from ceding companies is used to set initial expected loss ratios, to establish case reserves and to estimate reserves for incurred but not reported losses on assumed reinsurance business. This information, which is generally provided through reinsurance intermediaries, is gathered through the underwriting process and from periodic claim reports and other correspondence with ceding companies. The Company performs underwriting and claim audits of selected ceding companies to determine the accuracy and completeness of information provided to the Company. The information received from the ceding companies is supplemented by the Company’s own loss development experience with similar lines of business as well as industry loss trends and loss development benchmarks.
Following is a summary of the Company’s reserves for losses and loss expenses by business segment:
(In thousands)
September 30, 2017
 
December 31, 2016
Insurance
$
8,291,708

 
$
7,913,074

Reinsurance
1,756,766

 
1,677,191

Net reserves for losses and loss expenses
10,048,474

 
9,590,265

Ceded reserves for losses and loss expenses
1,605,872

 
1,606,930

Gross reserves for losses and loss expenses
$
11,654,346

 
$
11,197,195

Following is a summary of the Company’s net reserves for losses and loss expenses by major line of business:

30



 
(In thousands)
Reported Case
Reserves
 
Incurred But
Not Reported
 
Total
September 30, 2017
 
 
 
 
 
Other liability
$
1,243,208

 
$
2,162,031

 
$
3,405,239

Workers’ compensation (1)
1,530,194

 
1,246,084

 
2,776,278

Professional liability
299,418

 
584,606

 
884,024

Commercial automobile
341,998

 
267,136

 
609,134

Short-tail lines (2)
309,692

 
307,341

 
617,033

Total Insurance
3,724,510

 
4,567,198

 
8,291,708

Reinsurance (1)
909,690

 
847,076

 
1,756,766

Total
$
4,634,200

 
$
5,414,274

 
$
10,048,474

 
 
 
 
 
 
December 31, 2016
 
 
 
 
 
Other liability
$
1,159,082

 
$
2,061,966

 
$
3,221,048

Workers’ compensation (1)
1,453,318

 
1,228,774

 
2,682,092

Professional liability
264,188

 
542,539

 
806,727

Commercial automobile
344,143

 
252,978

 
597,121

Short-tail lines (2)
322,872

 
283,214

 
606,086

Total Insurance
3,543,603

 
4,369,471

 
7,913,074

Reinsurance (1)
823,516

 
853,675

 
1,677,191

Total
$
4,367,119

 
$
5,223,146

 
$
9,590,265

___________
(1) Reserves for workers’ compensation and reinsurance are net of an aggregate net discount of $599 million and $640
million as of September 30, 2017 and December 31, 2016, respectively.
(2) Short-tail lines include commercial multi-peril (non-liability), inland marine, accident and health, fidelity and surety, boiler and machinery and other lines.

The Company evaluates reserves for losses and loss adjustment expenses on a quarterly basis. Changes in estimates of prior year losses are reported when such changes are made. The changes in prior year loss reserve estimates are generally the result of ongoing analysis of recent loss development trends. Original estimates are increased or decreased as additional information becomes known regarding individual claims and aggregate claim trends.
    
Certain of the Company's insurance and reinsurance contracts are retrospectively rated, whereby the Company collects more or less premiums based on the level of loss activity. For those contracts, changes in loss and loss adjustment expenses for prior years may be fully or partially offset by additional or return premiums.

Net prior year development (i.e. the sum of prior year reserve changes and prior year earned premiums changes) for the nine months ended September 30, 2017 and 2016 are as follows:
 
(In thousands)
2017
 
2016
Net decrease in prior year loss reserves
$
7,648

 
$
23,518

Increase in prior year earned premiums
22,940

 
18,039

Net favorable prior year development
$
30,588

 
$
41,557

         
In 2017, favorable prior year development (net of additional and return premiums) of $31 million included $62 million of favorable development for the Insurance segment, partially offset by $31 million of adverse development for the Reinsurance segment. The favorable development for the Insurance segment was primarily attributable to workers' compensation business (including excess workers' compensation). The favorable workers' compensation development was spread across many accident years, including prior to 2008, but was most significant in accident years 2014 and 2015. The favorable workers' compensation development reflects a continuation of the benign loss cost trends experienced during 2016, particularly the favorable claim frequency trends (i.e., number of reported claims per unit of exposure). The adverse development for the Reinsurance segment was due to reserve strengthening associated with claims impacted by the change in

31



the Ogden discount rate in the U.K., as well as adverse development on the U.S. facultative casualty excess of loss business. The Ogden rate is the discount rate used to calculate lump-sum bodily injury payouts in the U.K., and was reduced by the U.K. Ministry of Justice from +2.5% to -0.75%; the adverse development mostly related to U.K. motor bodily injury claims which we reinsured on an excess of loss basis in accident years 2012 through 2016. The adverse development on U.S. facultative casualty business was due to construction-related risks in accident years 2008 and prior.
In 2016, favorable prior year development (net of additional and return premiums) of $42 million included $38 million for the Insurance segment and $4 million for the Reinsurance segment. The favorable development for the Insurance segment was primarily attributable to workers' compensation business, partially offset by adverse development for commercial auto liability and medical and other professional liability. The favorable development for workers' compensation stems from accident years 2003 through 2015, but is concentrated in accident years 2014 and 2015; it reflects claims frequency trends (i.e., number of reported claims per unit of exposure) that continue to be better than we expected. The unfavorable development for commercial auto liability was driven by higher large loss activity than expected in accident years 2014 and 2015, and the unfavorable development for medical professional liability was primarily in accident years prior to 2013 and stemmed from a class of medical professional liability business that we discontinued writing in 2013.
Reserve Discount . The Company discounts its liabilities for certain workers’ compensation reserves. The amount of workers’ compensation reserves that were discounted was $1,849 million and $1,907 million at September 30, 2017 and December 31, 2016, respectively. The aggregate net discount for those reserves, after reflecting the effects of ceded reinsurance, was $599 million and $640 million at September 30, 2017 and December 31, 2016, respectively. At September 30, 2017, discount rates by year ranged from 2.0% to 6.5%, with a weighted average discount rate of 3.8%.

             Substantially all of the workers’ compensation discount (97% of total discounted reserves at September 30, 2017) relates to excess workers’ compensation reserves. In order to properly match loss expenses with income earned on investment securities supporting the liabilities, reserves for excess workers’ compensation business are discounted using risk-free discount rates determined by reference to the U.S. Treasury yield curve. These rates are determined annually based on the weighted average rate for the period. Once established, no adjustments are made to the discount rate for that period, and any increases or decreases in loss reserves in subsequent years are discounted at the same rate, without regard to when any such adjustments are recognized. The expected loss and loss expense payout patterns subject to discounting are derived from the Company’s loss payout experience.  

        The Company also discounts reserves for certain other long-duration workers’ compensation reserves (representing approximately 3% of total discounted reserves at September 30, 2017), including reserves for quota share reinsurance and reserves related to losses regarding occupational lung disease. These reserves are discounted at statutory rates permitted by the Department of Insurance of the State of Delaware.
    
          Assumed Reinsurance Premiums . The Company estimates the amount of assumed reinsurance premiums that it will receive under treaty reinsurance agreements at the inception of the contracts. These premium estimates are revised as the actual amount of assumed premiums is reported to the Company by the ceding companies. As estimates of assumed premiums are made or revised, the related amount of earned premiums, commissions and incurred losses associated with those premiums are recorded. Estimated assumed premiums receivable were approximately $56 million at September 30, 2017 and $68 million at December 31, 2016. The assumed premium estimates are based upon terms set forth in reinsurance agreements, information received from ceding companies during the underwriting and negotiation of agreements, reports received from ceding companies and discussions and correspondence with reinsurance intermediaries. The Company also considers its own view of market conditions, economic trends and experience with similar lines of business. These premium estimates represent management’s best estimate of the ultimate amount of premiums to be received under its assumed reinsurance agreements.
Other-Than-Temporary Impairments (OTTI) of Investments . The cost of securities is adjusted where appropriate to include a provision for decline in value which is considered to be other-than-temporary. An other-than-temporary decline is considered to occur in investments where there has been a sustained reduction in fair value and where the Company does not expect the fair value to recover prior to the time of sale or maturity. Since equity securities do not have a contractual cash flow or maturity, the Company considers whether the price of an equity security is expected to recover within a reasonable period of time.
The Company classifies its fixed maturity securities and preferred stocks by credit rating, primarily based on ratings assigned by credit rating agencies. For purposes of classifying securities with different ratings, the Company uses the average of the credit ratings assigned, unless in limited situations the Company’s own analysis indicates an internal rating is more appropriate. Securities that are not rated by a rating agency are evaluated and classified by the Company on a case-by-case basis.

32



Fixed Maturity Securities – For securities that we intend to sell or, more likely than not, would be required to sell, a decline in value below amortized cost is considered to be OTTI. The amount of OTTI is equal to the difference between amortized cost and fair value at the balance sheet date. For securities that we do not intend to sell or expect to be required to sell, a decline in value below amortized cost is considered to be an OTTI if we do not expect to recover the entire amortized cost basis of a security (i.e., the present value of cash flows expected to be collected is less than the amortized cost basis of the security).
The portion of the decline in value considered to be a credit loss (i.e., the difference between the present value of cash flows expected to be collected and the amortized cost basis of the security) is recognized in earnings. The portion of the decline in value not considered to be a credit loss (i.e., the difference in the present value of cash flows expected to be collected and the fair value of the security) is recognized in other comprehensive income.
Impairment assessments for structured securities, including mortgage-backed securities and asset-backed securities, collateralized debt obligations and corporate debt, are generally evaluated based on the performance of the underlying collateral under various economic and default scenarios that may involve subjective judgments and estimates by management. Modeling these securities involves various factors, such as projected default rates, the nature and realizable value of the collateral, if any, the ability of the issuer to make scheduled payments, historical performance and other relevant economic and performance factors. If an OTTI determination is made, a discounted cash flow analysis is used to ascertain the amount of the credit impairment.

The following table provides a summary of fixed maturity securities in an unrealized loss position as of September 30, 2017:
($ in thousands)
Number of
Securities
 
Aggregate
Fair Value
 
Gross Unrealized
Loss
Unrealized loss less than 20% of amortized cost
592

 
$
3,864,164

 
$
40,565

Unrealized loss of 20% or greater of amortized cost:
 
 
 
 
 
Twelve months and longer
3

 
180

 
112

Total
595

 
$
3,864,344

 
$
40,677

A summary of the Company’s non-investment grade fixed maturity securities that were in an unrealized loss position at September 30, 2017 is presented in the table below:
($ in thousands)
Number of
Securities
 
Aggregate
Fair Value
 
Gross Unrealized
Loss
Foreign government
9

 
$
55,292

 
$
462

Mortgage-backed securities
6

 
5,975

 
150

Corporate
3

 
2,852

 
211

Asset-backed securities
3

 
1,331

 
115

Total
21

 
$
65,450

 
$
938

    
The Company has evaluated its fixed maturity securities in an unrealized loss position and believes the unrealized loss is due primarily to temporary market and sector-related factors rather than to issuer-specific factors. None of these securities are delinquent or in default under financial covenants. Based on its assessment of these issuers, the Company expects them to continue to meet their contractual payment obligations as they become due and does not consider any of these securities to be OTTI.
Preferred Stocks – At September 30, 2017, there was one preferred stock in an unrealized loss position, with a fair value of $24.0 million and a gross unrealized loss of $1.7 million. Based upon management's view of the underlying value of the security, the Company does not consider the equity security to be OTTI. For the nine months ended September 30, 2017 and 2016, there was no OTTI for preferred stocks.
Common Stocks – At September 30, 2017, there were three common stocks in an unrealized loss position, with an aggregate fair value of $14.1 million and a gross unrealized loss of $3.5 million. Based upon management’s view of the underlying value of these securities, the Company does not consider these equity securities to be OTTI. There was no OTTI of common stocks for the nine months ended September 30, 2017 . For the nine months ended September 30, 2016, OTTI for common stocks was $18.1 million.

33



Loans Receivable – The Company monitors the performance of its loans receivable, including current market conditions for each loan and the ability to collect principal and interest. For loans where the Company determines it is probable that the contractual terms will not be met, an analysis is performed and a valuation reserve is established, if necessary, with a charge to earnings. Loans receivable are reported net of a valuation reserve of $3 million at both September 30, 2017 and December 31, 2016.
The Company monitors the performance of its loans receivable and assesses the ability of each borrower to pay principal and interest based upon loan structure, underlying property values, cash flow and related financial and operating performance of the property and market conditions. Loans receivable with a potential for default are further assessed using discounted cash flow analysis and comparable cost and sales methodologies, if appropriate.
Fair Value Measurements . The Company’s fixed maturity and equity securities available for sale and its trading account securities are carried at fair value. Fair value is defined as “the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.” The Company utilizes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date. Level 2 inputs are inputs other than quoted prices included within Level 1 that are observable for similar assets in active markets. Level 3 inputs are unobservable inputs for the asset or liability. Unobservable inputs may only be used to measure fair value to the extent that observable inputs are not available. The fair value of the vast majority of the Company’s portfolio is based on observable data (other than quoted prices) and, accordingly, is classified as Level 2.

In classifying particular financial securities in the fair value hierarchy, the Company uses its judgment to determine whether the market for a security is active and whether significant pricing inputs are observable. The Company determines the existence of an active market by assessing whether transactions occur with sufficient frequency and volume to provide reliable pricing information. The Company determines whether inputs are observable based on the use of such information by pricing services and external investment managers, the uninterrupted availability of such inputs, the need to make significant adjustments to such inputs and the volatility of such inputs over time. If the market for a security is determined to be inactive or if significant inputs used to price a security are determined to be unobservable, the security is categorized in Level 3 of the fair value hierarchy.
Because many fixed maturity securities do not trade on a daily basis, the Company utilizes pricing models and processes which may include benchmark curves, benchmarking of like securities, sector groupings and matrix pricing. Market inputs used to evaluate securities include benchmark yields, reported trades, broker/dealer quotes, issuer spreads, two-sided markets, benchmark securities, bids, offers and reference data. Quoted prices are often unavailable for recently issued securities that are infrequently traded or securities that are only traded in private transactions. For publicly traded securities for which quoted prices are unavailable, the Company determines fair value based on independent broker quotations and other observable market data. For securities traded only in private negotiations, the Company determines fair value based primarily on the cost of such securities, which is adjusted to reflect prices of recent placements of securities of the same issuer, financial data, projections and business developments of the issuer and other relevant information.
The following is a summary of pricing sources for the Company's fixed maturity securities available for sale as of September 30, 2017:
($ in thousands)
Carrying
Value
 
Percent
of Total
Pricing source:
 
 
 
Independent pricing services
$
13,570,457

 
98.4
%
Syndicate manager
43,196

 
0.3

Directly by the Company based on:
 
 
 
Observable data
180,467

 
1.3

Cash flow model
174

 

Total
$
13,794,294

 
100.0
%

Independent pricing services – Substantially all of the Company’s fixed maturity securities available for sale were priced by independent pricing services (generally one U.S. pricing service plus additional pricing services with respect to a limited number of foreign securities held by the Company). The prices provided by the independent pricing services are generally based on observable market data in active markets (e.g., broker quotes and prices observed for comparable securities). The determination of whether markets are active or inactive is based upon the volume and level of activity for a particular asset class. The Company reviews the prices provided by pricing services for reasonableness based upon current trading levels for

34



similar securities. If the prices appear unusual to the Company, they are re-examined and the value is either confirmed or revised. In addition, the Company periodically performs independent price tests of a sample of securities to ensure proper valuation and to verify our understanding of how securities are priced. As of September 30, 2017, the Company did not make any adjustments to the prices provided by the pricing services. Based upon the Company’s review of the methodologies used by the independent pricing services, these securities were classified as Level 2.
Syndicate manager – The Company has a 15% participation in a Lloyd’s syndicate, and the Company’s share of the securities owned by the syndicate is priced by the syndicate’s manager. The majority of the securities are liquid, short duration fixed maturity securities. The Company reviews the syndicate manager’s pricing methodology and audited financial statements and holds discussions with the syndicate manager as necessary to confirm its understanding and agreement with security prices. Based upon the Company’s review of the methodologies used by the syndicate manager, these securities were classified as Level 2.
Observable data – If independent pricing is not available, the Company prices the securities directly. Prices are based on observable market data where available, including current trading levels for similar securities and non-binding quotations from brokers. The Company generally requests two or more quotes. If more than one quote is received, the Company sets a price within the range of quotes received based on its assessment of the credibility of the quote and its own evaluation of the security. The Company generally does not adjust quotes obtained from brokers. Since these securities were priced based on observable data, they were classified as Level 2.
Cash flow model – If the above methodologies are not available, the Company prices securities using a discounted cash flow model based upon assumptions as to prevailing credit spreads, interest rates and interest rate volatility, time to maturity and subordination levels. Discount rates are adjusted to reflect illiquidity where appropriate. These securities were classified as Level 3.



35



Results of Operations for the Nine Months Ended September 30, 2017 and 2016
 
Business Segment Results
Following is a summary of gross and net premiums written, net premiums earned, loss ratios (losses and loss expenses incurred expressed as a percentage of premiums earned), expense ratios (underwriting expenses expressed as a percentage of premiums earned) and United States Generally Accepted Accounting Principles (“GAAP”) combined ratios (sum of loss ratio and expense ratio) for each of our business segments for the nine months ended September 30, 2017 and 2016 . The GAAP combined ratio represents a measure of underwriting profitability, excluding investment income. A GAAP combined ratio in excess of 100 indicates an underwriting loss; a number below 100 indicates an underwriting profit.
($ in thousands)
2017
 
2016
Insurance:
 
 
 
Gross premiums written
$
5,233,692

 
$
5,184,033

Net premiums written
4,364,638

 
4,386,944

Net premiums earned
4,262,485

 
4,180,985

Loss ratio
61.7
%
 
61.1
%
Expense ratio
32.8
%
 
32.3
%
GAAP combined ratio
94.5
%
 
93.4
%
Reinsurance:
 
 
 
Gross premiums written
$
463,825

 
$
579,878

Net premiums written
417,634

 
526,712

Net premiums earned
457,759

 
492,087

Loss ratio
86.1
%
 
60.5
%
Expense ratio
37.1
%
 
39.1
%
GAAP combined ratio
123.2
%
 
99.6
%
Consolidated:
 
 
 
Gross premiums written
$
5,697,517

 
$
5,763,911

Net premiums written
4,782,272

 
4,913,656

Net premiums earned
4,720,244

 
4,673,072

Loss ratio
64.1
%
 
61.0
%
Expense ratio
33.2
%
 
33.1
%
GAAP combined ratio
97.3
%
 
94.1
%
Net Income to Common Stockholders . The following table presents the Company’s net income to common stockholders and net income per diluted share for the nine months ended September 30, 2017 and 2016:
(In thousands, except per share data)
2017
 
2016
Net income to common stockholders
$
394,505

 
$
449,127

Weighted average diluted shares
129,289

 
128,501

Net income per diluted share
$
3.05

 
$
3.50

The Company reported net income of $395 million in 2017 compared to $449 million in 2016. The 12% decrease in net income was primarily due to an after-tax decrease in underwriting income of $97 million mainly driven by increased catastrophe losses from Hurricanes Harvey, Irma and Maria, as well as two earthquakes in Mexico, an after-tax increase in net foreign currency losses of $17 million, and an after-tax decrease in income from non-insurance businesses of $7 million, partially offset by an increase in after-tax net investment gains of $57 million and an after-tax increase in investment income of $14 million. The number of weighted average diluted shares remained relatively unchanged for the nine months ended September 30, 2017 and 2016.
Premiums . Gross premiums written were $5,698 million in 2017, a decrease of 1% from $5,764 million in 2016. The decrease was due to a decrease in the Reinsurance segment of $116 million, partially offset by an increase in the Insurance segment of $50 million. Approximately 77.7% of policies expiring in 2017 were renewed, compared with a 77.8% renewal retention rate for policies expiring in 2016.
    Average renewal premium rates for insurance and facultative reinsurance increased 1.0% in 2017 when adjusted for change in exposures.


36




A summary of gross premiums written in 2017 compared with 2016 by line of business within each business segment follows:
Insurance - gross premiums increased 1% to $5,234 million in 2017 from $5,184 million in 2016. Gross premiums increased $25 million (5%) for professional liability, $19 million (4%) for commercial auto, $8 million (1%) for workers' compensation, and $2 million (less than 1%) for short-tail lines and decreased $4 million (less than 1%) for other liability.
Reinsurance - gross premiums decreased 20% to $464 million in 2017 from $580 million in 2016. Gross premiums decreased $87 million (35%) for property lines and $29 million (9%) for casualty lines.
Net premiums written were $4,782 million in 2017, a decrease of 3% from $4,914 million in 2016. Ceded reinsurance premiums as a percentage of gross written premiums were 16% in 2017 and 15% in 2016.
Premiums earned increased 1% to $4,720 million in 2017 from $4,673 million in 2016. Insurance premiums (including the impact of rate changes) are generally earned evenly over the policy term, and accordingly, recent rate increases will be earned over the upcoming quarters. Premiums earned in 2017 are related to business written during both 2017 and 2016. Audit premiums were $137 million in 2017 compared with $116 million in 2016.
Net investment Income . Following is a summary of net investment income for the nine months ended September 30, 2017 and 2016:  
 
Amount
 
Average Annualized
Yield
($ in thousands)
2017
 
2016
 
2017
 
2016
Fixed maturity securities, including cash and cash equivalents and loans receivable
$
347,976

 
$
331,448

 
3.3
%
 
3.3
%
Investment funds
50,744

 
60,385

 
5.5

 
6.6

Arbitrage trading account
16,235

 
12,883

 
4.0

 
4.4

Real estate
14,894

 
4,552

 
1.6

 
0.6

Equity securities available for sale
1,845

 
3,217

 
1.2

 
2.2

Gross investment income
431,694

 
412,485

 
3.3

 
3.3

Investment expenses
(5,093
)
 
(7,635
)
 
 
 
 
Total
$
426,601

 
$
404,850

 
3.3
%
 
3.3
%
Net investment income increased 5% to $427 million in 2017 from $405 million in 2016 due primarily to a $16 million increase in income from fixed maturity securities, a $10 million increase from real estate, a $3 million increase from the arbitrage trading account, and a reduction of investment expenses of $3 million, partially offset by a $10 million decrease from investment funds. Average invested assets, at cost (including cash and cash equivalents), were $17.4 billion in 2017 and $16.6 billion in 2016.
Insurance Service Fees . The Company earns fees from an insurance distribution business and as a servicing carrier of workers' compensation assigned risk plans for certain states. Service fees decreased to $100 million in 2017 from $109 million in 2016.
Net Realized Gains on Investment Sales . The Company buys and sells securities and other investment assets on a regular basis in order to maximize its total return on investments. Decisions to sell securities and other investment assets are based on management’s view of the underlying fundamentals of specific investments as well as management’s expectations regarding interest rates, credit spreads, currency values and general economic conditions. Net realized gains on investment sales were $277 million in 2017 compared with $208 million in 2016. The nine months ended September 30, 2017 include a gain of $124 million from the sale of an investment in an office building located in Washington D.C. The nine months ended September 30, 2016 include a gain of $135 million from the sale of Aero Precision Industries and certain related aviation services business.
Other-Than-Temporary Impairments . There were no impairments in 2017. Other-than-temporary impairments of $18.1 million in 2016 related to common stocks.
Revenues from Non-Insurance Businesses . Revenues from non-insurance businesses were derived from businesses engaged in the distribution of promotional merchandise, world-wide textile solutions and aviation-related businesses that

37



provide services to aviation markets, including (i) the distribution, manufacturing, repair and overhaul of aircraft parts and components, (ii) the sale of new and used aircraft, and (iii) avionics, fuel, maintenance, storage and charter services. Revenues from non-insurance businesses were $225 million in 2017 and $306 million in 2016. The decrease was primarily related to the sale of Aero Precision Industries in August 2016, partially offset by revenues from the textile business purchased in March 2017.
Losses and Loss Expenses . Losses and loss expenses increased to $3,025 million in 2017 from $2,852 million in 2016. The consolidated loss ratio was 64.1% in 2017 and 61.0% in 2016. Catastrophe losses, net of reinsurance recoveries and reinstatement premiums, were $167 million in 2017 and $68 million in 2016. Hurricanes Harvey, Irma and Maria, along with two earthquakes in Mexico, resulted in catastrophe losses of $107 million. Favorable prior year reserve development (net of premium offsets) was $31 million in 2017 and $42 million in 2016. The loss ratio excluding catastrophe losses and prior year reserve development increased 0.8 points to 61.2% in 2017 from 60.4% in 2016.
A summary of loss ratios in 2017 compared with 2016 by business segment follows:
Insurance - The loss ratio was 61.7% in 2017 and 61.1% in 2016. Catastrophe losses were $94 million in 2017 compared with $58 million in 2016. Favorable prior year reserve development was $62 million in 2017 and $38 million in 2016. The loss ratio excluding catastrophe losses and prior year reserve development increased 0.4 points to 61.0% in 2017 from 60.6% in 2016.
Reinsurance - The loss ratio of 86.1% in 2017 was 25.6 points higher than the loss ratio of 60.5% in 2016. Catastrophe losses were $73 million in 2017 compared with $10 million in 2016. Adverse prior year reserve development was $31 million in 2017 largely due to the impact of the change in the Ogden discount rate in the U.K. and adverse development related to the U.S. facultative casualty excess of loss business, compared with favorable prior year development of $4 million in 2016. The loss ratio excluding catastrophe losses and prior year reserve development i ncreased 4.1 points to 63.3% in 2017 from 59.2% in 2016.
Other Operating Costs and Expenses . Following is a summary of other operating costs and expenses:
($ in thousands)
2017
 
2016
Policy acquisition and operating insurance expenses
$
1,567,359

 
$
1,544,792

Insurance service expenses
97,308

 
103,868

Net foreign currency (gains) losses
14,255

 
(11,547
)
Other costs and expenses
142,233

 
133,337

Total
$
1,821,155

 
$
1,770,450


Policy acquisition and operating insurance expenses are comprised of commissions paid to agents and brokers, premium taxes and other assessments and internal underwriting costs. Policy acquisition and operating insurance expenses increased 1 % compared with an increase in net premiums earned of 1%. The expense ratio (underwriting expenses expressed as a percentage of premiums earned) was 33.2% and 33.1% for the nine months ended September 30, 2017 and 2016, respectively.
Service expenses, which represent the costs associated with the fee-based businesses, decreased to $97 million in 2017 from $104 million in 2016.
Net foreign currency (gains) losses result from transactions denominated in a currency other than a company's operating functional currency. Net foreign currency losses were $14 million in 2017 compared to gains of $12 million in 2016.
Other costs and expenses represent general and administrative expenses of the parent company and other expenses not allocated to business segments, including the cost of certain long-term incentive plans and new business ventures. Other costs and expenses increased to $142 million in 2017 from $133 million in 2016 primarily because of startup costs for new business ventures.
Expenses from Non-Insurance Businesses . Expenses from non-insurance businesses represent costs associated with businesses engaged in the distribution of promotional merchandise, world-wide textile solutions and aviation-related businesses that include (i) cost of goods sold related to aircraft and products sold and services provided, and (ii) general and administrative expenses. Expenses from non-insurance businesses were $221 million in 2017 compared to $291 million in 2016. The decline mainly relates to the sale of Aero Precision Industries in August 2016, partially offset by the expense from the textile business purchased in March 2017.

38



Interest Expense . Interest expense was $110 million in 2017 compared with $104 million in 2016. During 2017, the Company repaid $2 million of debt compared to $83 million in 2016, mainly in connection with the sale of Aero Precision Industries. In February 2016, the Company issued $110 million of 5.9% subordinated debentures maturing in 2056, and in May 2016, the Company issued $290 million of 5.75% subordinated debentures maturing in 2056.
Income Taxes . The effective income tax rate was 31% in 2017 and 32% in 2016. The effective income tax rate differs from the federal income tax rate of 35% primarily because of tax-exempt investment income.
The Company has not provided U.S. deferred income taxes on the undistributed earnings of approximately $40 million of its non-U.S. subsidiaries since these earnings are intended to be permanently reinvested in the non-U.S. subsidiaries. However, in the future, if such earnings were distributed to the Company, taxes of approximately $4 million, assuming all tax credits are realized, would be payable on such undistributed earnings and would be reflected in the tax provision for the year in which these earnings are no longer intended to be permanently reinvested in the foreign subsidiary.

Results of Operations for the Three Months Ended September 30, 2017 and 2016
 
Business Segment Results
Following is a summary of gross and net premiums written, net premiums earned, loss ratios (losses and loss expenses incurred expressed as a percentage of premiums earned), expense ratios (underwriting expenses expressed as a percentage of premiums earned) and United States Generally Accepted Accounting Principles (“GAAP”) combined ratios (sum of loss ratio and expense ratio) for each of our business segments for the three months ended September 30, 2017 and 2016 . The GAAP combined ratio represents a measure of underwriting profitability, excluding investment income. A GAAP combined ratio in excess of 100 indicates an underwriting loss; a number below 100 indicates an underwriting profit.
($ in thousands)
2017
 
2016
Insurance:
 
 
 
Gross premiums written
$
1,718,552

 
$
1,688,712

Net premiums written
1,432,334

 
1,443,986

Net premiums earned
1,433,729

 
1,423,635

Loss ratio
63.2
%
 
60.9
%
Expense ratio
32.4
%
 
32.3
%
GAAP combined ratio
95.6
%
 
93.2
%
Reinsurance:
 
 
 
Gross premiums written
$
155,606

 
$
180,137

Net premiums written
138,849

 
163,379

Net premiums earned
147,771

 
162,309

Loss ratio
118.7
%
 
61.3
%
Expense ratio
34.9
%
 
38.9
%
GAAP combined ratio
153.6
%
 
100.2
%
Consolidated:
 
 
 
Gross premiums written
$
1,874,158

 
$
1,868,849

Net premiums written
1,571,183

 
1,607,365

Net premiums earned
1,581,500

 
1,585,944

Loss ratio
68.4
%
 
60.9
%
Expense ratio
32.6
%
 
33.0
%
GAAP combined ratio
101.0
%
 
93.9
%
Net Income to Common Stockholders . The following table presents the Company’s net income to common stockholders and net income per diluted share for the three months ended September 30, 2017 and 2016:
(in thousands, except per share data)
2017
 
2016
Net income to common stockholders
$
162,054

 
$
220,650

Weighted average diluted shares
128,944

 
128,556

Net income per diluted share
$
1.26

 
$
1.72

The Company reported net income of $162 million in 2017 compared to $221 million in 2016 . The 27% decrease in net income was primarily due to an after-tax decrease in underwriting income of $73 million mainly driven by increased catastrophe losses from Hurricanes Harvey, Irma and Maria, as well as two earthquakes in Mexico, partially offset by an $11

39



million benefit related to stock compensation tax benefits being recognized within income tax expense starting in 2017 and an after-tax increase in net investment gains of $5 million. The number of weighted average diluted shares remained relatively unchanged for the three months ended September 30, 2017 and 2016.
Premiums . Gross premiums written were $1,874 million in 2017, an increase of less than 1% from $1,869 million in 2016. Approximately 77.5% of policies expiring in 2017 were renewed, compared with a 77.7% renewal retention rate for policies expiring in 2016.
Average renewal premium rates for insurance and facultative reinsurance increased 0.7% in 2017 when adjusted for change in exposures.
     A summary of gross premiums written in 2017 compared with 2016 by line of business within each business segment follows:
Insurance - gross premiums increased 2% to $1,719 million in 2017 from $1,689 million in 2016. Gross premiums increased $13 million (3%) for short tail lines, $12 million (3%) for workers' compensation, $6 million (3%) for commercial auto and $4 million (2%) for professional liability and decreased $5 million (1%) for other liability.
Reinsurance - gross premiums decreased 14% to $156 million in 2017 from $180 million in 2016. Gross premiums decreased $26 million (34%) for property lines and increased $2 million (2%) for casualty lines.
Net premiums written were $1,571 million in 2017, a decrease of 2% from $1,607 million in 2016. Ceded reinsurance premiums as a percentage of gross written premiums were 16% in 2017 and 14% in 2016.
Premiums earned decreased less than 1% to $1,582 million in 2017 from $1,586 million in 2016. Insurance premiums (including the impact of rate changes) are generally earned evenly over the policy term. Premiums earned in 2017 are related to business written during both 2017 and 2016. Audit premiums were $46 million in 2017 compared with $35 million in 2016.
Net Investment Income . Following is a summary of net investment income for the three months ended September 30, 2017 and 2016:  
 
Amount
 
Average Annualized
Yield
($ in thousands)
2017
 
2016
 
2017
 
2016
Fixed maturity securities, including cash and cash equivalents and loans receivable
$
118,834

 
$
114,271

 
3.4
%
 
3.3
%
Investment funds
15,200

 
25,293

 
5.2

 
8.1

Arbitrage trading account
4,418

 
6,441

 
3.5

 
5.6

Real estate
5,042

 
585

 
1.5

 
0.2

Equity securities available for sale
604

 
1,069

 
1.2

 
2.0

Gross investment income
144,098

 
147,659

 
3.3

 
3.5

Investment expenses
(1,619
)
 
(1,991
)
 
 
 
 
Total
$
142,479

 
$
145,668

 
3.2
%
 
3.4
%
Net investment income decreased 2% to $142 million in 2017 from $146 million in 2016 due primarily to a $10 million decrease from investment funds and a $2 million decrease from the arbitrage trading account, partially offset by a $4 million increase from fixed maturity securities and an increase of $4 million in income from real estate. Average invested assets, at cost (including cash and cash equivalents), were $17.6 billion in 2017 up from $17.0 billion in 2016.
Insurance Service Fees . The Company earns fees from an insurance distribution business and as a servicing carrier of workers' compensation assigned risk plans for certain states. Service fees in creased to $34 million in 2017 from $32 million in 2016.
Net Realized Gains on Investment Sales . The Company buys and sells securities and other investment assets on a regular basis in order to maximize its total return on investments. Decisions to sell securities and other investment assets are based on management’s view of the underlying fundamentals of specific investments as well as management’s expectations regarding interest rates, credit spreads, currency values and general economic conditions. Net realized gains on investment sales were $184 million in 2017 compared with $176 million in 2016. The three months ended September 30, 2017 include a gain of $124 million from the sale of an investment in an office building located in Washington D.C. The three months ended

40



September 30, 2016 include a gain of $135 million from the sale of Aero Precision Industries and certain related aviation services business.
Other-Than-Temporary Impairments . There were no other-than-temporary impairments during the three months ended September 30, 2017 and 2016.
Revenues from Non-Insurance Businesses . Revenues from non-insurance businesses were derived from businesses engaged in the distribution of promotional merchandise, world-wide textile solutions and aviation-related businesses that provide services to aviation markets, including (i) the distribution, manufacturing, repair and overhaul of aircraft parts and components, (ii) the sale of new and used aircraft, and (iii) avionics, fuel, maintenance, storage and charter services. Revenues from non-insurance businesses were $90 million in 2017 and $80 million in 2016. The increase was primarily related to the textile business purchased in March 2017.
Losses and Loss Expenses . Losses and loss expenses increased to $1,081 million in 2017 from $966 million in 2016. The consolidated loss ratio was 68.4% in 2017 and 60.9% in 2016. Catastrophe losses, net of reinsurance recoveries and reinstatement premiums, were $119 million in 2017 and $12 million in 2016. Hurricanes Harvey, Irma and Maria, along with two earthquakes in Mexico, resulted in catastrophe losses of $107 million. Favorable prior year reserve development (net of premium offsets) was $7 million in 2017 and $13 million in 2016. The loss ratio, excluding catastrophe losses and prior year reserve development, i ncreased 0.4 points to 61.3% in 2017 from 60.9% in 2016.
A summary of loss ratios in 2017 compared with 2016 by business segment follows:
Insurance - The loss ratio of 63.2% in 2017 was 2.3 points higher than the loss ratio of 60.9% in 2016. Catastrophe losses were $47 million in 2017 and $9 million in 2016. Favorable prior year reserve development was $13 million in both 2017 and 2016. The loss ratio, excluding catastrophe losses and prior year reserve development, decreased 0.4 points to 60.8% in 2017 from 61.2% in 2016.
Reinsurance - The loss ratio of 118.7% in 2017 was 57.4 points higher than the loss ratio of 61.3% in 2016. Catastrophe losses were $72 million in 2017 compared with $3 million in 2016. Adverse prior year reserve development was $6 million in 2017 compared with favorable prior year reserve development of $0.2 million in 2016. The loss ratio, excluding catastrophe losses and prior year reserve development, increased 6.9 points to 66.1% in 2017 from 59.2% in 2016 largely due to increased attritional losses.
Other Operating Costs and Expenses . Following is a summary of other operating costs and expenses:
(In thousands)
2017
 
2016
Policy acquisition and operating insurance expenses
$
516,243

 
$
523,254

Insurance service expenses
32,451

 
32,441

Net foreign currency (gains) losses
1,779

 
(2,193
)
Other costs and expenses
50,349

 
52,846

Total
$
600,822

 
$
606,348


Policy acquisition and operating insurance expenses are comprised of commissions paid to agents and brokers, premium taxes and other assessments and internal underwriting costs. Policy acquisition and operating insurance expenses decreased 1% compared with a decrease in net premiums earned of less than 1%. The expense ratio (underwriting expenses expressed as a percentage of premiums earned) decreased to 32.6% from 33.0% in 2016.

Service expenses, which represent the costs associated with the fee-based businesses, remained flat at $32 million for 2017 and 2016.
Net foreign currency (gains) losses result from transactions denominated in a currency other than a company's operating functional currency. Net foreign currency losses were $2 million in 2017 compared to gains of $2 million in 2016.
Other costs and expenses represent general and administrative expenses of the parent company and other expenses not allocated to business segments, including the cost of certain long-term incentive plans and new business ventures. Other costs and expenses decreased to $50 million in 2017 from $53 million in 2016.
Expenses from Non-Insurance Businesses . Expenses from non-insurance businesses represent costs associated with businesses engaged in the distribution of promotional merchandise, world-wide textile solutions and aviation-related businesses that include (i) cost of goods sold related to aircraft and products sold and services provided, and (ii) general and administrative

41



expenses. Expenses from non-insurance businesses were $86 million in 2017 compared to $79 million in 2016. The increase was primarily related to the textile business purchased in March 2017.
Interest Expense . Interest expense was $37 million in both 2017 and 2016. During 2017, the Company repaid $2 million of debt compared to $83 million in 2016, mainly in connection with the sale of Aero Precision Industries.
Income Taxes . The effective income tax rate was 28% in 2017 and 33% in 2016. The effective income tax rate differs from the federal income tax rate of 35% primarily because of tax-exempt investment income, as well as the new requirement in 2017 to recognize tax benefits for stock compensation in income tax expense.
The Company has not provided U.S. deferred income taxes on the undistributed earnings of approximately $40 million of its non-U.S. subsidiaries since these earnings are intended to be permanently reinvested in the non-U.S. subsidiaries. However, in the future, if such earnings were distributed to the Company, taxes of approximately $4 million, assuming all tax credits are realized, would be payable on such undistributed earnings and would be reflected in the tax provision for the year in which these earnings are no longer intended to be permanently reinvested in the foreign subsidiary.

42



Investments
As part of its investment strategy, the Company establishes a level of cash and highly liquid short-term and intermediate-term securities that, combined with expected cash flow, it believes is adequate to meet its payment obligations. Due to the historically low fixed maturity investment returns, the Company invests in equity securities, merger arbitrage securities, investment funds, private equity, loans and real estate related assets. The Company's investments in investment funds and its other alternative investments have experienced, and the Company expects to continue to experience, greater fluctuations in investment income.
The Company also attempts to maintain an appropriate relationship between the average duration of the investment portfolio and the approximate duration of its liabilities (i.e., policy claims and debt obligations). The average duration of the fixed maturity portfolio, including cash and cash equivalents, was 2.9 years at September 30, 2017 , down from 3.1 years at December 31, 2016. The Company’s fixed maturity investment portfolio and investment-related assets as of September 30, 2017 were as follows:
($ in thousands)
Carrying
Value
 
Percent
of Total
Fixed maturity securities:
 
 
 
U.S. government and government agency
$
411,605

 
2.2
%
State and municipal:
 
 
 
Special revenue
2,829,795

 
15.4

State general obligation
537,537

 
2.9

Local general obligation
415,635

 
2.3

Corporate backed
391,627

 
2.1

Pre-refunded (1)
303,947

 
1.8

Total state and municipal
4,478,541

 
24.4

Mortgage-backed securities:
 
 
 
Agency
832,993

 
4.5

Commercial
251,578

 
1.4

Residential-Prime
226,274

 
1.2

Residential-Alt A
23,298

 
0.2

Total mortgage-backed securities
1,334,143

 
7.2

Asset-backed securities
2,388,618

 
13.0

Corporate:
 
 
 
Industrial
2,636,885

 
14.4

Financial
1,374,021

 
7.5

Utilities
267,331

 
1.5

Other
42,137

 
0.2

Total corporate
4,320,374

 
23.6

Foreign government and foreign government agencies
940,409

 
5.1

Total fixed maturity securities
13,873,690

 
75.7

Equity securities available for sale:
 
 
 
Common stocks
419,520

 
2.3

Preferred stocks
194,505

 
1.1

Total equity securities available for sale
614,025

 
3.4

Real estate
1,391,274

 
7.5

Investment funds
1,119,907

 
6.0

Cash and cash equivalents
773,997

 
4.2

Arbitrage trading account
488,238

 
2.7

Loans receivable
74,229

 
0.5

Total investments
$
18,335,360

 
100.0
%
________________________
(1) Pre-refunded securities are securities for which an escrow account has been established to fund the remaining payments of principal and interest through maturity. Such escrow accounts are funded almost exclusively with U.S. Treasury and U.S. government agency securities.
Fixed Maturity Securities . The Company’s investment policy with respect to fixed maturity securities is generally to purchase instruments with the expectation of holding them to their maturity. However, management of the available for sale

43



portfolio is considered necessary to maintain an approximate matching of assets and liabilities as well as to adjust the portfolio as a result of changes in financial market conditions and tax considerations.
The Company’s philosophy related to holding or selling fixed maturity securities is based on its objective of maximizing total return. The key factors that management considers in its investment decisions as to whether to hold or sell fixed maturity securities are its view of the underlying fundamentals of specific securities as well as its expectations regarding interest rates, credit spreads and currency values. In a period in which management expects interest rates to rise, the Company may sell longer duration securities in order to mitigate the impact of an interest rate rise on the fair value of the portfolio. Similarly, in a period in which management expects credit spreads to widen, the Company may sell lower quality securities, and in a period in which management expects certain foreign currencies to decline in value, the Company may sell securities denominated in those foreign currencies. The sale of fixed maturity securities in order to achieve the objective of maximizing total return may result in realized gains; however, there is no reason to expect these gains to continue in future periods.
At September 30, 2017 , investments in foreign government fixed maturity securities (which are generally held by the Company's foreign operations) were as follows:
(In thousands)
Carrying Value
Argentina
$
259,720

Australia
217,397

Canada
175,816

United Kingdom
84,894

Brazil
53,547

Germany
48,794

Supranational (1)
40,591

Singapore
25,326

Norway
9,930

Mexico
9,490

Colombia
7,696

Uruguay
7,208

 Total
$
940,409

________
(1) Supranational represents investments in the North American Development Bank, European Investment Bank and International Bank for Reconstruction and Development.
Equity Securities . Equity securities primarily represent investments in common and preferred stocks in companies with potential growth opportunities in different sectors, including healthcare and financial institutions.
Investment Funds . At September 30, 2017 , the carrying value of investment funds was $1,120 million, including investments in real estate funds of $615 million, energy funds of $86 million, and other funds of $419 million. Investment funds are generally reported on a one-quarter lag.
Real Estate . Real estate is directly owned property held for investment. At September 30, 2017 , real estate properties in operation included a long-term ground lease in Washington, D.C., a hotel in Memphis, Tennessee, an office complex in New York City and office buildings in West Palm Beach and Palm Beach, Florida. In addition, there are two properties under development: an office building in London and a mixed-use project in Washington, D.C. The Company expects to fund further development costs for these projects with a combination of its own funds and external financing.
Arbitrage Trading Account . The arbitrage trading account is comprised of direct investments in arbitrage securities. Merger arbitrage is the business of investing in the securities of publicly held companies that are the targets in announced tender offers and mergers.
Loans Receivable . Loans receivable, which are carried at amortized cost, had an aggregate cost of $74 million and an aggregate fair value of $77 million at September 30, 2017 . The amortized cost of loans receivable is net of a valuation allowance of $3 million as of September 30, 2017 . Loans receivable include real estate loans of $59 million that are secured by commercial real estate located primarily in New York. Real estate loans receivable generally earn interest at floating LIBOR-based interest rates and have maturities (inclusive of extension options) through August 2025. Loans receivable include commercial loans of $15 million that are secured by business assets and have fixed interest rates with varying maturities not exceeding 10 years.

44



Market Risk . The fair value of the Company’s investments is subject to risks of fluctuations in credit quality and interest rates. The Company uses various models and stress test scenarios to monitor and manage interest rate risk. The Company attempts to manage its interest rate risk by maintaining an appropriate relationship between the effective duration of the investment portfolio and the approximate duration of its liabilities (i.e., policy claims and debt obligations). The effective duration for the fixed maturity portfolio (including cash and cash equivalents) was 2.9 years at September 30, 2017 , down from 3.1 years at December 31, 2016 .
In addition, the fair value of the Company’s international investments is subject to currency risk. The Company attempts to manage its currency risk by matching its foreign currency assets and liabilities where considered appropriate.


45



Liquidity and Capital Resources
             Cash Flow . Cash flow provided from operating activities decreased to $522 million in the first nine months of 2017 from $727 million in the comparable period in 2016 , primarily due to the timing of loss and loss expense payments and payments to taxing authorities.
The Company's insurance subsidiaries' principal sources of cash are premiums, investment income, service fees and proceeds from sales and maturities of portfolio investments. The principal uses of cash are payments for claims, taxes, operating expenses and dividends. The Company expects its insurance subsidiaries to fund the payment of losses with cash received from premiums, investment income and fees. The Company targets an average duration for its investment portfolio that is within one year of the average duration of its liabilities so that portions of its investment portfolio mature throughout the claim cycle and are available for the payment of claims if necessary. In the event operating cash flow and proceeds from maturities and prepayments of fixed income securities are not sufficient to fund claim payments and other cash requirements, the remainder of the Company's cash and investments is available to pay claims and other obligations as they become due. The Company's investment portfolio is highly liquid, with approximately 80% invested in cash, cash equivalents and marketable fixed maturity securities as of September 30, 2017 . If the sale of fixed maturity securities were to become necessary, a realized gain or loss equal to the difference between the cost and sales price of securities sold would be recognized.
Debt . At September 30, 2017 , the Company had senior notes, subordinated debentures and other debt outstanding with a carrying value of $2,488 million and a face amount of $2,521 million. The maturities of the outstanding debt are $442 million in 2019, $302 million in 2020, $427 million in 2022, $250 million in 2037, $350 million in 2044, $350 million in 2053 and $400 million in 2056.

In February 2016, the Company issued $110 million aggregate principal amount of its 5.9% subordinated debentures due 2056, and in May 2016, the Company issued $290 million aggregate principal amount of its 5.75% subordinated debentures due 2056. During 2017, the Company repaid $2 million of debt compared to $83 million of debt in 2016 mainly in connection with the sale of Areo Precision Industries.
Equity . At September 30, 2017 , total common stockholders’ equity was $5.4 billion, common shares outstanding were 121,769,109 and stockholders’ equity per outstanding share was $44.60. The Company repurchased 441,119 common shares for $28.4 million during the three months ended September 30, 2017. The number of common shares outstanding excludes shares held in a grantor trust established by the Company for delivery upon settlement of vested but mandatorily deferred RSUs.
Total Capital . Total capitalization (equity, debt and subordinated debentures) was $7.9 billion at September 30, 2017 . The percentage of the Company’s capital attributable to senior notes, subordinated debentures and other debt was 31% at September 30, 2017 and 33% at December 31, 2016.

Item 3.      Quantitative and Qualitative Disclosure About Market Risk
Reference is made to the information under “Investments - Market Risk” under the caption “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in this Form 10-Q.

Item 4.      Controls and Procedures
               Disclosure Controls and Procedures . The Company’s management, including its Chief Executive Officer and Chief Financial Officer, has conducted an evaluation of the effectiveness of the Company’s disclosure controls and procedures pursuant to Securities Exchange Act Rule 13a-14 as of the end of the period covered by this quarterly report. Based on that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that the Company has in place effective controls and procedures designed to ensure that information required to be disclosed by the Company in the reports it files or submits under the Securities Exchange Act of 1934, as amended, and the rules thereunder, is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms.
Changes in Internal Control over Financial Reporting . During the quarter ended September 30, 2017 , there were no changes in the Company’s internal control over financial reporting that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.


PART II — OTHER INFORMATION
Item 1. Legal Proceedings
Please see Note 21 to the notes to the interim consolidated financial statements.

46





Item 1A. Risk Factors
There have been no material changes from the risk factors previously disclosed in the Company's annual report on From 10-K for the fiscal year ended December 31, 2016.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds     

Set forth below is a summary of the shares repurchased by the Company during the three months ended September 30, 2017 and the number of shares remaining authorized for purchase by the Company:
 
Total number
of shares purchased
 
Average price
paid per share
 
Total number of shares purchased
as part of publicly announced plans or programs
 
Maximum number of
shares that may yet be purchased under the plans or programs
July 2017

 

 

 
6,851,086

August 2017

 

 

 
10,000,000 (1)

September 2017
441,119

 
$
64.333

 
441,119

 
9,558,881


(1) The Company's repurchase authorization was increased to 10,000,000 shares on August 8, 2017.


Item 6. Exhibits

Number 
 
 
( 10.1 )
 
Form of 2017 Performance-Based Restricted Stock Unit Agreement Under the W. R. Berkley Corporation 2012 Stock Incentive Plan
 
 
 
( 31.1 )
 
Certification of the Chief Executive Officer pursuant to Rule 13a-14(a)/ 15d-14(a).
 
 
 
( 31.2 )
 
Certification of the Chief Financial Officer pursuant to Rule 13a-14(a)/ 15d-14(a).
 
 
 
( 32.1 )
 
Certification of the Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

47



SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned thereunto duly authorized.
 
 
W. R. BERKLEY CORPORATION
 
Date:
November 8, 2017
/s/ W. Robert Berkley, Jr. 
 
 
W. Robert Berkley, Jr.
 
 
President and Chief Executive Officer 
 
 
 
Date:
November 8, 2017
/s/ Richard M. Baio 
 
 
Richard M. Baio
 
 
Senior Vice President - Chief Financial Officer and Treasurer

48
L12
PERF

PERFORMANCE-BASED RESTRICTED STOCK UNIT AGREEMENT
Under the W. R. Berkley Corporation 2012 Stock Incentive Plan
as Amended and Restated Effective June 2, 2015

THIS AGREEMENT, dated as of August 15, 2017, by and between W. R. BERKLEY CORPORATION, a Delaware corporation (the “ Company ”), and grantee as set forth on Exhibit A hereto (the “ Grantee ”). Important jurisdiction-specific modifications to this Agreement are contained in Exhibit B hereto and are incorporated herein by reference.
W I T N E S S E T H :
WHEREAS, the Grantee is an employee of the Company or subsidiary thereof, and the Company wishes to grant the Grantee a notional interest in shares of the Company’s common stock, par value $0.20 per share (the “ Stock ”), in the form of restricted stock units, subject to certain restrictions and on the terms and conditions set forth herein; and
WHEREAS, through the grant of these restricted stock units, the Company hopes to incentivize and retain the services of Grantee and encourage stock ownership by Grantee in order to give Grantee a proprietary interest in the Company’s success and align Grantee’s interest with those of the stockholders of the Company; and
WHEREAS, the Restricted Stock Units (as defined below) awarded Grantee hereunder vest based on the Company’s performance during the applicable Performance Period (as defined below), however, the issuance of the Stock after vesting is generally deferred until ninety (90) days following Grantee’s “separation from service” (as such term is used in Section 409A of the Internal Revenue Code of 1986, as amended (the “ Code ”)); and
WHEREAS, the Company and Grantee recognize that if Grantee engages in certain activities during or, in certain instances, following the termination of Grantee’s employment with the Company (the “ Competitive Actions ” or “ Misconduct ” as defined in Section 3 below), Grantee’s interests are no longer aligned with the interests of the Company and Grantee will no longer be entitled to retain certain benefits of the grants made herein.
NOW, THEREFORE, in consideration of the covenants and agreements herein contained, the parties hereto hereby agree as follows:
SECTION 1.      Grant of Restricted Stock Units . As of the date hereof, subject to the terms and conditions of this Agreement and the W. R. Berkley Corporation 2012 Stock Incentive Plan, as amended and restated effective June 2, 2015 (the “ Plan ”), the Company hereby grants to the Grantee the targeted number of restricted stock units set forth on Exhibit A hereto (the restricted stock units granted or earned hereunder are hereafter referred to as the “ Restricted Stock Units ”). A portion of the Restricted Stock Units shall be designated as Tranche 1 Restricted Stock Units, Tranche 2 Restricted Stock Units and Tranche 3 Restricted Stock Units, as set forth on Exhibit A. The number of Restricted Stock Units granted represents the number of Restricted Stock Units that would be earned if the Company were to achieve the target level of

- 1 -



ROE Relative Performance for each of the Performance Periods. The number of Restricted Stock Units earned respectively, if any, is subject to increase or decrease based on the Company’s actual ROE Relative Performance and may range from 0% to 110% of the Restricted Stock Units. Each Restricted Stock Unit shall represent the right to receive one share of Stock subject to the terms and conditions set forth herein. Capitalized terms not defined herein, including Section 21, shall have the meaning ascribed to them in the Plan. This grant shall be administered by the Compensation Committee (the “ Committee ”) of the Board of Directors of the Company (the “ Board ”).
SECTION 2.      Non‑Transferability . Except as specifically consented to by the Committee, the Grantee may not sell, transfer, pledge, or otherwise encumber or dispose of the Restricted Stock Units other than by will, the laws of descent and distribution, or as otherwise provided for in the Plan.
SECTION 3.      Vesting; Forfeiture; Recapture; Other Remedies .
(a)      Following the completion of each Performance Period, the Committee shall determine for such Performance Period, the Average Return on Equity, the ROE Relative Performance, the ROE Relative Performance Vesting Percentage and, respectively, the portion of the Tranche 1 Restricted Stock Units, Tranche 2 Restricted Stock Units and Tranche 3 Restricted Stock Units, as applicable, that have become earned (determined by multiplying the number of Restricted Stock Units subject to the applicable tranche by the ROE Relative Performance Vesting Percentage). Immediately following the Committee’s determination of the number of earned Tranche 1 Restricted Stock Units, Tranche 2 Restricted Stock Units and Tranche 3 Restricted Stock Units for a respective Performance Period, the earned Restricted Stock Units shall vest as of the last day of the applicable Performance Period (subject to forfeiture, as set forth in Section 3(d) below), provided the Grantee has remained continuously employed by the Company from the date hereof through the completion of the applicable Performance Period. Restricted Stock Units granted herein which have not become vested Restricted Stock Units following the completion of the applicable Performance Period or otherwise vested shall be immediately forfeited without payment of any consideration and the Grantee shall have no further rights with respect to such Restricted Stock Units.
(b)      In the event that Grantee’s employment with the Company is terminated for any reason, all unvested Restricted Stock Units (except for those that vest immediately upon termination as provided in Sections 3(c) and 3(h) below) shall be forfeited, and the Grantee shall have no further rights with respect to such Restricted Stock Units. For purposes of this Agreement, Grantee’s employment will be considered terminated as of the date Grantee is no longer actively providing services to the Company (regardless of the reason for such termination and whether or not later found to be invalid or in breach of employment laws in the jurisdiction where Grantee is employed or the terms of Grantee’s employment agreement, if any), and unless otherwise expressly provided in this Agreement or determined by the Company, Grantee’s right to continue to vest in the Restricted Stock Units granted hereunder, if any, will terminate as of such date and will not be extended by any notice period arising under local law or contract. However, Grantee’s period of service would not include any contractual notice period (except for such period of time Grantee is actively providing substantial services during any notice period as

- 2 -



required by the Company) or any period of “garden leave” or similar period arising under employment laws in the jurisdictions where Grantee is employed or the terms of Grantee’s employment agreement, if any.
(c)      In the event the Grantee’s employment with the Company is terminated on account of death or Disability prior to the completion of the applicable Performance Period, the number of earned Restricted Stock Units for any incomplete Performance Period (including, for the avoidance of doubt, any Performance Period that has yet to commence as of the date of such termination) shall be immediately determined assuming the Company achieved the target level of ROE Relative Performance for such Performance Period and the number of earned Tranche 1 Restricted Stock Units, earned Tranche 2 Restricted Stock Units and earned Tranche 3 Restricted Stock Units that become vested shall be determined by multiplying the number of earned Restricted Stock Units by a fraction, the numerator of which is the number of days the Grantee served as an employee from the date of this Agreement to the date of such termination and the denominator of which is 1,095 with respect to the Tranche 1 Restricted Stock Units, 1,460 with respect to the Tranche 2 Restricted Stock Units and 1,825 with respect to the Tranche 3 Restricted Stock Units.
(d)      The Restricted Stock Units granted hereunder shall be subject to the following forfeiture, recapture and other remedial provisions as provided below:
a.
In the event that the Committee determines that the Grantee, prior to the Vesting Date during Grantee’s employment, has engaged in a Competitive Action or enters into, or has entered into, an agreement (written, oral or otherwise) to engage in a Competitive Action or has engaged in Misconduct, all of the unvested Restricted Stock Units granted hereunder shall be immediately forfeited, and the Grantee shall have no further rights with respect to such Restricted Stock Units.
b.
In the event that the Committee determines that the Grantee, (1) on or after the Vesting Date during Grantee’s employment or within one year following Grantee’s termination of employment for any reason, has engaged in a Competitive Action or has entered into an agreement (written, oral or otherwise) to engage in a Competitive Action, or (2) on or after the Vesting Date, has engaged in Misconduct, or prior to the Vesting Date Grantee has engaged in Misconduct that is not discovered or acted upon by the Company until on or after the Vesting Date, (x) the Grantee shall immediately forfeit all shares of Stock not yet delivered to Grantee with respect to the Restricted Stock Units and all rights to future payments of Dividend Equivalents (as defined below), and (y) the Grantee shall pay to the Company, upon demand by the Company, an amount equal to (i) the value, as of the Settlement Date (as defined below), of the number of shares of Stock delivered to the Grantee with respect to the Restricted Stock Units, (ii) all amounts paid to Grantee on or at any time prior to the Settlement Date in respect of Dividend Equivalents, and (iii) the value of all dividends, if any, paid to the Grantee in respect of the shares of Stock delivered to the Grantee on the Settlement Date. The Grantee

- 3 -



may satisfy the payment obligation to the Company of the portion due under (i) above by returning the shares delivered to the Grantee on the Settlement Date, provided that any amounts due under (ii) and (iii) above must be remitted to the Company in addition to the return of the shares.
C.
Grantee acknowledges that engaging in (1) a Competitive Action during the Restricted Period within the geographic areas set forth in Section 3(e) below or (2) Misconduct is contrary to the interests of the Company and would result in irreparable injuries to the Company and would cause loss in an amount that cannot be readily quantified. Grantee acknowledges that retaining the amounts required to be paid to the Company pursuant to this Section 3(d) once Grantee has (x) chosen to engage in or to agree to engage in a Competitive Action or (y) engaged in Misconduct is contrary to the interests of the Company. The amounts forfeited or paid to the Company hereunder do not and are not intended to constitute actual or liquidated damages. Any action or inaction by the Company with respect to enforcing the forfeiture or recapture provisions set forth herein shall not reduce, eliminate or in any way affect the Company’s right to enforce the forfeiture or recapture provisions in any other agreement with Grantee.
D.
The term “ Restricted Period ” as used herein shall mean the period beginning on the date hereof and ending one year following Grantee’s termination of employment for any reason.
E.
Furthermore, if the Grantee engages in Misconduct or a Competitive Action or has entered into an agreement (written, oral or otherwise) to engage in a Competitive Action during the Restricted Period, then the Company shall be entitled to, and reserves the right to, pursue any other legal or equitable remedies in addition to the right to receive forfeitures and/or payments pursuant to this Section 3(d), including, but not limited to, the recovery of monetary damages resulting from such action set forth in Section 3(e) and injunctive relief.
(e)      For purposes of this Agreement, the Grantee has engaged in a “ Competitive Action ” if, either directly or indirectly, and whether as an employee, consultant, independent contractor, partner, joint venturer or otherwise, the Grantee (i) who was employed by W. R. Berkley Corporation, engages in or directs any business activities, except those which are ministerial or clerical in nature, which are competitive with any business activities conducted by the Company, in or directed into any geographical area (x) where Grantee had responsibilities on behalf of the Company or about which Grantee received Confidential Information (defined below) and (y) in which the Company is engaged in business at the relevant time of enforcement, (ii) who was employed by, or previously employed by, a subsidiary or subsidiaries of the Company, engages in or directs any business activities, except those which are ministerial or clerical in nature, which are competitive with any business activities conducted by such subsidiary or subsidiaries, in or directed into any geographical area (x) where Grantee had responsibilities on behalf of such subsidiary or subsidiaries or about which Grantee received

- 4 -



Confidential Information and (y) in which the subsidiary/subsidiaries is or are engaged in business at the relevant time of enforcement, (iii) on behalf of any person or entity engaged in business activities competitive with the business activities of the Company, solicits or induces, or in any manner attempts to solicit or induce, any person employed by, or as an agent or producer of, the Company to terminate such person’s employment, agency or producer relationship, as the case may be, with the Company, (iv) diverts, or attempts to divert, any Covered Business Partner (defined below) from doing business with the Company or attempts to induce any Covered Business Partner to cease being a customer of the Company, (v) solicits a Covered Business Partner to do business with a competitor or prospective competitor of the Company or (vi) makes use of, or attempts to make use of, the Company’s property or Confidential Information, other than in the course of the performance of services to the Company or at the direction of the Company. The determination as to whether the Grantee has engaged in a Competitive Action shall be made by the Committee in its sole and absolute discretion. The Committee has sole and absolute discretion to determine whether, notwithstanding its determination that Grantee has engaged in a Competitive Action, recapture or forfeiture as provided herein shall not occur. The Committee’s exercise or nonexercise of its discretion with respect to any particular event or occurrence by or with respect to the Grantee or any other recipient of restricted stock units shall not in any way reduce or eliminate the authority of the Committee to (i) determine that any event or occurrence by or with respect to the Grantee constitutes engaging in a Competitive Action or (ii) determine the related Competitive Action date.
(f)      For purposes of this Agreement, the Grantee has engaged in “ Misconduct ” if the Grantee, during Grantee’s employment with the Company, has engaged in an act which would, in the judgment of the Committee, constitute fraud that could be punishable as a crime or embezzlement against either the Company or any of its subsidiaries. The determination as to whether the Grantee has engaged in Misconduct shall be made by the Committee in its sole and absolute discretion. The Committee has sole and absolute discretion to determine whether, notwithstanding its determination that Grantee has engaged in Misconduct, recapture or forfeiture as provided herein shall not occur. The Committee’s exercise or nonexercise of such discretion with respect to any particular event or occurrence by or with respect to the Grantee or any other recipient of restricted stock units shall not in any way reduce or eliminate the authority of the Committee to (i) determine that any event or occurrence by or with respect to the Grantee constitutes an act of Misconduct or (ii) determine the related Misconduct date.
(g)      The Grantee hereby agrees to notify the Company within ten (10) days of commencing any employment or other service provider relationship with any company or business during the Restricted Period, specifying in reasonable detail (i) the name of such company or business and the line of business in which it is engaged, and (ii) the Grantee’s position or title and the types of services to be rendered by the Grantee in such position or title. The Grantee hereby acknowledges that this notice requirement is reasonable and necessary for the Company to enforce the provisions of Sections 3(d) hereof. Furthermore, if the Grantee fails to so notify the Company, the Grantee shall be required to repay (at the Committee’s sole discretion) to the Company the amounts described in Section 3(d) hereof as if the Grantee had engaged in a Competitive Action during the Restricted Period, unless the Grantee can provide dispositive evidence, which shall be determined in the Committee’s sole discretion, that a Competitive Action did not occur.

- 5 -



(h)      Certain Definitions. (i) “ Client ” shall mean any insured, agent, producer or other intermediary to or through whom the Company provides insurance or reinsurance or related services;
(ii) “ Confidential Information ” shall mean an item of information or a compilation of information, in any form (tangible or intangible), related to the business of the Company or of a subsidiary for whom Grantee performs services that the Company/subsidiary has not made public or authorized public disclosure of, and that is not generally known to the public through proper means, including but not limited to:
(1)
underwriting premiums or quotes, income and receipts, claims records and levels, renewals, policy wording and terms, reinsurance quotas, profit commission;
(2)
operating unit or other business projections and forecasts;
(3)
Client lists, brokers lists and price sensitive information;
(4)
technical information, reports, interpretations, forecasts, corporate and business plans and accounts, business methods, financial details, projections and targets;
(5)
remuneration and personnel details;
(6)
planned products, planned services, marketing surveys, research reports, market share and pricing statistics, budgets, fee levels;
(7)
computer passwords, the contents of any databases, tables, know how documents or materials;
(8)
commissions, commission charges, pricing policies and all information about research and development; and
(9) the Company’s suppliers’, Clients’ or Prospective Clients’ names, addresses (including email addresses), telephone, facsimile or other contact numbers and contact names, the nature of their business operations, their requirements for services supplied by the Company and all confidential aspects of their relationship with the Company;
(iii) “ Covered Business Partner ” shall mean any person, concern or entity (including, without limitation, any Client) as to which Grantee, or persons supervised by Grantee, had material business-related contact or received Confidential Information during the most recent two years of Grantee’s employment with the Company or such shorter period of time as employed (the “ Look Back Period ”); and
(iv) “ Prospective Client ” shall mean any person, concern or entity (including, without limitation, any potential insured, agent, producer or other intermediary) to or through whom the Company has been in negotiations during the Look Back Period to provide insurance or reinsurance or related services.
(i)      In the event of a Change in Control, unless otherwise specifically prohibited under applicable laws or by the rules and regulations of any governing governmental agencies or

- 6 -



national securities exchanges, in the event that the Grantee’s employment with the Company is terminated (i) by the Company without Cause or (ii) by the Grantee for Good Reason, in each case during the eighteen (18) month period following such Change in Control, the number of earned Restricted Stock Units for any incomplete Performance Period (including, for the avoidance of doubt, any Performance Period that has yet to commence as of the date of such termination) shall be immediately determined assuming the Company achieved the target level of ROE Relative Performance for such Performance Period and the number of earned Tranche 1 Restricted Stock Units, earned Tranche 2 Restricted Stock Units and earned Tranche 3 Restricted Stock Units shall immediately become vested Restricted Stock Units. All vested Restricted Stock Units pursuant to this Section 3(h) shall be settled in accordance with Section 4.
SECTION 4.      Delivery and Possession of Share Certificates . Ninety (90) days following the Grantee’s “separation from service” (for purposes of Section 409A of the Code) for any reason, including death or Disability (the “ Settlement Date ”), provided the Grantee has neither engaged in, nor entered into an agreement (written, oral or otherwise) to engage in, a Competitive Action nor engaged in Misconduct, the Company shall deliver to the Grantee (or the Grantee’s estate in the event of death) a certificate or certificates representing the number of shares of Stock equal to the number of vested Restricted Stock Units, if any, as of the date of such separation from service and Grantee shall take possession thereof; provided, however, that if the Grantee is a “specified employee” pursuant to Section 409A(a)(2)(B)(i) of the Code, distribution of shares of Stock shall be delayed for such period of time as may be necessary to satisfy Section 409A(a)(2)(B)(i) of the Code (generally six months), and on the earliest date on which such distribution can be made following such delay without violating the requirements of Section 409A(a)(2)(B)(i) of the Code, the Company shall deliver to the Grantee a certificate or certificates representing the number of shares of Stock equal to the number of such vested Restricted Stock Units. A delay shall not be required to the extent the Grantee terminates employment on account of death or Disability, provided that if in the event of a Disability the Grantee is “disabled” within the meaning of Section 409A(a)(2)(C) of the Code, then the Restricted Stock Units shall be settled ninety (90) days following the occurrence of such death or Disability. Notwithstanding the foregoing, in the event of a Change in Control, which also constitutes a change in the ownership or effective control of the Company or in the ownership of a substantial portion of the assets of the Company within the meaning of Section 409A(a)(2)(A)(v) of the Code, the Company shall immediately deliver to the Grantee a certificate or certificates representing the number of then vested Restricted Stock Units.
SECTION 5.      Dividends and Dividend Equivalents . No dividends or dividend equivalents shall accrue or be paid with respect to any outstanding unvested Restricted Stock Units. On the second Tuesday of each January, April, July and October (each, a “ Dividend Equivalent Payment Date ”) occurring during the period commencing on the Vesting Date and ending on the Settlement Date, the Grantee shall be paid an amount in cash, with respect to each vested Restricted Stock Unit then outstanding and held by such Grantee, equal to the aggregate cash dividends paid by the Company in respect of one share of Stock (the “ Dividend Equivalent ”) following the immediately prior Dividend Equivalent Payment Date, or with respect to the first Dividend Equivalent Payment Date only, on or following the Vesting Date; provided, however, that with respect to the first Dividend Equivalent Payment Date, no Dividend Equivalents shall be paid to the Grantee in respect of any cash dividends declared or paid by the

- 7 -



Company prior to such Vesting Date. To the extent a cash dividend is paid by the Company on or prior to the Settlement Date but the Dividend Equivalent Payment Date relating thereto would not occur prior to the Settlement Date, the Dividend Equivalents relating thereto shall be paid to the Grantee on the Settlement Date. The Grantee’s right to future payments of Dividend Equivalents shall be subject to forfeiture to the same extent that the corresponding Restricted Stock Units are subject to forfeiture pursuant to Section 3.
SECTION 6.      Rights of Stockholder . Neither the Grantee nor any transferee will have any rights as a stockholder with respect to any share covered by this Agreement until the Grantee or transferee becomes the holder of record of such shares.
SECTION 7.      Company; Grantee .
(a)      The term “ Company ” as used in Section 3 or otherwise in this Agreement with reference to the Grantee’s employment shall include the Company and its subsidiaries. The term “subsidiary” as used in this Agreement shall mean any subsidiary of the Company within the meaning of Section 424(f) of the Code.
(b)      Whenever the word “ Grantee ” is used in any provision of this Agreement under circumstances where the provision should logically be construed to apply to the executors, the administrators, or the person or persons to whom the Restricted Stock Units may be transferred by will or by the laws of descent and distribution, the word “Grantee” shall be deemed to include such person or persons.
SECTION 8.      Compliance with Law . Notwithstanding any of the provisions hereof, the Grantee hereby agrees and the Company will not be obligated to issue or transfer shares to Grantee hereunder, if the issuance or transfer of such shares will constitute a violation by the Grantee or the Company of any provision of any law or regulation of any governmental authority. Any determination in this connection by the Committee will be final, binding and conclusive. The Company shall in no event be obliged to register any securities pursuant to the Securities Act or to take any other affirmative action in order to cause the issuance or transfer of shares acquired pursuant to this Agreement to comply with any law or regulation of any governmental authority.
SECTION 9.      Notice . Every notice or other communication relating to this Agreement shall be in writing, and shall be mailed to or delivered to the party for whom it is intended at such address as may from time to time be designated by it in a notice mailed or delivered to the other party as herein provided, provided that, unless and until some other address be so designated, all notices or communications by the Grantee to the Company shall be mailed or delivered to the Company at its principal executive office, and all notices or communications by the Company to the Grantee may be given to the Grantee personally or may be mailed to Grantee at the Grantee’s last known address, as reflected in the Company’s records.
SECTION 10.      Changes in Capital Structure . The existence of this Agreement will not affect in any way the right or power of the Company or its stockholders to make or authorize any of the following:

- 8 -



(a)      any adjustments, recapitalization, reorganizations or other changes in the Company’s capital structure or its business;
(b)      any merger or consolidation of the Company;
(c)      any issue of stock or of options, warrants or rights to purchase stock or of bonds, debentures, preferred to prior preference stocks ahead of or affecting the Stock or the rights thereof or convertible into or exchangeable for Stock;
(d)      the dissolution or liquidation of the Company;
(e)      any sale or transfer of all or any part of its assets or business; or
(f)      any other corporate act or proceeding.

- 9 -



SECTION 11.      Other Share Issues . Except as expressly provided in the Plan, the issue by the Company of shares of stock of any class, or securities convertible into or exchangeable for shares of stock of any class, for cash, property or services, either upon direct sale or upon the exercise of options, rights or warrants, or upon conversion of shares or obligations of the Company convertible into such shares or other securities will not affect, and no adjustment by reason thereof will be made with respect to, the number of shares subject to this Agreement.
SECTION 12.      Withholding . At the time of vesting and/or settlement of the Restricted Stock Units, as appropriate, the Committee shall require the Grantee to pay to the Company an amount sufficient to pay all federal, state and local withholding taxes applicable (including FICA taxes upon vesting), in the Committee’s judgment, to the vesting or settlement of the Restricted Stock Units, and the Grantee’s right to vesting and/or settlement, as appropriate, shall be contingent upon such payment. Such payment to the Company may be effected through (a) payment by the recipient to the Company of the aggregate withholding taxes in cash or cash equivalents; (b) at the discretion of the Committee, the Company’s withholding from the number of shares of Stock that would otherwise be delivered to the Grantee upon settlement of the Restricted Stock Units, a number of shares of Stock with an aggregate fair market value on the date of settlement (as determined by the Committee) equal to the aggregate amount of withholding taxes; or (c) at the discretion of the Committee, any combination of these two methods.
SECTION 13.      Grantee’s Tax Considerations . The tax impact of the award hereunder can be quite complex and will vary with each Grantee. It is recommended that each Grantee review such Grantee’s own tax situation and consult their tax advisor.
SECTION 14.      Waiver of Right to Trial by Jury . AS ALLOWED BY APPLICABLE LAW, BOTH PARTIES HEREBY WAIVE AND RELEASE ANY CLAIM UNDER STATE OR FEDERAL LAW THEY MAY HAVE HAD TO A JURY TRIAL IN CONNECTION WITH CLAIMS ARISING UNDER OR RELATED TO THIS AGREEMENT OR ANY ACTIONS TAKEN OR DETERMINATIONS MADE HEREUNDER.
SECTION 15.      No Right to Continued Service . This Agreement does not confer upon the Grantee any right to continue as an employee of the Company, nor shall it interfere in any way with the right of the Company to terminate Grantee’s employment at any time for any reason.
SECTION 16.      Agreement Confidentiality . Grantee understands and agrees that Grantee will keep the terms and conditions of this Agreement strictly confidential unless Grantee is compelled to do otherwise by a court of competent jurisdiction, and Grantee further agrees not to disclose the terms and conditions of this Agreement to any third party other than Grantee’s immediate family members, attorney, financial advisor, or accountant, all of whom must also agree to keep these terms and conditions strictly confidential unless compelled to do otherwise by a court of competent jurisdiction. Notwithstanding anything herein to the contrary, Grantee shall notify any subsequent employer, prior to commencing employment, of the restrictions and obligations in Sections 3(d), (e), (f) and (g) of this Agreement (as modified by Exhibit B to this Agreement, if and as applicable to the Grantee).

- 10 -



SECTION 17.      Binding Effect . This Agreement shall be binding upon the heirs, executors, administrators and successors of the parties hereto.    
SECTION 18.      The Plan and Prior Agreements . The terms and provisions of the Plan are incorporated herein by reference. In the event of any inconsistency between the Plan and this Agreement, the terms of the Plan shall govern. If there is any inconsistency between this Agreement and Exhibit B, Exhibit B shall prevail. The Grantee hereby acknowledges that he or she has received a copy of the Plan and understands and agrees to the terms thereof. This Agreement, together with the Plan, constitutes the entire agreement by and between the parties hereto with respect to the subject matter hereof, and this Agreement and the Plan supersede all prior agreements, correspondence and understandings and all prior and contemporaneous oral agreements and understandings, among the parties hereto with regard to the subject matter hereof. As additional consideration for the grant of Restricted Stock Units made pursuant to this Agreement, the parties agree that the provisions in Sections 3(b), (d), (e), (f), (g) and (h); Section 12; Section 14; Section 16; Section 18; Section 19; Section 22; Section 23; and Exhibit B of this Agreement shall supersede and replace, and be substituted for inconsistent provisions (and, for new provisions herein, added to the covenants and obligations) in any previous restricted stock unit award agreements between Grantee and the Company, including for the avoidance of doubt any dispute resolution provisions therein, whether the awards under those agreements have vested or are unvested.
SECTION 19.      Governing Law . This Agreement shall be construed and interpreted in accordance with the laws of the State of Delaware, without regard to the principles of conflicts of law thereof. The jurisdiction and venue for any dispute arising under, or any action brought to enforce or otherwise relating to, this Agreement will be exclusively in the courts of the State of Delaware, including the federal courts located in Delaware in the event federal jurisdiction exists. Grantee hereby irrevocably consents to the exclusive personal jurisdiction and venue of the federal and State courts of the State of Delaware for the resolution of any disputes arising out of, or relating to, this Agreement and irrevocably waives any claim or argument that the courts of the State of Delaware are an inconvenient forum. In any action arising under or relating to this Agreement, the court shall not have the authority to, and shall not, conduct a de novo review of any determination made by the Committee or the Company but is instead authorized to determine solely whether the determination was the result of fraud or bad faith under Delaware law.
SECTION 20.      Severability . The invalidity or unenforceability of any provision or provisions of this Agreement shall not affect the validity or enforceability of any other provision or provisions of this Agreement, which shall remain in full force and effect. If any provision of this Agreement is held to be invalid, void or unenforceable in any jurisdiction, any court so holding shall substitute a valid, enforceable provision that preserves, to the maximum lawful extent, the terms and intent of such provisions of this Agreement. If any of the provisions of, or covenants contained in, this Agreement are hereafter construed to be invalid or unenforceable in any jurisdiction, the same shall not affect the remainder of the provisions or the enforceability thereof in any other jurisdiction, which shall be given full effect, without regard to the invalidity or unenforceability in such other jurisdiction. Any such holding shall affect such provision of this Agreement, solely as to that jurisdiction, without rendering that or any other provisions of

- 11 -



this Agreement invalid, illegal or unenforceable in any other jurisdiction. If any covenant should be deemed invalid, illegal or unenforceable because its scope is considered excessive, such covenant will be modified so that the scope of the covenant is reduced only to the minimum extent necessary to render the modified covenant valid, legal and enforceable.
SECTION 21.      Definitions . The following terms shall have the following meanings:
(a)      Average Return on Equity ” means the percentage equal to the product of four (4) times the result of (i) the sum of the Return on Equity for each quarter in the applicable Performance Period, divided by (ii) the number of quarters in the applicable Performance Period.
(b)      Cause ” means “Cause” as defined in any active employment agreement between the Grantee and the Company or, in the absence of any such definition, means the occurrence of any one of the following events: (i) fraud, personal dishonesty, embezzlement or acts of gross negligence or gross misconduct on the part of the Grantee in the course of his or her employment or services; (ii) the Grantee’s engagement in conduct that is materially injurious to the Company; (iii) the Grantee’s conviction by a court of competent jurisdiction of, or pleading “guilty” or “no contest” to, (x) a felony or (y) any other criminal charge (other than minor traffic violations) which could reasonably be expected to have a material adverse impact on the Company’s reputation or business; (iv) public or consistent drunkenness by the Grantee or his or her illegal use of narcotics which is, or could reasonably be expected to become, materially injurious to the reputation or business of the Company or which impairs, or could reasonably be expected to impair, the performance of the Grantee’s duties to the Company; (v) willful failure by the Grantee to follow the lawful directions of a superior officer; or (vi) the Grantee’s continued and material failure to fulfill his or her employment obligations to the Company.
(c)      Disability ” means the total and permanent disability of the Grantee, as determined by the Committee in its sole discretion.
(d)      Good Reason ” means “Good Reason” as defined in any active employment agreement between the Grantee and the Company or, in the absence of any such definition, means the occurrence of any one of the following events, unless the Grantee agrees in writing that such event shall not constitute Good Reason: (i) a material reduction in the Grantee’s duties or responsibilities from those in effect immediately prior to a Change in Control; (ii) a material reduction in the Grantee’s base salary below the levels in effect immediately prior to a Change in Control; or (iii) relocation of the Grantee’s primary place of employment to a location more than fifty (50) miles from its location, and further from the Grantee’s primary residence, immediately prior to a Change in Control; provided, however , that with respect to any Good Reason termination, the Company will be given not less than thirty (30) days’ written notice by the Grantee (within sixty (60) days of the occurrence of the event constituting Good Reason) of the Grantee’s intention to terminate the Grantee’s employment for Good Reason, such notice to state in detail the particular act or acts or failure or failures to act that constitute the grounds on which the proposed termination for Good Reason is based, and such termination shall be effective at the expiration of such thirty (30) day notice period only if the Company has not fully cured such act or acts or failure or failures to act that give rise to Good Reason during such period. Further notwithstanding any provision in this definition to the contrary, in order to constitute a

- 12 -



termination for Good Reason, such termination must occur within six (6) months of the initial existence of the applicable condition.
(e)      Performance Period ” means the Tranche 1 Performance Period, Tranche 2 Performance Period or Tranche 3 Performance Period, respectively.
(f)      ROE Relative Performance ” means the Average Return on Equity less the Treasury Note Rate of Return, expressed in basis points.
(g)      ROE Relative Performance Vesting Percentage ” means a function of the ROE Relative Performance during the applicable Performance Period, and shall be determined as follows:
ROE Relative Performance*
ROE Relative Performance
Vesting Percentage
(% of Target)*
+
0%
+
80.0%
≥+633 basis points
90.0%
≥+766 basis points
100.0% (target)
+
110.0%
*
In the event that the ROE Relative Performance falls between any two values listed in the table above, the ROE Relative Performance Vesting Percentage shall be determined using a straight line interpolation between such two values. For the avoidance of doubt if the ROE Relative Performance is less than +500 basis points ( i.e. , the Average Return on Equity is less than 6.89%), the ROE Relative Vesting Percentage shall be 0% ( i.e. , no linear interpolation between 0% and 80%) and if the ROE Relative Performance is equal to or greater than +900 basis points ( i.e. , the Average Return on Equity at least 10.89%), the ROE Relative Vesting Percentage shall be 110%.
(h)      Return on Equity ” means for a quarter, a fraction (expressed as percentage) equal to the consolidated net income from continuing operations of the Company as determined under U.S. Generally Accepted Accounting Principles divided by the stockholders’ equity at the beginning of the calendar year for that quarter.
(i)      Tranche 1 Performance Period ” means the period commencing July 1, 2017 and ending on June 30, 2020.
(j)      Tranche 2 Performance Period ” means the period commencing July 1, 2018 and ending on June 30, 2021.
(k)      Tranche 3 Performance Period ” means the period commencing July 1, 2019 and ending on June 30, 2022.
(l)      Treasury Note Rate of Return ” means the five-year Treasury Note rate on June 30, 2017, which is 1.89%.

- 13 -



(m)      Vesting Date ” means the date on which the Tranche 1 Restricted Stock Units, Tranche 2 Restricted Stock Units, and Tranche 3 Restricted Stock Units, as applicable, vest hereunder.
SECTION 22.      Signature in Counterparts . This Agreement may be signed in counterparts, each of which shall be an original, with the same effect as if the signatures thereto and hereto were upon the same instrument.
SECTION 23.      Protected Conduct . Nothing in this Agreement prohibits Grantee from reporting an event that Grantee reasonably and in good faith believes is a violation of law to the relevant law-enforcement agency (such as the Securities and Exchange Commission or Department of Labor), requires notice to or approval from the Company before doing so, or prohibits Grantee from cooperating in an investigation conducted by such a government agency. This may include a disclosure of trade secret information provided that it must comply with the restrictions in the Defend Trade Secrets Act of 2016 (DTSA). The DTSA provides that no individual will be held criminally or civilly liable under Federal or State trade secret law for the disclosure of a trade secret that: (i) is made in confidence to a Federal, State, or local government official, either directly or indirectly, or to an attorney; and made solely for the purpose of reporting or investigating a suspected violation of law; or, (ii) is made in a complaint or other document if such filing is under seal so that it is not made public. Also, the DTSA further provides that an individual who pursues a lawsuit for retaliation by an employer for reporting a suspected violation of the law may disclose the trade secret to the attorney of the individual and use the trade secret information in the court proceeding, if the individual files any document containing the trade secret under seal, and does not disclose the trade secret, except as permitted by court order. To the extent that Grantee is covered by Section 7 of the National Labor Relations Act (NLRA) because Grantee is not in a supervisor or management role, nothing in this Agreement shall be construed to prohibit Grantee from using information Grantee acquires regarding the wages, benefits, or other terms and conditions of employment at the Company for any purpose protected under the NLRA.
SECTION 24. The Grantee agrees that he or she has entered into this Agreement voluntarily and that the Grantee has not been induced to participate in the distribution of Restricted Stock Units by the Company by expectation of appointment, employment, continued appointment or continued employment of the Grantee with the Company or a related entity of the Company. The Grantee further agrees that the Company has not made any representations or warranties with respect to the Restricted Stock Units, the Company, the business of the Company or its prospects, and that no securities commission, agency, governmental authority, regulatory body, stock exchange or similar regulatory authority has reviewed or passed on the merits of the Restricted Stock Units and that the Grantee’s ability to transfer the Restricted Stock Units will be limited by the Plan, this Agreement and applicable securities laws.


*    *    *

- 14 -




IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the day and year first above written.
W. R. BERKLEY CORPORATION
By:__________________________
Name: William R. Berkley
Title:     Executive Chairman
__________________________________
Grantee




RSU Agreement L12 Perf (8.2017)

- 15 -



EXHIBIT A
TO THE RESTRICTED STOCK UNIT AGREEMENT DATED
AS OF _________ UNDER THE W. R. BERKLEY CORPORATION
2012 STOCK INCENTIVE PLAN



NAME OF GRANTEE: ________________________________________

TARGET NUMBER OF TRANCHE 1 RESTRICTED STOCK UNITS AWARDED TO GRANTEE: _____________

TARGET NUMBER OF TRANCHE 2 RESTRICTED STOCK UNITS AWARDED TO GRANTEE: _____________

TARGET NUMBER OF TRANCHE 3 RESTRICTED STOCK UNITS AWARDED TO GRANTEE: _____________

TOTAL TARGET NUMBER OF RESTRICTED STOCK UNITS AWARDED TO GRANTEE: _____________



By accepting the terms and conditions of the above grant agreement, you expressly acknowledge that you have read and agree to all the terms and conditions set forth above.

If you decide to reject the terms and conditions of the grant, you will decline your right to receive the grant, and the grant of the Restricted Stock Units to you will be cancelled ab initio.

Please select one of the following actions. You will be asked to confirm your selection on the following page.

- 16 -



EXHIBIT B

JURISDICTION SPECIFIC MODIFICATIONS
I. States of the United States of America
A.     Arkansas, Connecticut, Illinois, Indiana, Maryland, Minnesota, South Carolina, South Dakota, Texas, and Virginia : Sections 3(e)(i) and 3(e)(ii) are further limited to situations where Grantee is performing services that are the same as or similar in function or purpose to the services Grantee performed for W. R. Berkley Corporation or its subsidiary/subsidiaries (as appropriate) during the Look Back Period.
B.     Arizona . For an Arizona resident, for so long as the Grantee resides in Arizona and is subject to the laws of Arizona: (i) the restrictions in Sections 3(e)(i), (ii), (iv) and (v) will only apply within any geographical area (x) where Grantee had responsibilities on behalf of the Company or about which Grantee received Confidential Information during the Look Back Period and (y) in which the Company is engaged in business; (ii) Sections 3(e)(i) and 3(e)(ii) are further limited to situations where Grantee is performing services that are the same as or similar in function or purpose to the services Grantee performed for W. R. Berkley Corporation or its subsidiary/subsidiaries (as appropriate) during the Look Back Period; and (iii) with respect to Grantee’s nondisclosure obligation under Section 3(e)(vi), Grantee’s nondisclosure obligation only extends during the Restricted Period (this is not a deviation from the text of the Agreement, but a clarification for the avoidance of any doubt).
C.     California . For a resident of California, for so long as Grantee resides in California and is subject to the laws of California: (i) no provision or requirement of this Agreement will be construed or interpreted in a manner contrary to the public policy of the State of California; (ii) the restrictions in Sections 3(e)(i) and (ii) shall not apply; (iii) Sections 3(e)(iv) and (v) shall be limited to situations where Grantee is aided in his or her conduct by Grantee’s use or disclosure of trade secrets (as defined by applicable law); (iv) the last sentence of Section (3)(g) shall not apply and the remainder of Section 3(g) shall apply; and (v) Section 14 shall not apply.
D.     Nebraska . For a Nebraska resident, for so long as Grantee resides in Nebraska and is subject to the laws of Nebraska: (i) Sections 3(e)(i) and (ii) shall not apply; and (ii) the definition of “Covered Business Partner” in Section 3(h) is modified so that it means any persons or entities with which Grantee, or persons supervised by Grantee, did business and had personal business-related contact during the Look Back Period.
E.     North Carolina . For a North Carolina resident, for so long as Grantee resides in North Carolina and is subject to the laws of North Carolina: (i) Sections 3(e)(i) and 3(e)(ii) are further limited to situations where Grantee is performing services that are the same as or similar in function or purpose to the services Grantee performed for W. R. Berkley Corporation or its subsidiary/subsidiaries (as appropriate) during the Look Back Period; and (ii) the Look Back Period shall be calculated looking back two years from the date of enforcement and not from the date employment ends.

- 17 -



F.     North Dakota . For a resident of North Dakota, for so long as Grantee resides in and is subject to the laws of North Dakota: (i) no provision or requirement of this Agreement will be construed or interpreted in a manner contrary to the public policy of the State of North Dakota; (ii) the restrictions in Sections 3(e)(i) and (ii) shall not apply; (iii) Sections 3(e)(iv) and (v) shall be limited to situations where Grantee is aided in his or her conduct by Grantee’s use or disclosure of trade secrets (as defined by applicable law); and (iv) the last sentence of Section (3)(g) shall not apply and the remainder of Section 3(g) shall apply.
G.     Oklahoma . For an Oklahoma resident, for so long as Grantee resides in Oklahoma and is subject to the laws of Oklahoma: the restrictions in Sections 3(e)(i) and (ii) shall not apply and “Covered Business Partner” of the Company means any individual, company, or business entity (including, without limitation, any Client) with which the Company has transacted business within the Look Back Period and with which Grantee, or persons supervised by Grantee, had material business-related contact or about which Grantee had access to Confidential Information during the Look Back Period.
H.      Wisconsin . For a Wisconsin resident, for so long as Grantee resides in Wisconsin and is subject to the laws of Wisconsin: (i) Sections 3(e)(i) and 3(e)(ii) are further limited to situations where Grantee is performing services that are the same as or similar in function or purpose to the services Grantee performed for W. R. Berkley Corporation or its subsidiary/subsidiaries (as appropriate) during the Look Back Period; and (ii) Section 3(e)(iii) is rewritten as follows: “participates in soliciting or attempting to solicit any employee of the Company that is in a Sensitive Position to leave the employment of the Company on behalf of (or for the benefit of) a competing business, or knowingly assists a competing business in efforts to hire such an employee away from the Company.  An employee in a “Sensitive Position” refers to an employee of the Company who is in a management, supervisory, sales, research and development, underwriting, claims, actuarial, loss control or similar role where the employee is provided Confidential Information or is involved in business dealings with the Company’s customers.”

- 18 -



II. Countries Other than the United States of America
Argentina . For an Argentinian resident, for so long as Grantee resides in Argentina and is subject to the laws of Argentina:
(i)      Section 19 shall be deleted in its entirety and replaced with the following:

“SECTION 19. Governing Law . This Agreement shall be construed and interpreted in accordance with the laws of Argentina. Grantee hereby irrevocably consents to the exclusive personal jurisdiction of the Argentine courts for the resolution of any disputes arising out of, or relating, to this Agreement.”
(ii)
This Agreement shall not be effective unless the Grantee physically signs an original Agreement.
Australia . For an Australian resident, for so long as Grantee resides in Australia and is subject to the laws of Australia:
(i)
Section 19 shall be deleted in its entirety and replaced with the following:

“SECTION 19. Governing Law . This Agreement shall be construed and interpreted in accordance with the laws of the State of New South Wales in Australia. Grantee hereby irrevocably consents to the personal jurisdiction of the federal and state courts of the State of New South Wales in Australia for the resolution of any disputes arising out of, or relating to, this Agreement.”

(ii)
The provisions in “Addendum for Australia, Canada, Hong Kong and Singapore” set forth below shall be applicable.
Brazil . For a Brazilian resident, for so long as Grantee resides in Brazil and is subject to the laws of Brazil:
A new sentence shall be added at the end of SECTION 18 as follows:
“The Grantee acknowledges that the provisions of this Agreement set forth above that supersede, replace and are added to previous restricted stock unit agreements are not detrimental in comparison to those provided in any previous restricted stock unit award agreements between the Grantee and the Company.”
Canada . For a Canadian resident, for so long as Grantee resides in Canada and is subject to the laws of Canada:
(i)
A new Section 24 shall be added as follows:

SECTION 24. Release . In consideration of the grant of the Restricted Stock Units from the Company to Grantee and a further cash payment of CAN$100 to be made to Grantee on a regular pay date as soon as administratively practicable after Grantee accepts such grant (the “ Consideration ”), and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the Grantee on behalf

- 19 -



of him or herself, his or her heirs, successors, administrators and assigns (hereinafter collectively referred to as the “ Releasor ”) hereby releases and forever discharges the Company, along with all parents, subsidiaries, affiliates and associated companies, and together with all respective officers, directors, employees, servants and agents and their successors and assigns (hereinafter collectively referred to as the “Releasee”) jointly and severally from any and all actions, causes of actions, contracts, covenants, whether express or implied of any nature and kind whatsoever, made under or in relation to the Restricted Stock Unit Agreement under the Plan including any claims for damages, contractual breach, indemnity, costs, interest, and/or claims for loss of every nature and kind whatsoever and howsoever arising which the Releasor may heretofore have had, may now have, or may hereinafter have, in any way relating to vested entitlements or grants of any kind under the Plan to the date of this Agreement and any and all matters raised or which could have been raised by the Grantor in relation to the Plan prior to entering into this Agreement. The Releasor further acknowledges, covenants and warrants that he or she has not filed with any Court, Commission, Tribunal or Agency or any other judicial or quasi-judicial body, any claim or complaint of the type described above, and that if such a claim or complaint has been filed, this Release and Indemnity, entered into freely and without duress, constitutes a full and final bar and/or answer to such claim or complaint. For clarity, the Releasor further agrees that he or she will take all necessary steps to ensure the withdrawal or dismissal of such claim or complaint. And for said consideration the Releasor further acknowledges, covenants and agrees that in the event that he or she should hereafter make any claim, or demand or take any action or proceeding against the Releasee in connection with any matter covered by this Release or threaten to do so, this document may be raised as an estoppel and complete bar to any such claim, demand, action or proceeding, and that the Releasor will be liable to the Releasee for its costs and expenses, including reasonable legal fees, incurred in responding thereto. And for said consideration, the Releasor further acknowledges, covenants and agrees that he or she shall not make any claim or demand or take any action or proceeding in connection with any matter covered by this Release against any other person or corporation who might claim contribution or indemnity from the Releasee by virtue of the said claim or proceeding. The Releasor agrees that, if any such claim, demand, action or proceeding is made by the Releasor against the Releasee, the Releasee may raise this document as an estoppel and complete bar to any such claim, demand, action or proceeding and that the Releasor will be liable to the Releasee for its costs and expenses, including reasonable legal fees, incurred in responding thereto. The Releasor acknowledges and agrees that he or she is executing these terms voluntarily and without duress after having been afforded the opportunity to obtain legal advice and having either received such advice or chosen not to do so.
(ii)
The provisions in “Addendum for Australia, Canada, Hong Kong and Singapore” set forth below shall be applicable.


- 20 -



Colombia . For a Colombian resident, for so long as Grantee resides in Colombia and is subject to the laws of Colombia:
Grantee agrees that the Restricted Stock Units rights derived from this Agreement are not consideration for the services rendered by the Grantee in Colombia. For this Agreement to be effective, the Grantee must enter into a local agreement, governed by Colombian laws, with Grantee’s current employer in which Grantee agrees to the statement in the prior sentence.
Hong Kong . For a Hong Kong resident, for so long as Grantee resides in Hong Kong and is subject to the laws of Hong Kong:

(i)
Section 2 shall be deleted in its entirety and replaced with the following:

SECTION 2. Non-Transferability . (a) Subject to Section 2(b) below and except as specifically consented to by the Committee, the Grantee may not sell, transfer, pledge, or otherwise encumber or dispose of the Restricted Stock Units other than by will, the laws of descent and distribution, or as otherwise provided for in the Plan.

(b) Notwithstanding any other provisions of this Agreement, if the Grantee resides in, or received this offer in Hong Kong, the Grantee shall have no rights or entitlement to sell, transfer or otherwise dispose of the Restricted Stock Units, except if such sale, transfer or disposal is permitted pursuant to the Plan and specifically consented to by the Committee.

(ii)
Section 23 is amended to add the following two paragraphs at the end thereof:

“The contents of this Agreement have not been reviewed by any regulatory authority in Hong Kong. You are advised to exercise caution in relation to the offer. If you are in any doubt about any of the contents of this Agreement, you should obtain independent professional advice.

This Agreement must not be issued, circulated or distributed in Hong Kong other than (1) to “professional investors” as defined in the Securities and Futures Ordinance (“SFO”) and any rules made under the SFO, (2) to persons and in circumstances which do not result in this Agreement being a “prospectus” as defined in section 2(1) of the CWMO or which do not constitute an offer to the public within the meaning of the Companies (Winding Up and Miscellaneous Provisions) Ordinance (“CWMO”) or an invitation to the public within the meaning of the SFO or (3) otherwise pursuant to, and in accordance with the conditions of, any other applicable provisions of the SFO and CWMO.”

(iii)
In addition to the grant of the Restricted Stock Units, the Company shall pay the Grantee a further cash payment of HK$700 to be made on a regular pay date as soon as administratively practicable after Grantee accepts such grant as further consideration for the agreement contained in the last sentence of Section 18.

- 21 -




(iv)
The provisions in “Addendum for Australia, Canada, Hong Kong and Singapore” set forth below shall be applicable.

Norway . For a Norwegian resident, for so long as Grantee resides in Norway and is subject to the laws of Norway:
(i)
In the third recital under WITNESSETH the words “or Solicitation” shall be added after the word “Misconduct”;

(ii)
In Section 3(d)A., the words “or Solicitation” shall be added after the word “Misconduct”;

(iii)
In Section 3(d)B., the phrase, “or (3) on or after the Vesting Date or within one year following Grantee’s termination of employment, has engaged in Solicitation,” shall be added after the phrase “until on or after the Vesting Date” in subsection (2) of Section 3(d)B;

(iv)
In Section 3(d)C., the phrase, “or (3) Solicitation” shall be added after the phrase “(2) Misconduct”;

(v)
In Section 3(d)C., the phrase, “or (z) engaged in Solicitation” shall be added after the phrase “(y) engaged in Misconduct,”;

(vi)
In Section 3(d)E., the words “or Solicitation” shall be added after the words “Misconduct,”;

(vii)
In Section 3(e), subsections (iv) and (v) shall be deleted and subsection (vi) shall be renumbered as subsection (iv); and

(viii)
In Section 3, the following new subsections shall be added after subsection (g):
“(h) For purposes of this Agreement, the Grantee has engaged in " Solicitation " if the Grantee during the term of employment, and for a period of 12 months after the expiry of the agreed notice period (alternatively from the date of summary dismissal), directly or indirectly (i) diverts, or attempts to divert, any person, concern or entity from doing business with the Company or attempts to induce any such person, concern or entity to cease being a customer of the Company, (ii) solicits the business of the Company or (iii) influences customers, suppliers and/or other business associates/contract parties of the Company or any subsidiary to limit or terminate their relationship with the Company and/or any subsidiary. With respect to customers, the preceding sentence only applies to customers which the Grantee has had contact with and/or responsibility for during the last 12 months prior to the time of the written statement as mentioned below.
(i) The Company may, upon the request from the Grantee and in connection with termination, summary dismissal or other cessation of employment, decide whether

- 22 -



and to what extent the Grantee’s obligation to refrain from Solicitation shall be invoked. With respect to customers, the procedure in connection with such a decision shall comply with the mandatory provisions of Chapter 14A in the Norwegian Working Environment Act, including the specification of which customers are covered by the Grantee’s obligation to refrain from Solicitation in a written statement.”
Singapore . For a Singaporean resident, for so long as Grantee resides in Singapore and is subject to the laws of the Republic of Singapore:
(i)
In Section 3(d)B., the phrase “that, in the Committee’s sole and absolute discretion, reflects the seriousness of the Competitive Action and/or the Misconduct. The maximum amount that the Company may demand from the Grantee is” shall be added after the words “an amount” in subsection (2) of Section 3(d)B;

(ii)
    In Section 3(d)B, the last sentence shall be deleted and replaced with the following sentence:

“The Grantee may satisfy the payment obligation to the Company, in whole or in part (as the case may be), by returning the shares delivered to the Grantee on the Settlement Date.";

(iii)
    In Section 3(d)C., the following sentence shall be deleted:

“The amounts forfeited or paid to the Company hereunder do not and are not intended to constitute actual or liquidated damages.”;

(iv)
    In Section 3(g), the last sentence shall be deleted;

(v)
    Section 19 shall be deleted in its entirety and replaced with the following:
“SECTION 19. Governing Law . This Agreement shall be construed and interpreted in accordance with the laws of the State of Delaware. Grantee hereby irrevocably consents to the personal jurisdiction of the courts of the Republic of Singapore for the resolution of any disputes arising out of, or relating to, this Agreement.”
(vi)
    The provisions in “Addendum for Australia, Canada, Hong Kong and Singapore” set forth below shall be applicable.

United Kingdom. For a United Kingdom resident, for so long as Grantee resides in the United Kingdom and is subject to the laws of England and Wales or if the Grantee is employed under an employment contract which is governed by English law at the time of grant of the Restricted Stock Units: (i) delete the parenthetical phrase in the third recital under “WITNESSETH” and (ii) the following terms and provisions shall amend and supersede the terms and provisions of Section 3(b), (d), (e), (f), (g) and (h) and Section 19 of this Agreement as follows:



- 23 -



1.     TERMINATION OF EMPLOYMENT
With effect from the earlier of the date of termination of the Grantee’s employment or the date that the Grantee gives or receives notice of termination of the Grantee’s employment for any reason, any unvested Restricted Stock Units shall lapse and be forfeited (except for those that vest immediately upon termination as set out in Section 3(a) of this Agreement and subject to the forfeiture provisions in paragraph 3 below) and the Grantee shall have no further rights with respect to any such unvested Restricted Stock Units.
2.
RESTRICTIVE COVENANTS
2.1
The Grantee covenants with the Company and the Group that the Grantee will not, save with the prior written consent of the Committee (in its absolute discretion):
2.1.1.
during the Restricted Period directly or indirectly be employed, engaged or retained by or otherwise concerned or interested in any Competing Business. For this purpose, the Grantee is directly or indirectly employed, engaged or retained by or concerned or interested in a Competing Business if:
(a)    the Grantee carries it on as principal or agent; or
(b)
the Grantee is a partner, director, employee, secondee, consultant or agent in, of or to any person who carries on the Competing Business;
(c)
the Grantee has any direct or indirect financial interest (as shareholder, creditor or otherwise) in any person who carries on the Competing Business; and/or
(d)
the Grantee is a partner, director, employee, secondee, consultant or agent in, of or to any person who has a direct or indirect financial interest (as shareholder, creditor or otherwise) in any person who carries on the Competing Business,
disregarding any financial interest the Grantee may have in securities which are listed or dealt in on a recognised investment exchange if the Grantee is interested in securities which amount to less than 3% of the issued securities of that class and which, in all circumstances, carry less than 3% of the voting rights (if any) attaching to the issued securities of that class;
2.1.2
during the Restricted Period and whether directly or indirectly, either alone or with or on behalf of any person, firm, company or entity and whether on his or her own account or as principal, partner, shareholder, director, employee, consultant or in any other capacity whatsoever, have any business dealings with any Client or Prospective Client in relation to or for the benefit of a Competing Business;    
2.1.3
during the Restricted Period and whether directly or indirectly, either alone or with or on behalf of any person, firm, company or entity and whether on his or her own account or as principal, partner, shareholder, director, employee, consultant or in any other capacity whatsoever, canvass or solicit business or custom from or seek to entice away any Client

- 24 -



or Prospective Client from the Company or any Group Company in relation to or for the benefit of a Competing Business;
2.1.4
during the Restricted Period, directly or indirectly, solicit or endeavour to solicit the employment or engagement of any Key Employee (whether or not such person would thereby breach their contract of employment or engagement);
2.1.5
at any time after the Termination Date represent himself as being in any way connected with (other than as a former employee) or interested in the business of the Company or any Group Company or use any registered names, domain names or trading names the same as or that could reasonably be expected to be confused with any such names used by the Company or any Group Company.
2.1.6
before or after the Termination Date, and except in the proper performance of his or her duties of employment by the Company or any Group Company, directly or indirectly use for his or her own purposes or those of a third party or disclose to any third party any Confidential Information. The Grantee will use his or her best endeavours to prevent any unauthorised use or disclosure of Confidential Information. The obligations contained in this clause 2.1.6 will not apply to any disclosures required by law or to any information or documents which after the Termination Date are in the public domain other than by way of unauthorised disclosure.
2.2
The Grantee gives the covenants above to the Company as trustee for itself (and any company forming part of the Group).
2.3
Each restriction contained in this clause 2 is an entirely separate and independent restriction, despite the fact that they may be contained in the same phrase, and if any part is found to be unenforceable the remainder will remain valid and enforceable.
2.4
While the restrictions in this clause 2 are considered by the parties to be fair and reasonable in the circumstances, it is agreed that if any such restriction should be held to be void or ineffective for any reason but would be treated as valid and effective if some part of parts of the restriction were deleted, the restriction in question will apply with such deletion as may be necessary to make it valid and effective.
2.5
If, during the Grantee’s employment or any period during which these restrictions apply, any person, firm, company or entity offers the Grantee any employment, engagement, arrangement or contract which might or would cause him or her to breach any of the restrictions, he or she will notify that person, firm, company or entity of the terms of these restrictions.
2.6
The period of any restraint on the Grantee’s activities after the Termination Date imposed pursuant to clauses 2.1.1 to 2.1.4 shall be reduced pro rata by any period of garden leave served by the Grantee pursuant to his or her service agreement with the Company or any Group Company.

- 25 -



2.7
If the Grantee breaches any of the covenants contained in clauses 2.1.1 to 2.1.6, then any unvested Restricted Stock Units will lapse with immediate effect and the Grantee will be obliged to return all shares of Company stock issued or issuable in respect of Restricted Stock Units which have vested within the three years immediately preceding the breach or their equivalent value (determined by reference to the date of vesting) granted under this Agreement or any Prior Agreement to the Company within 14 days of being notified by the Company of its discovery of the breach.
2.8
In this clause, the following definitions shall apply:
“Client”

means any person, firm, company or other business entity whom or which during the Relevant Period:
(a) to whom the Company or any Group Company provided insurance or reinsurance; or
(b) was an insurance intermediary which introduced such insurance or reinsurance business to the Company or any Group Company,
and in each case with whom or which during the Relevant Period:
i)      the Grantee (or any person reporting to the Grantee) had Material Dealings in relation to Relevant Business; or
ii)      about whom or which the Grantee has had Confidential Information during the course of his or her employment.
“Competing Business”
means any business which at any time is in or which intends to be in competition with any Relevant Business.

- 26 -



“Confidential Information”
means any and all information which is of a confidential nature or which the Company reasonably regards as being confidential or a trade secret concerning the business, business performance or prospective business, financial information or arrangements, plans or internal affairs of the Company, any Group Company or any of their respective Clients or Prospective Clients including without prejudice to the generality of the foregoing all information, records and materials relating to:
(1)      underwriting premiums or quotes, income and receipts, claims records and levels, renewals, policy wording and terms, reinsurance quotas, profit commission;
(2)      syndicate or other business projections and forecasts;
(3)      Client lists, brokers lists and price sensitive information;
(4)      technical information, reports, interpretations, forecasts, corporate and business plans and accounts, business methods, financial details, projections and targets;
(5)      remuneration and personnel details;
(6)      planned products, planned services, marketing surveys, research reports, market share and pricing statistics, budgets, fee levels;
(7)      computer passwords, the contents of any databases, tables, know how documents or materials;
(8)      commissions, commission charges, pricing policies and all information about research and development; and
(9)      the Company’s or any Group Company’s suppliers’, Clients’ or Prospective Clients’ names, addresses (including email addresses), telephone, facsimile or other contact numbers and contact names, the nature of their business operations, their requirements for services supplied by the Company or any Group Company and all confidential aspects of their relationship with the Company or any Group Company.

- 27 -



“directly or indirectly”
means (without prejudice to the generality of the expression) either alone or jointly with or on behalf of any other person and whether on his or her own account or in partnership with another or others or as the holder of any interest in or as officer, employee or agent of or consultant to any other person.
“Group”
means the Company, its subsidiaries or holding companies from time to time and any subsidiary of any holding company from time to time; and “Group Company” means any company within the Group.
“Key Employee”
means any director or officer of the Company or any Group Company and/or any employee (other than administrative or clerical personnel) of the Company or any Group Company, in each case who, at any time during the Relevant Period:
i)      was employed by the Company or any Group Company; and
ii)      with whom the Grantee has had Material Dealings or exercised control or had management responsibility for; and/or
iii)      has had access to or has obtained Confidential Information during the Relevant Period.
“Material Dealings”
means receiving orders, instructions or enquiries from, contracting or making preparations to contract with, making sales or presenting to or with, tendering for business from, having responsibility with or for, having personal knowledge of or otherwise having significant other contact.
“Prior Agreements”
means any previous restricted stock unit award agreement between Grantee and the Company whether the awards under those agreements have vested or are unvested.

- 28 -



“Prospective Client”

means any person, firm, company or other business entity who was at any time during the Relevant Period:
(a) in negotiations with the Company or any Group Company for the provision of insurance or reinsurance; or
(b) an insurance intermediary who may introduce such insurance or reinsurance business to the Company or any Group Company,
and in each case with whom or which during the Relevant Period:
i)      the Grantee (or any person reporting to the Grantee) had Material Dealings in relation to Relevant Business; or
ii)      about whom or which the Grantee has had Confidential Information during the course of Grantee’s employment.
Provided that this definition shall not apply to any such person, firm, company or other business entity which has withdrawn from or discontinued such negotiations or discussions, having stated its intention to do so (other than through any unlawful activity by the Grantee).
“Relevant Business”
means any class or classes of insurance or reinsurance business which was underwritten in the twelve months immediately prior to the Termination Date by the Company or any Group Company and with which the Grantee was directly or indirectly materially concerned or involved or had personal knowledge in the course of Grantee’s duties during the Relevant Period.
“Relevant Period”
means (1) during employment, the twelve month period immediately prior to the action or activity that may be in breach of clauses 2.1.1 to 2.1.4 and (2) after termination of employment, the twelve month period immediately prior to the Termination Date.
“Restricted Period”
means the period beginning on the date hereof and ending one year following the Termination Date.
Termination Date”

means the date on which the Grantee’s employment or engagement with the Company terminates for any reason.

3.
CLAWBACK

- 29 -



3.1
If at any time after any Restricted Stock Units have vested under the terms of this Agreement the Committee becomes aware of any material wrongdoing, negligence or misconduct on the part of the Grantee that would have entitled the Company to terminate the Grantee's employment with or without notice for Cause, any unvested Restricted Stock Units will lapse with immediate effect and the Company will be entitled, in its absolute discretion, to recover from the Grantee up to 100% of the shares of Company common stock issued or issuable in respect of the Restricted Stock Units (which have vested within the 7 years prior to such determination by the Committee) or their equivalent value (determined by reference to the date of vesting) granted under this Agreement or any Prior Agreement to the Company within 14 days of being notified in writing by the Company of its discovery of the material wrongdoing, negligence or misconduct.
3.2
Clause 3.1 is without prejudice to the Company's other remedies for such wrongdoing or any other clawback policy that the Company may adopt from time to time as required by applicable laws or the applicable listing rules of any securities exchange.
3.3
The Committee may review any Restricted Stock Units granted to the Grantee under the terms of this Agreement, in light of:
a.
there being a significant deterioration in the financial health of the Company, the Group or the business area or team in which the Grantee worked;
b.
the Grantee having caused harm to the reputation of the Company or the Group;
c.
the Grantee having deliberately misled the Company in relation to the financial performance of the Company, the Group or the business area or team in which he or she worked; and/or
d.
the Grantee’s actions having amounted to gross misconduct, incompetence or negligence.
Following a review, the Committee may, in its sole discretion, determine that up to 100% of any unvested Restricted Stock Units granted under this Agreement or any Prior Agreement will lapse with immediate effect and, in addition, the Company will be entitled in its absolute discretion to recover from the Grantee up to 100% of the shares issued or issuable on the vesting of the Restricted Stock Units granted under this Agreement or any Prior Agreement (which have vested within the 7 years prior to such determination by the Committee) or their equivalent value (determined by reference to the date of vesting).
3.4
The Grantee agrees that any sums owed to the Company or any Group Company under this Agreement including any adjustment, forfeiture or repayment may be deducted from any sums due to the Grantee from the Company or any Group Company. For the avoidance of doubt, this is without prejudice to any right the Company or the Group may have at any time to recover any sums from the Grantee and the Grantee agrees that such sums are recoverable by the Company or any Group Company as a debt.

- 30 -



3.5
In this Clause 3, “Cause” means:
a.
any serious negligence or gross misconduct by the Grantee in connection with or affecting the business or affairs of the Company or any member of the Group;
b.
the Grantee being convicted of any arrestable offence other than an offence under road traffic legislation in the UK; or
c.
the Grantee being convicted of an offence under any statutory enactment or regulation relating to insider dealing or market abuse.

4.      CHOICE OF LAW
4.1
Any dispute or claim (including non-contractual disputes or claims) arising out of or in connection with this Agreement or its subject matter or formation shall be governed by and construed in accordance with the law of England and Wales.
5.    ARBITRATION
5.1
If at any time any dispute or question shall arise between the parties arising out of or in connection with this Agreement or its or their validity, construction or performance then the same shall be referred to and finally resolved by arbitration under the London Court of International Arbitration Rules, which Rules are deemed to be incorporated by reference into this clause.
The number of arbitrators shall be three.
The seat, or legal place, of arbitration shall be London, England.
The language to be used in the arbitral proceedings shall be English.
The governing law of the contract shall be the substantive law of England and Wales.
Addendum for Australia, Canada, Hong Kong and Singapore. For residents of Australia, Canada, Hong Kong or Singapore, for so long as Grantee resides in his or her respective country and is subject to the laws of such country, Sections 3(e) and (h) shall be deleted and replaced as follows:
(e)    The Grantee covenants with the Company and the Group that the Grantee will not, save with the prior written consent of the Committee (in its absolute discretion):
A.
during the Restricted Period, directly or indirectly, be employed, engaged or retained by or otherwise concerned or interested in any Competing Business. For this purpose, the Grantee is directly or indirectly employed, engaged or retained by or concerned or interested in a Competing Business if:
(i)    the Grantee carries it on as principal or agent; or

- 31 -



(ii)
the Grantee is a partner, director, employee, secondee, consultant or agent in, of or to any person who carries on the Competing Business;
(iii)
the Grantee has any direct or indirect financial interest (as shareholder, creditor or otherwise) in any person who carries on the Competing Business; and/or
(iv)
the Grantee is a partner, director, employee, secondee, consultant or agent in, of or to any person who has a direct or indirect financial interest (as shareholder, creditor or otherwise) in any person who carries on the Competing Business,
disregarding any financial interest the Grantee may have in securities which are listed or dealt in on a recognised investment exchange if the Grantee is interested in securities which amount to less than 3% of the issued securities of that class and which, in all circumstances, carry less than 3% of the voting rights (if any) attaching to the issued securities of that class;
B.
during the Restricted Period and whether directly or indirectly, either alone or with or on behalf of any person, firm, company or entity and whether on his or her own account or as principal, partner, shareholder, director, employee, consultant or in any other capacity whatsoever, have any business dealings with any Client or Prospective Client in relation to or for the benefit of a Competing Business;    
C.
during the Restricted Period and whether directly or indirectly, either alone or with or on behalf of any person, firm, company or entity and whether on his or her own account or as principal, partner, shareholder, director, employee, consultant or in any other capacity whatsoever, canvass or solicit business or custom from or seek to entice away any Client or Prospective Client from the Company or any Group Company in relation to or for the benefit of a Competing Business;
D.
during the Restricted Period, directly or indirectly, solicit or endeavour to solicit the employment or engagement of any Key Employee (whether or not such person would thereby breach their contract of employment or engagement);
E.
at any time after the Termination Date represent himself or herself as being in any way connected with (other than as a former employee) or interested in the business of the Company or any Group Company or use any registered names, domain names or trading names the same as or that could reasonably be expected to be confused with any such names used by the Company or any Group Company.
F.
before or after the Termination Date and except in the proper performance of his or her duties of employment for the Company or Group Company directly or indirectly use for his or her own purposes or those of a third party or disclose to any third party any Confidential Information. The Grantee will use his or her best endeavours to prevent any unauthorised use or disclosure of Confidential Information. The obligations contained in this subsection F will not apply to any disclosures required by law or to any information or documents which after the Termination Date are in the public domain other than by way of unauthorised disclosure.

- 32 -



The Grantee gives the covenants above to the Company as trustee for itself (and any company forming part of the Group).
Each restriction contained in this Section 3(e) is an entirely separate and independent restriction, despite the fact that they may be contained in the same phrase, and if any part is found to be unenforceable the remainder will remain valid and enforceable.
While the restrictions in this Section 3(e) are considered by the parties to be fair and reasonable in the circumstances, it is agreed that if any such restriction should be held to be void or ineffective for any reason but would be treated as valid and effective if some part of parts of the restriction were deleted, the restriction in question will apply with such deletion as may be necessary to make it valid and effective.
The period of any restraint on the Grantee’s activities after the Termination Date imposed pursuant to sub-section A to D of Section 3(e) shall be reduced pro rata by any period of garden leave served by the Grantee pursuant to his or her service agreement with the Company or any Group Company.
The determination as to whether the Grantee has engaged in a Competitive Action shall be made by the Committee in its sole and absolute discretion. The Committee has sole and absolute discretion to determine whether, notwithstanding its determination that Grantee has engaged in a Competitive Action, recapture or forfeiture as provided herein shall not occur. The Committee’s exercise or nonexercise of its discretion with respect to any particular event or occurrence by or with respect to the Grantee or any other recipient of restricted stock units shall not in any way reduce or eliminate the authority of the Committee to (i) determine that any event or occurrence by or with respect to the Grantee constitutes engaging in a Competitive Action or (ii) determine the related Competitive Action date.
In this Agreement, the following definitions shall apply:

- 33 -



“Client”

means any person, firm, company or other business entity whom or which during the Relevant Period:
(a) to whom the Company or any Group Company provided insurance or reinsurance; or
(b) was an insurance intermediary which introduced such insurance or reinsurance business to the Company or any Group Company,
and in each case with whom or which during the Relevant Period:
i)      the Grantee (or any person reporting to the
Grantee) had Material Dealings in relation to Relevant Business; or
ii)      about whom or which the Grantee has had Confidential Information during the course of his or her employment.

“Competitive Action”
means any of the activities, individually or in the aggregate, described in sub-sections A through F of Section 3(e).
“Competing Business”
means any business which at any time is in or which intends to be in competition with any Relevant Business.

- 34 -



“Confidential Information”
means any and all information which is of a confidential nature or which the Company reasonably regards as being confidential or a trade secret concerning the business, business performance or prospective business, financial information or arrangements, plans or internal affairs of the Company, any Group Company or any of their respective Clients or Prospective Clients including without prejudice to the generality of the foregoing all information, records and materials relating to:
(1)      underwriting premiums or quotes, income and receipts, claims records and levels, renewals, policy wording and terms, reinsurance quotas, profit commission;
(2)      syndicate or other business projections and forecasts;
(3)      Client lists, brokers lists and price sensitive information;
(4)      technical information, reports, interpretations, forecasts, corporate and business plans and accounts, business methods, financial details, projections and targets;
(5)      remuneration and personnel details;
(6)      planned products, planned services, marketing surveys, research reports, market share and pricing statistics, budgets, fee levels;
(7)      computer passwords, the contents of any databases, tables, know how documents or materials;
(8)      commissions, commission charges, pricing policies and all information about research and development; and
(9)      the Company’s or any Group Company’s suppliers’, Clients’ or Prospective Clients’ names, addresses (including email addresses), telephone, facsimile or other contact numbers and contact names, the nature of their business operations, their requirements for services supplied by the Company or any Group Company and all confidential aspects of their relationship with the Company or any Group Company.

- 35 -



“directly or indirectly”
means (without prejudice to the generality of the expression) either alone or jointly with or on behalf of any other person and whether on his or her own account or in partnership with another or others or as the holder of any interest in or as officer, employee or agent of or consultant to any other person.
“Group”
means the Company, its subsidiaries or holding companies from time to time and any subsidiary of any holding company from time to time; and “Group Company” means any company within the Group.
“Key Employee”
means any director or officer of the Company or any Group Company and/or any employee (other than administrative or clerical personnel) of the Company or any Group Company, in each case who, at any time during the Relevant Period:
i)      was employed by the Company or any Group
Company; and
ii)      with whom the Grantee has had Material Dealings or exercised control or had management responsibility for; and/or
iii)      has had access to or has obtained Confidential Information during the Relevant Period.
“Material Dealings”
means receiving orders, instructions or enquiries from, contracting or making preparations to contract with, making sales or presenting to or with, tendering for business from, having responsibility with or for, having personal knowledge of or otherwise having significant other contact.

- 36 -



“Prospective Client”

means any person, firm, company or other business entity who was at any time during the Relevant Period:
(a) in negotiations with the Company or any Group Company for the provision of insurance or reinsurance; or
(b) an insurance intermediary who may introduce such insurance or reinsurance business to the Company or any Group Company,
and in each case with whom or which during the Relevant Period:
i)      the Grantee (or any person reporting to the
Grantee) had Material Dealings in relation to Relevant Business; or
ii)      about whom or which the Grantee has had Confidential Information during the course of Grantee’s employment.
Provided that this definition shall not apply to any such person, firm, company or other business entity which has withdrawn from or discontinued such negotiations or discussions, having stated its intention to do so (other than through any unlawful activity by the Grantee).
“Relevant Business”
means any class or classes of insurance or reinsurance business which was underwritten in the twelve months immediately prior to the Termination Date by the Company or any Group Company and with which the Grantee was directly or indirectly materially concerned or involved or had personal knowledge in the course of Grantee’s duties during the Relevant Period.
“Relevant Period”
means (1) during employment, the twelve month period immediately prior to the action or activity that may be in breach of clauses 2.1.1 to 2.1.4 and (2) after termination of employment, the twelve month period immediately prior to the Termination Date.
Termination Date”
means the date on which the Grantee’s employment or engagement with the Company terminates for any reason.



- 37 -


Exhibit 31.1
CERTIFICATIONS
I, W. Robert Berkley, Jr., President and Chief Executive Officer of W. R. Berkley Corporation (the “registrant”), certify that:
1. I have reviewed this quarterly report on Form 10-Q of the registrant;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d) disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
Date: November 8, 2017

 
/s/ W. Robert Berkley, Jr.
 
W. Robert Berkley, Jr.
 
President and
Chief Executive Officer 




Exhibit 31.2
CERTIFICATIONS
I, Richard M. Baio, Senior Vice President - Chief Financial Officer and Treasurer of W. R. Berkley Corporation (the “registrant”), certify that:
1. I have reviewed this quarterly report on Form 10-Q of the registrant;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d) disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
Date: November 8, 2017

 
/s/ Richard M. Baio
 
Richard M. Baio
 
Senior Vice President — Chief Financial Officer and Treasurer





Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of W. R. Berkley Corporation (the “Company”) on Form 10-Q for the period ended September 30, 2017 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), we, W. Robert Berkley, Jr., President and Chief Executive Officer of the Company, and Richard M. Baio, Senior Vice President - Chief Financial Officer and Treasurer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that:
(1)
The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
/s/ W. Robert Berkley, Jr.
 
W. Robert Berkley, Jr.
President and Chief Executive Officer
 
/s/ Richard M. Baio
 
Richard M. Baio
Senior Vice President — Chief Financial Officer and Treasurer
November 8, 2017
A signed original of this written statement required by Section 906 has been provided to W. R. Berkley Corporation (the “Company”) and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.